id	sid	tid	token	lemma	pos
ajlm-1028	1	1	abstract	abstract	ADJ
ajlm-1028	1	2	introduction	introduction	NOUN
ajlm-1028	1	3	methods	method	NOUN
ajlm-1028	1	4	results	result	VERB
ajlm-1028	1	5	discussion	discussion	NOUN
ajlm-1028	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1028	1	7	references	reference	NOUN
ajlm-1028	1	8	about	about	ADP
ajlm-1028	1	9	the	the	DET
ajlm-1028	1	10	author(s	author(s	NOUN
ajlm-1028	1	11	)	)	PUNCT
ajlm-1028	1	12	wanda	wanda	PROPN
ajlm-1028	1	13	s.	s.	PROPN
ajlm-1028	1	14	tshabalala	tshabalala	PROPN
ajlm-1028	1	15	department	department	PROPN
ajlm-1028	1	16	of	of	ADP
ajlm-1028	1	17	internal	internal	ADJ
ajlm-1028	1	18	medicine	medicine	NOUN
ajlm-1028	1	19	,	,	PUNCT
ajlm-1028	1	20	grey	grey	PROPN
ajlm-1028	1	21	’s	’s	PART
ajlm-1028	1	22	hospital	hospital	NOUN
ajlm-1028	1	23	,	,	PUNCT
ajlm-1028	1	24	university	university	NOUN
ajlm-1028	1	25	of	of	ADP
ajlm-1028	1	26	kwazulu	kwazulu	PROPN
ajlm-1028	1	27	-	-	PUNCT
ajlm-1028	1	28	natal	natal	PROPN
ajlm-1028	1	29	,	,	PUNCT
ajlm-1028	1	30	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	1	31	,	,	PUNCT
ajlm-1028	1	32	south	south	PROPN
ajlm-1028	1	33	africa	africa	PROPN
ajlm-1028	1	34	somasundram	somasundram	PROPN
ajlm-1028	1	35	pillay	pillay	PROPN
ajlm-1028	1	36	department	department	PROPN
ajlm-1028	1	37	of	of	ADP
ajlm-1028	1	38	internal	internal	ADJ
ajlm-1028	1	39	medicine	medicine	NOUN
ajlm-1028	1	40	,	,	PUNCT
ajlm-1028	1	41	edendale	edendale	ADJ
ajlm-1028	1	42	hospital	hospital	NOUN
ajlm-1028	1	43	,	,	PUNCT
ajlm-1028	1	44	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	1	45	complex	complex	NOUN
ajlm-1028	1	46	,	,	PUNCT
ajlm-1028	1	47	university	university	NOUN
ajlm-1028	1	48	of	of	ADP
ajlm-1028	1	49	kwazulu	kwazulu	PROPN
ajlm-1028	1	50	-	-	PUNCT
ajlm-1028	1	51	natal	natal	PROPN
ajlm-1028	1	52	,	,	PUNCT
ajlm-1028	1	53	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	1	54	,	,	PUNCT
ajlm-1028	1	55	south	south	PROPN
ajlm-1028	1	56	africa	africa	PROPN
ajlm-1028	1	57	douglas	douglas	PROPN
ajlm-1028	1	58	p.k	p.k	PROPN
ajlm-1028	1	59	.	.	PROPN
ajlm-1028	1	60	wilson	wilson	PROPN
ajlm-1028	1	61	department	department	PROPN
ajlm-1028	1	62	of	of	ADP
ajlm-1028	1	63	internal	internal	ADJ
ajlm-1028	1	64	medicine	medicine	NOUN
ajlm-1028	1	65	,	,	PUNCT
ajlm-1028	1	66	edendale	edendale	ADJ
ajlm-1028	1	67	hospital	hospital	NOUN
ajlm-1028	1	68	,	,	PUNCT
ajlm-1028	1	69	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	1	70	complex	complex	NOUN
ajlm-1028	1	71	,	,	PUNCT
ajlm-1028	1	72	university	university	NOUN
ajlm-1028	1	73	of	of	ADP
ajlm-1028	1	74	kwazulu	kwazulu	PROPN
ajlm-1028	1	75	-	-	PUNCT
ajlm-1028	1	76	natal	natal	PROPN
ajlm-1028	1	77	,	,	PUNCT
ajlm-1028	1	78	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	1	79	,	,	PUNCT
ajlm-1028	1	80	south	south	PROPN
ajlm-1028	1	81	africa	africa	PROPN
ajlm-1028	1	82	citation	citation	PROPN
ajlm-1028	1	83	tshabalala	tshabalala	PROPN
ajlm-1028	1	84	ws	ws	PROPN
ajlm-1028	1	85	,	,	PUNCT
ajlm-1028	1	86	pillay	pillay	PROPN
ajlm-1028	1	87	s	s	PROPN
ajlm-1028	1	88	,	,	PUNCT
ajlm-1028	1	89	wilson	wilson	PROPN
ajlm-1028	1	90	dpk	dpk	PROPN
ajlm-1028	1	91	.	.	PUNCT
ajlm-1028	2	1	diagnostic	diagnostic	ADJ
ajlm-1028	2	2	outcomes	outcome	NOUN
ajlm-1028	2	3	of	of	ADP
ajlm-1028	2	4	bone	bone	NOUN
ajlm-1028	2	5	marrow	marrow	NOUN
ajlm-1028	2	6	aspirate	aspirate	NOUN
ajlm-1028	2	7	and	and	CCONJ
ajlm-1028	2	8	trephine	trephine	NOUN
ajlm-1028	2	9	biopsies	biopsy	NOUN
ajlm-1028	2	10	performed	perform	VERB
ajlm-1028	2	11	at	at	ADP
ajlm-1028	2	12	a	a	DET
ajlm-1028	2	13	hospital	hospital	NOUN
ajlm-1028	2	14	in	in	ADP
ajlm-1028	2	15	kwazulu	kwazulu	NOUN
ajlm-1028	2	16	-	-	PUNCT
ajlm-1028	2	17	natal	natal	ADJ
ajlm-1028	2	18	,	,	PUNCT
ajlm-1028	2	19	south	south	PROPN
ajlm-1028	2	20	africa	africa	PROPN
ajlm-1028	2	21	.	.	PUNCT
ajlm-1028	3	1	afr	afr	PROPN
ajlm-1028	3	2	j	j	PROPN
ajlm-1028	3	3	lab	lab	PROPN
ajlm-1028	3	4	med	me	VERB
ajlm-1028	3	5	.	.	PUNCT
ajlm-1028	3	6	2020;9(1	2020;9(1	NUM
ajlm-1028	3	7	)	)	PUNCT
ajlm-1028	3	8	,	,	PUNCT
ajlm-1028	3	9	a1028	a1028	PROPN
ajlm-1028	3	10	.	.	PUNCT
ajlm-1028	4	1	https://doi.org/10.4102/ajlm.v9i1.1028	https://doi.org/10.4102/ajlm.v9i1.1028	ADJ
ajlm-1028	4	2	original	original	ADJ
ajlm-1028	4	3	research	research	NOUN
ajlm-1028	4	4	diagnostic	diagnostic	ADJ
ajlm-1028	4	5	outcomes	outcome	NOUN
ajlm-1028	4	6	of	of	ADP
ajlm-1028	4	7	bone	bone	NOUN
ajlm-1028	4	8	marrow	marrow	NOUN
ajlm-1028	4	9	aspirate	aspirate	NOUN
ajlm-1028	4	10	and	and	CCONJ
ajlm-1028	4	11	trephine	trephine	NOUN
ajlm-1028	4	12	biopsies	biopsy	NOUN
ajlm-1028	4	13	performed	perform	VERB
ajlm-1028	4	14	at	at	ADP
ajlm-1028	4	15	a	a	DET
ajlm-1028	4	16	hospital	hospital	NOUN
ajlm-1028	4	17	in	in	ADP
ajlm-1028	4	18	kwazulu	kwazulu	NOUN
ajlm-1028	4	19	-	-	PUNCT
ajlm-1028	4	20	natal	natal	ADJ
ajlm-1028	4	21	,	,	PUNCT
ajlm-1028	4	22	south	south	PROPN
ajlm-1028	4	23	africa	africa	PROPN
ajlm-1028	4	24	wanda	wanda	PROPN
ajlm-1028	4	25	s.	s.	PROPN
ajlm-1028	4	26	tshabalala	tshabalala	PROPN
ajlm-1028	4	27	,	,	PUNCT
ajlm-1028	4	28	somasundram	somasundram	PROPN
ajlm-1028	4	29	pillay	pillay	PROPN
ajlm-1028	4	30	,	,	PUNCT
ajlm-1028	4	31	douglas	douglas	PROPN
ajlm-1028	4	32	p.k	p.k	PROPN
ajlm-1028	4	33	.	.	PROPN
ajlm-1028	4	34	wilson	wilson	PROPN
ajlm-1028	4	35	received	receive	VERB
ajlm-1028	4	36	:	:	PUNCT
ajlm-1028	4	37	12	12	NUM
ajlm-1028	4	38	apr	apr	NOUN
ajlm-1028	4	39	.	.	PROPN
ajlm-1028	4	40	2019	2019	NUM
ajlm-1028	4	41	;	;	PUNCT
ajlm-1028	4	42	accepted	accept	VERB
ajlm-1028	4	43	:	:	PUNCT
ajlm-1028	4	44	26	26	NUM
ajlm-1028	4	45	nov	nov	PROPN
ajlm-1028	4	46	.	.	PROPN
ajlm-1028	4	47	2019	2019	NUM
ajlm-1028	4	48	;	;	PUNCT
ajlm-1028	4	49	published	publish	VERB
ajlm-1028	4	50	:	:	PUNCT
ajlm-1028	4	51	25	25	NUM
ajlm-1028	4	52	feb	feb	X
ajlm-1028	4	53	.	.	PROPN
ajlm-1028	4	54	2020	2020	NUM
ajlm-1028	5	1	copyright	copyright	NOUN
ajlm-1028	5	2	:	:	PUNCT
ajlm-1028	5	3	©	©	PROPN
ajlm-1028	5	4	2020	2020	NUM
ajlm-1028	5	5	.	.	PUNCT
ajlm-1028	6	1	the	the	DET
ajlm-1028	6	2	author(s	author(s	PROPN
ajlm-1028	6	3	)	)	PUNCT
ajlm-1028	6	4	.	.	PUNCT
ajlm-1028	7	1	licensee	licensee	NOUN
ajlm-1028	7	2	:	:	PUNCT
ajlm-1028	7	3	aosis	aosis	NOUN
ajlm-1028	7	4	.	.	PUNCT
ajlm-1028	8	1	this	this	PRON
ajlm-1028	8	2	is	be	AUX
ajlm-1028	8	3	an	an	DET
ajlm-1028	8	4	open	open	ADJ
ajlm-1028	8	5	access	access	NOUN
ajlm-1028	8	6	article	article	NOUN
ajlm-1028	8	7	distributed	distribute	VERB
ajlm-1028	8	8	under	under	ADP
ajlm-1028	8	9	the	the	DET
ajlm-1028	8	10	terms	term	NOUN
ajlm-1028	8	11	of	of	ADP
ajlm-1028	8	12	the	the	DET
ajlm-1028	8	13	creative	creative	ADJ
ajlm-1028	8	14	commons	common	NOUN
ajlm-1028	8	15	attribution	attribution	NOUN
ajlm-1028	8	16	license	license	NOUN
ajlm-1028	8	17	,	,	PUNCT
ajlm-1028	8	18	which	which	PRON
ajlm-1028	8	19	permits	permit	VERB
ajlm-1028	8	20	unrestricted	unrestricted	ADJ
ajlm-1028	8	21	use	use	NOUN
ajlm-1028	8	22	,	,	PUNCT
ajlm-1028	8	23	distribution	distribution	NOUN
ajlm-1028	8	24	,	,	PUNCT
ajlm-1028	8	25	and	and	CCONJ
ajlm-1028	8	26	reproduction	reproduction	NOUN
ajlm-1028	8	27	in	in	ADP
ajlm-1028	8	28	any	any	DET
ajlm-1028	8	29	medium	medium	NOUN
ajlm-1028	8	30	,	,	PUNCT
ajlm-1028	8	31	provided	provide	VERB
ajlm-1028	8	32	the	the	DET
ajlm-1028	8	33	original	original	ADJ
ajlm-1028	8	34	work	work	NOUN
ajlm-1028	8	35	is	be	AUX
ajlm-1028	8	36	properly	properly	ADV
ajlm-1028	8	37	cited	cite	VERB
ajlm-1028	8	38	.	.	PUNCT
ajlm-1028	9	1	abstract	abstract	ADJ
ajlm-1028	9	2	background	background	NOUN
ajlm-1028	9	3	:	:	PUNCT
ajlm-1028	9	4	bone	bone	NOUN
ajlm-1028	9	5	marrow	marrow	NOUN
ajlm-1028	9	6	aspiration	aspiration	NOUN
ajlm-1028	9	7	and	and	CCONJ
ajlm-1028	9	8	trephine	trephine	NOUN
ajlm-1028	9	9	biopsy	biopsy	NOUN
ajlm-1028	9	10	(	(	PUNCT
ajlm-1028	9	11	bmat	bmat	NOUN
ajlm-1028	9	12	)	)	PUNCT
ajlm-1028	9	13	are	be	AUX
ajlm-1028	9	14	widely	widely	ADV
ajlm-1028	9	15	performed	perform	VERB
ajlm-1028	9	16	in	in	ADP
ajlm-1028	9	17	adults	adult	NOUN
ajlm-1028	9	18	to	to	PART
ajlm-1028	9	19	evaluate	evaluate	VERB
ajlm-1028	9	20	haematological	haematological	ADJ
ajlm-1028	9	21	and	and	CCONJ
ajlm-1028	9	22	malignant	malignant	ADJ
ajlm-1028	9	23	conditions	condition	NOUN
ajlm-1028	9	24	.	.	PUNCT
ajlm-1028	10	1	however	however	ADV
ajlm-1028	10	2	,	,	PUNCT
ajlm-1028	10	3	the	the	DET
ajlm-1028	10	4	diagnostic	diagnostic	ADJ
ajlm-1028	10	5	yield	yield	NOUN
ajlm-1028	10	6	from	from	ADP
ajlm-1028	10	7	the	the	DET
ajlm-1028	10	8	procedure	procedure	NOUN
ajlm-1028	10	9	in	in	ADP
ajlm-1028	10	10	unselected	unselected	ADJ
ajlm-1028	10	11	patients	patient	NOUN
ajlm-1028	10	12	in	in	ADP
ajlm-1028	10	13	the	the	DET
ajlm-1028	10	14	south	south	ADJ
ajlm-1028	10	15	african	african	ADJ
ajlm-1028	10	16	public	public	ADJ
ajlm-1028	10	17	sector	sector	NOUN
ajlm-1028	10	18	has	have	AUX
ajlm-1028	10	19	not	not	PART
ajlm-1028	10	20	previously	previously	ADV
ajlm-1028	10	21	been	be	AUX
ajlm-1028	10	22	described	describe	VERB
ajlm-1028	10	23	.	.	PUNCT
ajlm-1028	11	1	objectives	objective	NOUN
ajlm-1028	11	2	:	:	PUNCT
ajlm-1028	11	3	we	we	PRON
ajlm-1028	11	4	identified	identify	VERB
ajlm-1028	11	5	the	the	DET
ajlm-1028	11	6	main	main	ADJ
ajlm-1028	11	7	indications	indication	NOUN
ajlm-1028	11	8	and	and	CCONJ
ajlm-1028	11	9	most	most	ADV
ajlm-1028	11	10	common	common	ADJ
ajlm-1028	11	11	diagnoses	diagnosis	NOUN
ajlm-1028	11	12	encountered	encounter	VERB
ajlm-1028	11	13	for	for	ADP
ajlm-1028	11	14	bmat	bmat	NOUN
ajlm-1028	11	15	and	and	CCONJ
ajlm-1028	11	16	described	describe	VERB
ajlm-1028	11	17	the	the	DET
ajlm-1028	11	18	demographic	demographic	ADJ
ajlm-1028	11	19	and	and	CCONJ
ajlm-1028	11	20	blood	blood	NOUN
ajlm-1028	11	21	profiles	profile	NOUN
ajlm-1028	11	22	of	of	ADP
ajlm-1028	11	23	patients	patient	NOUN
ajlm-1028	11	24	,	,	PUNCT
ajlm-1028	11	25	including	include	VERB
ajlm-1028	11	26	hiv	hiv	PROPN
ajlm-1028	11	27	-	-	PUNCT
ajlm-1028	11	28	positive	positive	ADJ
ajlm-1028	11	29	patients	patient	NOUN
ajlm-1028	11	30	,	,	PUNCT
ajlm-1028	11	31	who	who	PRON
ajlm-1028	11	32	had	have	AUX
ajlm-1028	11	33	undergone	undergo	VERB
ajlm-1028	11	34	the	the	DET
ajlm-1028	11	35	procedure	procedure	NOUN
ajlm-1028	11	36	at	at	ADP
ajlm-1028	11	37	a	a	DET
ajlm-1028	11	38	tertiary	tertiary	ADJ
ajlm-1028	11	39	hospital	hospital	NOUN
ajlm-1028	11	40	in	in	ADP
ajlm-1028	11	41	kwazulu	kwazulu	NOUN
ajlm-1028	11	42	-	-	PUNCT
ajlm-1028	11	43	natal	natal	NOUN
ajlm-1028	11	44	.	.	PUNCT
ajlm-1028	12	1	methods	method	NOUN
ajlm-1028	12	2	:	:	PUNCT
ajlm-1028	12	3	we	we	PRON
ajlm-1028	12	4	retrospectively	retrospectively	ADV
ajlm-1028	12	5	reviewed	review	VERB
ajlm-1028	12	6	laboratory	laboratory	NOUN
ajlm-1028	12	7	data	datum	NOUN
ajlm-1028	12	8	from	from	ADP
ajlm-1028	12	9	january	january	PROPN
ajlm-1028	12	10	2016	2016	NUM
ajlm-1028	12	11	to	to	ADP
ajlm-1028	12	12	december	december	PROPN
ajlm-1028	12	13	2016	2016	NUM
ajlm-1028	12	14	for	for	ADP
ajlm-1028	12	15	all	all	DET
ajlm-1028	12	16	patients	patient	NOUN
ajlm-1028	12	17	aged	age	VERB
ajlm-1028	12	18	≥	≥	NOUN
ajlm-1028	12	19	13	13	NUM
ajlm-1028	12	20	years	year	NOUN
ajlm-1028	12	21	who	who	PRON
ajlm-1028	12	22	underwent	undergo	VERB
ajlm-1028	12	23	the	the	DET
ajlm-1028	12	24	procedure	procedure	NOUN
ajlm-1028	12	25	and	and	CCONJ
ajlm-1028	12	26	stratified	stratified	ADJ
ajlm-1028	12	27	findings	finding	NOUN
ajlm-1028	12	28	by	by	ADP
ajlm-1028	12	29	demographic	demographic	ADJ
ajlm-1028	12	30	data	datum	NOUN
ajlm-1028	12	31	.	.	PUNCT
ajlm-1028	13	1	results	result	NOUN
ajlm-1028	13	2	:	:	PUNCT
ajlm-1028	13	3	among	among	ADP
ajlm-1028	13	4	120	120	NUM
ajlm-1028	13	5	bmat	bmat	ADJ
ajlm-1028	13	6	biopsies	biopsy	NOUN
ajlm-1028	13	7	studied	study	VERB
ajlm-1028	13	8	,	,	PUNCT
ajlm-1028	13	9	80	80	NUM
ajlm-1028	13	10	(	(	PUNCT
ajlm-1028	13	11	67	67	NUM
ajlm-1028	13	12	%	%	NOUN
ajlm-1028	13	13	)	)	PUNCT
ajlm-1028	13	14	cases	case	NOUN
ajlm-1028	13	15	were	be	AUX
ajlm-1028	13	16	performed	perform	VERB
ajlm-1028	13	17	to	to	PART
ajlm-1028	13	18	evaluate	evaluate	VERB
ajlm-1028	13	19	suspected	suspect	VERB
ajlm-1028	13	20	malignancy	malignancy	NOUN
ajlm-1028	13	21	and	and	CCONJ
ajlm-1028	13	22	a	a	DET
ajlm-1028	13	23	further	further	ADJ
ajlm-1028	13	24	40	40	NUM
ajlm-1028	13	25	(	(	PUNCT
ajlm-1028	13	26	33	33	NUM
ajlm-1028	13	27	%	%	NOUN
ajlm-1028	13	28	)	)	PUNCT
ajlm-1028	13	29	cases	case	NOUN
ajlm-1028	13	30	for	for	ADP
ajlm-1028	13	31	non	non	ADJ
ajlm-1028	13	32	-	-	ADJ
ajlm-1028	13	33	malignant	malignant	ADJ
ajlm-1028	13	34	indications	indication	NOUN
ajlm-1028	13	35	.	.	PUNCT
ajlm-1028	14	1	the	the	DET
ajlm-1028	14	2	main	main	ADJ
ajlm-1028	14	3	indications	indication	NOUN
ajlm-1028	14	4	for	for	ADP
ajlm-1028	14	5	bone	bone	NOUN
ajlm-1028	14	6	marrow	marrow	NOUN
ajlm-1028	14	7	examination	examination	NOUN
ajlm-1028	14	8	were	be	AUX
ajlm-1028	14	9	:	:	PUNCT
ajlm-1028	14	10	cytopenias	cytopenias	PROPN
ajlm-1028	14	11	38	38	NUM
ajlm-1028	14	12	(	(	PUNCT
ajlm-1028	14	13	32	32	NUM
ajlm-1028	14	14	%	%	NOUN
ajlm-1028	14	15	)	)	PUNCT
ajlm-1028	14	16	,	,	PUNCT
ajlm-1028	14	17	lymphoma	lymphoma	VERB
ajlm-1028	14	18	35	35	NUM
ajlm-1028	14	19	(	(	PUNCT
ajlm-1028	14	20	29	29	NUM
ajlm-1028	14	21	%	%	NOUN
ajlm-1028	14	22	)	)	PUNCT
ajlm-1028	14	23	,	,	PUNCT
ajlm-1028	14	24	leukaemia	leukaemia	NOUN
ajlm-1028	14	25	21	21	NUM
ajlm-1028	14	26	(	(	PUNCT
ajlm-1028	14	27	18	18	NUM
ajlm-1028	14	28	%	%	NOUN
ajlm-1028	14	29	)	)	PUNCT
ajlm-1028	14	30	,	,	PUNCT
ajlm-1028	14	31	and	and	CCONJ
ajlm-1028	14	32	multiple	multiple	ADJ
ajlm-1028	14	33	myeloma	myeloma	NOUN
ajlm-1028	14	34	17	17	NUM
ajlm-1028	14	35	(	(	PUNCT
ajlm-1028	14	36	14	14	NUM
ajlm-1028	14	37	%	%	NOUN
ajlm-1028	14	38	)	)	PUNCT
ajlm-1028	14	39	.	.	PUNCT
ajlm-1028	15	1	bmat	bmat	PROPN
ajlm-1028	15	2	results	result	NOUN
ajlm-1028	15	3	revealed	reveal	VERB
ajlm-1028	15	4	that	that	SCONJ
ajlm-1028	15	5	60	60	NUM
ajlm-1028	15	6	cases	case	NOUN
ajlm-1028	15	7	(	(	PUNCT
ajlm-1028	15	8	50	50	NUM
ajlm-1028	15	9	%	%	NOUN
ajlm-1028	15	10	)	)	PUNCT
ajlm-1028	15	11	were	be	AUX
ajlm-1028	15	12	malignant	malignant	ADJ
ajlm-1028	15	13	in	in	ADP
ajlm-1028	15	14	origin	origin	NOUN
ajlm-1028	15	15	,	,	PUNCT
ajlm-1028	15	16	30	30	NUM
ajlm-1028	15	17	cases	case	NOUN
ajlm-1028	15	18	(	(	PUNCT
ajlm-1028	15	19	25	25	NUM
ajlm-1028	15	20	%	%	NOUN
ajlm-1028	15	21	)	)	PUNCT
ajlm-1028	15	22	were	be	AUX
ajlm-1028	15	23	non	non	ADJ
ajlm-1028	15	24	-	-	ADJ
ajlm-1028	15	25	malignant	malignant	ADJ
ajlm-1028	15	26	and	and	CCONJ
ajlm-1028	15	27	30	30	NUM
ajlm-1028	15	28	cases	case	NOUN
ajlm-1028	15	29	(	(	PUNCT
ajlm-1028	15	30	25	25	NUM
ajlm-1028	15	31	%	%	NOUN
ajlm-1028	15	32	)	)	PUNCT
ajlm-1028	15	33	were	be	AUX
ajlm-1028	15	34	classified	classify	VERB
ajlm-1028	15	35	as	as	ADP
ajlm-1028	15	36	normal	normal	ADJ
ajlm-1028	15	37	.	.	PUNCT
ajlm-1028	16	1	the	the	DET
ajlm-1028	16	2	common	common	ADJ
ajlm-1028	16	3	diagnoses	diagnosis	NOUN
ajlm-1028	16	4	were	be	AUX
ajlm-1028	16	5	:	:	PUNCT
ajlm-1028	16	6	leukaemia	leukaemia	NOUN
ajlm-1028	16	7	,	,	PUNCT
ajlm-1028	16	8	24	24	NUM
ajlm-1028	16	9	(	(	PUNCT
ajlm-1028	16	10	20	20	NUM
ajlm-1028	16	11	%	%	NOUN
ajlm-1028	16	12	)	)	PUNCT
ajlm-1028	16	13	;	;	PUNCT
ajlm-1028	16	14	multiple	multiple	ADJ
ajlm-1028	16	15	myeloma	myeloma	NOUN
ajlm-1028	16	16	,	,	PUNCT
ajlm-1028	16	17	16	16	NUM
ajlm-1028	16	18	(	(	PUNCT
ajlm-1028	16	19	13	13	NUM
ajlm-1028	16	20	%	%	NOUN
ajlm-1028	16	21	)	)	PUNCT
ajlm-1028	16	22	and	and	CCONJ
ajlm-1028	16	23	lymphoma	lymphoma	NOUN
ajlm-1028	16	24	,	,	PUNCT
ajlm-1028	16	25	13	13	NUM
ajlm-1028	16	26	(	(	PUNCT
ajlm-1028	16	27	11	11	NUM
ajlm-1028	16	28	%	%	NOUN
ajlm-1028	16	29	)	)	PUNCT
ajlm-1028	16	30	.	.	PUNCT
ajlm-1028	17	1	cases	case	NOUN
ajlm-1028	17	2	aged	age	VERB
ajlm-1028	17	3	≥	≥	NOUN
ajlm-1028	17	4	50	50	NUM
ajlm-1028	17	5	years	year	NOUN
ajlm-1028	17	6	were	be	AUX
ajlm-1028	17	7	more	more	ADV
ajlm-1028	17	8	likely	likely	ADJ
ajlm-1028	17	9	to	to	PART
ajlm-1028	17	10	have	have	VERB
ajlm-1028	17	11	a	a	DET
ajlm-1028	17	12	malignant	malignant	ADJ
ajlm-1028	17	13	diagnosis	diagnosis	NOUN
ajlm-1028	17	14	(	(	PUNCT
ajlm-1028	17	15	odds	odd	NOUN
ajlm-1028	17	16	ratio	ratio	NOUN
ajlm-1028	17	17	:	:	PUNCT
ajlm-1028	17	18	5.8	5.8	NUM
ajlm-1028	17	19	(	(	PUNCT
ajlm-1028	17	20	95	95	NUM
ajlm-1028	17	21	%	%	NOUN
ajlm-1028	17	22	confidence	confidence	NOUN
ajlm-1028	17	23	interval	interval	NOUN
ajlm-1028	17	24	:	:	PUNCT
ajlm-1028	17	25	2.2–17.1	2.2–17.1	X
ajlm-1028	17	26	)	)	PUNCT
ajlm-1028	17	27	p	p	NOUN
ajlm-1028	17	28	-	-	PUNCT
ajlm-1028	17	29	value	value	NOUN
ajlm-1028	17	30	<	<	NOUN
ajlm-1028	17	31	0.001	0.001	NUM
ajlm-1028	17	32	)	)	PUNCT
ajlm-1028	17	33	.	.	PUNCT
ajlm-1028	18	1	conclusion	conclusion	NOUN
ajlm-1028	18	2	:	:	PUNCT
ajlm-1028	18	3	the	the	DET
ajlm-1028	18	4	diagnostic	diagnostic	ADJ
ajlm-1028	18	5	yield	yield	NOUN
ajlm-1028	18	6	of	of	ADP
ajlm-1028	18	7	bmat	bmat	NOUN
ajlm-1028	18	8	was	be	AUX
ajlm-1028	18	9	high	high	ADJ
ajlm-1028	18	10	,	,	PUNCT
ajlm-1028	18	11	with	with	ADP
ajlm-1028	18	12	significant	significant	ADJ
ajlm-1028	18	13	abnormalities	abnormality	NOUN
ajlm-1028	18	14	detected	detect	VERB
ajlm-1028	18	15	in	in	ADP
ajlm-1028	18	16	three	three	NUM
ajlm-1028	18	17	quarters	quarter	NOUN
ajlm-1028	18	18	of	of	ADP
ajlm-1028	18	19	cases	case	NOUN
ajlm-1028	18	20	.	.	PUNCT
ajlm-1028	19	1	haematological	haematological	ADJ
ajlm-1028	19	2	malignancy	malignancy	NOUN
ajlm-1028	19	3	was	be	AUX
ajlm-1028	19	4	the	the	DET
ajlm-1028	19	5	more	more	ADV
ajlm-1028	19	6	common	common	ADJ
ajlm-1028	19	7	diagnosis	diagnosis	NOUN
ajlm-1028	19	8	.	.	PUNCT
ajlm-1028	20	1	increasing	increase	VERB
ajlm-1028	20	2	age	age	NOUN
ajlm-1028	20	3	was	be	AUX
ajlm-1028	20	4	associated	associate	VERB
ajlm-1028	20	5	with	with	ADP
ajlm-1028	20	6	an	an	DET
ajlm-1028	20	7	increase	increase	NOUN
ajlm-1028	20	8	in	in	ADP
ajlm-1028	20	9	reporting	reporting	NOUN
ajlm-1028	20	10	of	of	ADP
ajlm-1028	20	11	haematology	haematology	NOUN
ajlm-1028	20	12	malignancy	malignancy	NOUN
ajlm-1028	20	13	.	.	PUNCT
ajlm-1028	21	1	keywords	keyword	NOUN
ajlm-1028	21	2	:	:	PUNCT
ajlm-1028	21	3	age	age	NOUN
ajlm-1028	21	4	;	;	PUNCT
ajlm-1028	21	5	human	human	ADJ
ajlm-1028	21	6	immune	immune	ADJ
ajlm-1028	21	7	virus	virus	NOUN
ajlm-1028	21	8	;	;	PUNCT
ajlm-1028	21	9	indications	indication	NOUN
ajlm-1028	21	10	;	;	PUNCT
ajlm-1028	21	11	outcomes	outcome	NOUN
ajlm-1028	21	12	;	;	PUNCT
ajlm-1028	21	13	haematological	haematological	ADJ
ajlm-1028	21	14	malignant	malignant	ADJ
ajlm-1028	21	15	diseases	disease	NOUN
ajlm-1028	21	16	;	;	PUNCT
ajlm-1028	21	17	diffuse	diffuse	VERB
ajlm-1028	21	18	large	large	ADJ
ajlm-1028	21	19	b	b	NOUN
ajlm-1028	21	20	cell	cell	NOUN
ajlm-1028	21	21	lymphoma	lymphoma	NOUN
ajlm-1028	21	22	;	;	PUNCT
ajlm-1028	21	23	bone	bone	NOUN
ajlm-1028	21	24	marrow	marrow	NOUN
ajlm-1028	21	25	aspirate	aspirate	NOUN
ajlm-1028	21	26	and	and	CCONJ
ajlm-1028	21	27	trephine	trephine	ADJ
ajlm-1028	21	28	biopsy	biopsy	NOUN
ajlm-1028	21	29	.	.	PUNCT
ajlm-1028	22	1	introduction	introduction	NOUN
ajlm-1028	22	2	bone	bone	NOUN
ajlm-1028	22	3	marrow	marrow	PROPN
ajlm-1028	22	4	examination	examination	NOUN
ajlm-1028	22	5	may	may	AUX
ajlm-1028	22	6	provide	provide	VERB
ajlm-1028	22	7	vital	vital	ADJ
ajlm-1028	22	8	information	information	NOUN
ajlm-1028	22	9	in	in	ADP
ajlm-1028	22	10	the	the	DET
ajlm-1028	22	11	diagnosis	diagnosis	NOUN
ajlm-1028	22	12	and	and	CCONJ
ajlm-1028	22	13	monitoring	monitoring	NOUN
ajlm-1028	22	14	of	of	ADP
ajlm-1028	22	15	haematological	haematological	ADJ
ajlm-1028	22	16	disease.1	disease.1	PROPN
ajlm-1028	22	17	bone	bone	NOUN
ajlm-1028	22	18	marrow	marrow	NOUN
ajlm-1028	22	19	examination	examination	NOUN
ajlm-1028	22	20	can	can	AUX
ajlm-1028	22	21	be	be	AUX
ajlm-1028	22	22	very	very	ADV
ajlm-1028	22	23	effective	effective	ADJ
ajlm-1028	22	24	when	when	SCONJ
ajlm-1028	22	25	it	it	PRON
ajlm-1028	22	26	is	be	AUX
ajlm-1028	22	27	utilised	utilise	VERB
ajlm-1028	22	28	in	in	ADP
ajlm-1028	22	29	conjunction	conjunction	NOUN
ajlm-1028	22	30	with	with	ADP
ajlm-1028	22	31	a	a	DET
ajlm-1028	22	32	good	good	ADJ
ajlm-1028	22	33	clinical	clinical	ADJ
ajlm-1028	22	34	assessment	assessment	NOUN
ajlm-1028	22	35	.	.	PUNCT
ajlm-1028	23	1	in	in	ADP
ajlm-1028	23	2	some	some	DET
ajlm-1028	23	3	cases	case	NOUN
ajlm-1028	23	4	,	,	PUNCT
ajlm-1028	23	5	diagnosis	diagnosis	NOUN
ajlm-1028	23	6	can	can	AUX
ajlm-1028	23	7	not	not	PART
ajlm-1028	23	8	be	be	AUX
ajlm-1028	23	9	reached	reach	VERB
ajlm-1028	23	10	solely	solely	ADV
ajlm-1028	23	11	on	on	ADP
ajlm-1028	23	12	an	an	DET
ajlm-1028	23	13	assessment	assessment	NOUN
ajlm-1028	23	14	of	of	ADP
ajlm-1028	23	15	peripheral	peripheral	ADJ
ajlm-1028	23	16	blood	blood	NOUN
ajlm-1028	23	17	samples	sample	NOUN
ajlm-1028	23	18	alone	alone	ADV
ajlm-1028	23	19	,	,	PUNCT
ajlm-1028	23	20	and	and	CCONJ
ajlm-1028	23	21	in	in	ADP
ajlm-1028	23	22	these	these	DET
ajlm-1028	23	23	situations	situation	NOUN
ajlm-1028	23	24	examination	examination	NOUN
ajlm-1028	23	25	of	of	ADP
ajlm-1028	23	26	the	the	DET
ajlm-1028	23	27	bone	bone	NOUN
ajlm-1028	23	28	marrow	marrow	NOUN
ajlm-1028	23	29	is	be	AUX
ajlm-1028	23	30	crucial.2	crucial.2	PROPN
ajlm-1028	23	31	several	several	ADJ
ajlm-1028	23	32	south	south	ADJ
ajlm-1028	23	33	african	african	ADJ
ajlm-1028	23	34	studies	study	NOUN
ajlm-1028	23	35	have	have	AUX
ajlm-1028	23	36	evaluated	evaluate	VERB
ajlm-1028	23	37	outcomes	outcome	NOUN
ajlm-1028	23	38	from	from	ADP
ajlm-1028	23	39	the	the	DET
ajlm-1028	23	40	procedure	procedure	NOUN
ajlm-1028	23	41	in	in	ADP
ajlm-1028	23	42	selected	select	VERB
ajlm-1028	23	43	cohorts	cohort	NOUN
ajlm-1028	23	44	with	with	ADP
ajlm-1028	23	45	hiv	hiv	PROPN
ajlm-1028	23	46	,	,	PUNCT
ajlm-1028	23	47	tuberculosis	tuberculosis	NOUN
ajlm-1028	23	48	or	or	CCONJ
ajlm-1028	23	49	lymphoma	lymphoma	NOUN
ajlm-1028	23	50	.	.	PUNCT
ajlm-1028	24	1	karsteadt	karsteadt	PROPN
ajlm-1028	24	2	et	et	PROPN
ajlm-1028	24	3	al	al	PROPN
ajlm-1028	24	4	.	.	PROPN
ajlm-1028	24	5	,	,	PUNCT
ajlm-1028	24	6	in	in	ADP
ajlm-1028	24	7	their	their	PRON
ajlm-1028	24	8	study	study	NOUN
ajlm-1028	24	9	examining	examine	VERB
ajlm-1028	24	10	the	the	DET
ajlm-1028	24	11	benefits	benefit	NOUN
ajlm-1028	24	12	of	of	ADP
ajlm-1028	24	13	bone	bone	NOUN
ajlm-1028	24	14	marrow	marrow	NOUN
ajlm-1028	24	15	examination	examination	NOUN
ajlm-1028	24	16	in	in	ADP
ajlm-1028	24	17	hiv	hiv	PROPN
ajlm-1028	24	18	-	-	PUNCT
ajlm-1028	24	19	positive	positive	ADJ
ajlm-1028	24	20	adults	adult	NOUN
ajlm-1028	24	21	,	,	PUNCT
ajlm-1028	24	22	showed	show	VERB
ajlm-1028	24	23	that	that	SCONJ
ajlm-1028	24	24	a	a	DET
ajlm-1028	24	25	low	low	ADJ
ajlm-1028	24	26	cd4	cd4	PROPN
ajlm-1028	24	27	count	count	NOUN
ajlm-1028	24	28	(	(	PUNCT
ajlm-1028	24	29	<	<	X
ajlm-1028	24	30	100	100	NUM
ajlm-1028	24	31	cells	cell	NOUN
ajlm-1028	24	32	/	/	SYM
ajlm-1028	24	33	μl	μl	CCONJ
ajlm-1028	24	34	)	)	PUNCT
ajlm-1028	24	35	had	have	VERB
ajlm-1028	24	36	a	a	DET
ajlm-1028	24	37	higher	high	ADJ
ajlm-1028	24	38	diagnostic	diagnostic	ADJ
ajlm-1028	24	39	yield	yield	NOUN
ajlm-1028	24	40	in	in	ADP
ajlm-1028	24	41	granulomatous	granulomatous	ADJ
ajlm-1028	24	42	disease	disease	NOUN
ajlm-1028	24	43	of	of	ADP
ajlm-1028	24	44	the	the	DET
ajlm-1028	24	45	bone	bone	NOUN
ajlm-1028	24	46	marrow.3	marrow.3	PROPN
ajlm-1028	24	47	in	in	ADP
ajlm-1028	24	48	2014	2014	NUM
ajlm-1028	24	49	,	,	PUNCT
ajlm-1028	24	50	naidoo	naidoo	PROPN
ajlm-1028	24	51	et	et	PROPN
ajlm-1028	24	52	al	al	PROPN
ajlm-1028	24	53	.	.	PROPN
ajlm-1028	24	54	studied	study	VERB
ajlm-1028	24	55	the	the	DET
ajlm-1028	24	56	outcome	outcome	NOUN
ajlm-1028	24	57	of	of	ADP
ajlm-1028	24	58	histological	histological	ADJ
ajlm-1028	24	59	comparison	comparison	NOUN
ajlm-1028	24	60	to	to	ADP
ajlm-1028	24	61	cytology	cytology	NOUN
ajlm-1028	24	62	in	in	ADP
ajlm-1028	24	63	antiretroviral	antiretroviral	ADJ
ajlm-1028	24	64	-	-	PUNCT
ajlm-1028	24	65	therapy	therapy	NOUN
ajlm-1028	24	66	-	-	PUNCT
ajlm-1028	24	67	naïve	naïve	ADJ
ajlm-1028	24	68	vs.	vs.	CCONJ
ajlm-1028	24	69	antiretroviral	antiretroviral	ADJ
ajlm-1028	24	70	-	-	PUNCT
ajlm-1028	24	71	therapy	therapy	NOUN
ajlm-1028	24	72	-	-	PUNCT
ajlm-1028	24	73	experienced	experience	VERB
ajlm-1028	24	74	hiv	hiv	NOUN
ajlm-1028	24	75	-	-	PUNCT
ajlm-1028	24	76	positive	positive	ADJ
ajlm-1028	24	77	patients	patient	NOUN
ajlm-1028	24	78	presenting	present	VERB
ajlm-1028	24	79	with	with	ADP
ajlm-1028	24	80	peripheral	peripheral	ADJ
ajlm-1028	24	81	blood	blood	NOUN
ajlm-1028	24	82	cytopenias	cytopenia	NOUN
ajlm-1028	24	83	and	and	CCONJ
ajlm-1028	24	84	found	find	VERB
ajlm-1028	24	85	higher	high	ADJ
ajlm-1028	24	86	rates	rate	NOUN
ajlm-1028	24	87	of	of	ADP
ajlm-1028	24	88	granulomatous	granulomatous	ADJ
ajlm-1028	24	89	disease	disease	NOUN
ajlm-1028	24	90	and	and	CCONJ
ajlm-1028	24	91	pure	pure	ADJ
ajlm-1028	24	92	red	red	ADJ
ajlm-1028	24	93	cell	cell	NOUN
ajlm-1028	24	94	aplasia	aplasia	NOUN
ajlm-1028	24	95	in	in	ADP
ajlm-1028	24	96	antiretroviral	antiretroviral	ADJ
ajlm-1028	24	97	-	-	PUNCT
ajlm-1028	24	98	therapy	therapy	NOUN
ajlm-1028	24	99	-	-	PUNCT
ajlm-1028	24	100	naïve	naïve	ADJ
ajlm-1028	24	101	patients.4	patients.4	PROPN
ajlm-1028	24	102	more	more	ADV
ajlm-1028	24	103	recently	recently	ADV
ajlm-1028	24	104	in	in	ADP
ajlm-1028	24	105	2018	2018	NUM
ajlm-1028	24	106	,	,	PUNCT
ajlm-1028	24	107	in	in	ADP
ajlm-1028	24	108	a	a	DET
ajlm-1028	24	109	study	study	NOUN
ajlm-1028	24	110	conducted	conduct	VERB
ajlm-1028	24	111	by	by	ADP
ajlm-1028	24	112	philips	philip	NOUN
ajlm-1028	24	113	and	and	CCONJ
ajlm-1028	24	114	opie	opie	PROPN
ajlm-1028	24	115	to	to	PART
ajlm-1028	24	116	assess	assess	VERB
ajlm-1028	24	117	the	the	DET
ajlm-1028	24	118	use	use	NOUN
ajlm-1028	24	119	of	of	ADP
ajlm-1028	24	120	bone	bone	NOUN
ajlm-1028	24	121	marrow	marrow	NOUN
ajlm-1028	24	122	examination	examination	NOUN
ajlm-1028	24	123	in	in	ADP
ajlm-1028	24	124	lymphoma	lymphoma	NOUN
ajlm-1028	24	125	sufferers	sufferer	NOUN
ajlm-1028	24	126	in	in	ADP
ajlm-1028	24	127	south	south	PROPN
ajlm-1028	24	128	africa	africa	PROPN
ajlm-1028	24	129	,	,	PUNCT
ajlm-1028	24	130	it	it	PRON
ajlm-1028	24	131	was	be	AUX
ajlm-1028	24	132	shown	show	VERB
ajlm-1028	24	133	that	that	SCONJ
ajlm-1028	24	134	out	out	ADP
ajlm-1028	24	135	of	of	ADP
ajlm-1028	24	136	the	the	DET
ajlm-1028	24	137	1215	1215	NUM
ajlm-1028	24	138	bone	bone	NOUN
ajlm-1028	24	139	marrow	marrow	NOUN
ajlm-1028	24	140	aspiration	aspiration	NOUN
ajlm-1028	24	141	and	and	CCONJ
ajlm-1028	24	142	trephine	trephine	ADJ
ajlm-1028	24	143	(	(	PUNCT
ajlm-1028	24	144	bmat	bmat	NOUN
ajlm-1028	24	145	)	)	PUNCT
ajlm-1028	24	146	records	record	NOUN
ajlm-1028	24	147	,	,	PUNCT
ajlm-1028	24	148	bone	bone	NOUN
ajlm-1028	24	149	marrow	marrow	PROPN
ajlm-1028	24	150	involvement	involvement	NOUN
ajlm-1028	24	151	was	be	AUX
ajlm-1028	24	152	most	most	ADV
ajlm-1028	24	153	commonly	commonly	ADV
ajlm-1028	24	154	present	present	ADJ
ajlm-1028	24	155	in	in	ADP
ajlm-1028	24	156	non	non	ADJ
ajlm-1028	24	157	-	-	ADJ
ajlm-1028	24	158	hodgkin	hodgkin	ADJ
ajlm-1028	24	159	’s	’s	PART
ajlm-1028	24	160	lymphoma	lymphoma	NOUN
ajlm-1028	24	161	(	(	PUNCT
ajlm-1028	24	162	43.7	43.7	NUM
ajlm-1028	24	163	%	%	NOUN
ajlm-1028	24	164	)	)	PUNCT
ajlm-1028	24	165	,	,	PUNCT
ajlm-1028	24	166	followed	follow	VERB
ajlm-1028	24	167	by	by	ADP
ajlm-1028	24	168	high	high	ADJ
ajlm-1028	24	169	-	-	PUNCT
ajlm-1028	24	170	grade	grade	NOUN
ajlm-1028	24	171	b	b	NOUN
ajlm-1028	24	172	subtypes	subtype	NOUN
ajlm-1028	24	173	(	(	PUNCT
ajlm-1028	24	174	28.9	28.9	NUM
ajlm-1028	24	175	%	%	NOUN
ajlm-1028	24	176	)	)	PUNCT
ajlm-1028	24	177	and	and	CCONJ
ajlm-1028	24	178	hodgkin	hodgkin	PROPN
ajlm-1028	24	179	’s	’s	PART
ajlm-1028	24	180	lymphoma	lymphoma	NOUN
ajlm-1028	24	181	(	(	PUNCT
ajlm-1028	24	182	35.7%).5	35.7%).5	NUM
ajlm-1028	24	183	more	more	ADJ
ajlm-1028	24	184	than	than	ADP
ajlm-1028	24	185	200	200	NUM
ajlm-1028	24	186	bone	bone	NOUN
ajlm-1028	24	187	marrow	marrow	NOUN
ajlm-1028	24	188	examinations	examination	NOUN
ajlm-1028	24	189	are	be	AUX
ajlm-1028	24	190	performed	perform	VERB
ajlm-1028	24	191	annually	annually	ADV
ajlm-1028	24	192	by	by	ADP
ajlm-1028	24	193	our	our	PRON
ajlm-1028	24	194	institution	institution	NOUN
ajlm-1028	24	195	.	.	PUNCT
ajlm-1028	25	1	a	a	DET
ajlm-1028	25	2	bone	bone	NOUN
ajlm-1028	25	3	marrow	marrow	NOUN
ajlm-1028	25	4	examination	examination	NOUN
ajlm-1028	25	5	is	be	AUX
ajlm-1028	25	6	a	a	DET
ajlm-1028	25	7	crucial	crucial	ADJ
ajlm-1028	25	8	test	test	NOUN
ajlm-1028	25	9	that	that	PRON
ajlm-1028	25	10	comes	come	VERB
ajlm-1028	25	11	at	at	ADP
ajlm-1028	25	12	a	a	DET
ajlm-1028	25	13	cost	cost	NOUN
ajlm-1028	25	14	to	to	ADP
ajlm-1028	25	15	the	the	DET
ajlm-1028	25	16	health	health	NOUN
ajlm-1028	25	17	institution	institution	NOUN
ajlm-1028	25	18	.	.	PUNCT
ajlm-1028	26	1	in	in	ADP
ajlm-1028	26	2	the	the	DET
ajlm-1028	26	3	interest	interest	NOUN
ajlm-1028	26	4	of	of	ADP
ajlm-1028	26	5	healthcare	healthcare	NOUN
ajlm-1028	26	6	cost	cost	NOUN
ajlm-1028	26	7	effectiveness	effectiveness	NOUN
ajlm-1028	26	8	measures	measure	NOUN
ajlm-1028	26	9	,	,	PUNCT
ajlm-1028	26	10	we	we	PRON
ajlm-1028	26	11	avoid	avoid	VERB
ajlm-1028	26	12	performing	perform	VERB
ajlm-1028	26	13	bmat	bmat	NOUN
ajlm-1028	26	14	for	for	ADP
ajlm-1028	26	15	treatable	treatable	ADJ
ajlm-1028	26	16	nutritional	nutritional	ADJ
ajlm-1028	26	17	disorders	disorder	NOUN
ajlm-1028	26	18	with	with	ADP
ajlm-1028	26	19	peripheral	peripheral	ADJ
ajlm-1028	26	20	blood	blood	NOUN
ajlm-1028	26	21	cytopenias	cytopenia	NOUN
ajlm-1028	26	22	.	.	PUNCT
ajlm-1028	27	1	serum	serum	NOUN
ajlm-1028	27	2	tests	test	NOUN
ajlm-1028	27	3	to	to	PART
ajlm-1028	27	4	confirm	confirm	VERB
ajlm-1028	27	5	and	and	CCONJ
ajlm-1028	27	6	assess	assess	VERB
ajlm-1028	27	7	for	for	ADP
ajlm-1028	27	8	nutritional	nutritional	ADJ
ajlm-1028	27	9	deficiencies	deficiency	NOUN
ajlm-1028	27	10	are	be	AUX
ajlm-1028	27	11	freely	freely	ADV
ajlm-1028	27	12	available	available	ADJ
ajlm-1028	27	13	at	at	ADP
ajlm-1028	27	14	our	our	PRON
ajlm-1028	27	15	institution	institution	NOUN
ajlm-1028	27	16	.	.	PUNCT
ajlm-1028	28	1	patients	patient	NOUN
ajlm-1028	28	2	with	with	ADP
ajlm-1028	28	3	cytopenias	cytopenia	NOUN
ajlm-1028	28	4	are	be	AUX
ajlm-1028	28	5	therefore	therefore	ADV
ajlm-1028	28	6	routinely	routinely	ADV
ajlm-1028	28	7	screened	screen	VERB
ajlm-1028	28	8	for	for	ADP
ajlm-1028	28	9	nutritional	nutritional	ADJ
ajlm-1028	28	10	deficiencies	deficiency	NOUN
ajlm-1028	28	11	such	such	ADJ
ajlm-1028	28	12	as	as	ADP
ajlm-1028	28	13	vitamin	vitamin	NOUN
ajlm-1028	28	14	b12	b12	NOUN
ajlm-1028	28	15	and	and	CCONJ
ajlm-1028	28	16	folate	folate	NOUN
ajlm-1028	28	17	deficiency	deficiency	NOUN
ajlm-1028	28	18	,	,	PUNCT
ajlm-1028	28	19	which	which	PRON
ajlm-1028	28	20	can	can	AUX
ajlm-1028	28	21	mimic	mimic	VERB
ajlm-1028	28	22	leukaemia	leukaemia	NOUN
ajlm-1028	28	23	and	and	CCONJ
ajlm-1028	28	24	had	have	AUX
ajlm-1028	28	25	been	be	AUX
ajlm-1028	28	26	reported	report	VERB
ajlm-1028	28	27	in	in	ADP
ajlm-1028	28	28	literature	literature	NOUN
ajlm-1028	28	29	case	case	NOUN
ajlm-1028	28	30	studies.6	studies.6	PROPN
ajlm-1028	28	31	studies	study	NOUN
ajlm-1028	28	32	have	have	AUX
ajlm-1028	28	33	demonstrated	demonstrate	VERB
ajlm-1028	28	34	that	that	SCONJ
ajlm-1028	28	35	the	the	DET
ajlm-1028	28	36	most	most	ADV
ajlm-1028	28	37	common	common	ADJ
ajlm-1028	28	38	reasons	reason	NOUN
ajlm-1028	28	39	for	for	ADP
ajlm-1028	28	40	bone	bone	NOUN
ajlm-1028	28	41	marrow	marrow	NOUN
ajlm-1028	28	42	examination	examination	NOUN
ajlm-1028	28	43	were	be	AUX
ajlm-1028	28	44	for	for	ADP
ajlm-1028	28	45	diagnoses	diagnosis	NOUN
ajlm-1028	28	46	of	of	ADP
ajlm-1028	28	47	haematological	haematological	NOUN
ajlm-1028	28	48	malignancies.7,8	malignancies.7,8	ADP
ajlm-1028	28	49	the	the	DET
ajlm-1028	28	50	spectrum	spectrum	NOUN
ajlm-1028	28	51	of	of	ADP
ajlm-1028	28	52	haematological	haematological	ADJ
ajlm-1028	28	53	disease	disease	NOUN
ajlm-1028	28	54	at	at	ADP
ajlm-1028	28	55	our	our	PRON
ajlm-1028	28	56	institution	institution	NOUN
ajlm-1028	28	57	has	have	AUX
ajlm-1028	28	58	not	not	PART
ajlm-1028	28	59	been	be	AUX
ajlm-1028	28	60	previously	previously	ADV
ajlm-1028	28	61	studied	study	VERB
ajlm-1028	28	62	and	and	CCONJ
ajlm-1028	28	63	reported	report	VERB
ajlm-1028	28	64	.	.	PUNCT
ajlm-1028	29	1	we	we	PRON
ajlm-1028	29	2	therefore	therefore	ADV
ajlm-1028	29	3	undertook	undertake	VERB
ajlm-1028	29	4	a	a	DET
ajlm-1028	29	5	retrospective	retrospective	ADJ
ajlm-1028	29	6	analysis	analysis	NOUN
ajlm-1028	29	7	of	of	ADP
ajlm-1028	29	8	sequential	sequential	ADJ
ajlm-1028	29	9	bmat	bmat	NOUN
ajlm-1028	29	10	biopsies	biopsy	NOUN
ajlm-1028	29	11	performed	perform	VERB
ajlm-1028	29	12	over	over	ADP
ajlm-1028	29	13	a	a	DET
ajlm-1028	29	14	12	12	NUM
ajlm-1028	29	15	-	-	PUNCT
ajlm-1028	29	16	month	month	NOUN
ajlm-1028	29	17	period	period	NOUN
ajlm-1028	29	18	to	to	PART
ajlm-1028	29	19	evaluate	evaluate	VERB
ajlm-1028	29	20	the	the	DET
ajlm-1028	29	21	indications	indication	NOUN
ajlm-1028	29	22	for	for	ADP
ajlm-1028	29	23	and	and	CCONJ
ajlm-1028	29	24	diagnostic	diagnostic	ADJ
ajlm-1028	29	25	yield	yield	NOUN
ajlm-1028	29	26	from	from	ADP
ajlm-1028	29	27	the	the	DET
ajlm-1028	29	28	procedure	procedure	NOUN
ajlm-1028	29	29	.	.	PUNCT
ajlm-1028	30	1	methods	method	NOUN
ajlm-1028	30	2	ethical	ethical	ADJ
ajlm-1028	30	3	considerations	consideration	NOUN
ajlm-1028	30	4	ethical	ethical	ADJ
ajlm-1028	30	5	clearance	clearance	NOUN
ajlm-1028	30	6	was	be	AUX
ajlm-1028	30	7	obtained	obtain	VERB
ajlm-1028	30	8	from	from	ADP
ajlm-1028	30	9	the	the	DET
ajlm-1028	30	10	biomedical	biomedical	ADJ
ajlm-1028	30	11	research	research	NOUN
ajlm-1028	30	12	ethics	ethic	NOUN
ajlm-1028	30	13	committee	committee	PROPN
ajlm-1028	30	14	,	,	PUNCT
ajlm-1028	30	15	university	university	NOUN
ajlm-1028	30	16	of	of	ADP
ajlm-1028	30	17	kwazulu	kwazulu	PROPN
ajlm-1028	30	18	-	-	PUNCT
ajlm-1028	30	19	natal	natal	ADJ
ajlm-1028	30	20	(	(	PUNCT
ajlm-1028	30	21	ethical	ethical	ADJ
ajlm-1028	30	22	clearance	clearance	NOUN
ajlm-1028	30	23	number	number	NOUN
ajlm-1028	30	24	:	:	PUNCT
ajlm-1028	30	25	be465/17	be465/17	NOUN
ajlm-1028	30	26	)	)	PUNCT
ajlm-1028	30	27	.	.	PUNCT
ajlm-1028	31	1	study	study	NOUN
ajlm-1028	31	2	site	site	NOUN
ajlm-1028	31	3	and	and	CCONJ
ajlm-1028	31	4	design	design	VERB
ajlm-1028	31	5	the	the	DET
ajlm-1028	31	6	haematology	haematology	NOUN
ajlm-1028	31	7	unit	unit	NOUN
ajlm-1028	31	8	at	at	ADP
ajlm-1028	31	9	grey	grey	PROPN
ajlm-1028	31	10	’s	’s	PART
ajlm-1028	31	11	hospital	hospital	NOUN
ajlm-1028	31	12	,	,	PUNCT
ajlm-1028	31	13	pietermaritzburg	pietermaritzburg	PROPN
ajlm-1028	31	14	,	,	PUNCT
ajlm-1028	31	15	south	south	PROPN
ajlm-1028	31	16	africa	africa	PROPN
ajlm-1028	31	17	,	,	PUNCT
ajlm-1028	31	18	offers	offer	VERB
ajlm-1028	31	19	tertiary	tertiary	ADJ
ajlm-1028	31	20	inpatient	inpatient	NOUN
ajlm-1028	31	21	and	and	CCONJ
ajlm-1028	31	22	outpatient	outpatient	NOUN
ajlm-1028	31	23	services	service	NOUN
ajlm-1028	31	24	to	to	ADP
ajlm-1028	31	25	the	the	DET
ajlm-1028	31	26	western	western	ADJ
ajlm-1028	31	27	half	half	NOUN
ajlm-1028	31	28	of	of	ADP
ajlm-1028	31	29	kwazulu	kwazulu	PROPN
ajlm-1028	31	30	-	-	PUNCT
ajlm-1028	31	31	natal	natal	NOUN
ajlm-1028	31	32	and	and	CCONJ
ajlm-1028	31	33	performs	perform	VERB
ajlm-1028	31	34	all	all	DET
ajlm-1028	31	35	the	the	DET
ajlm-1028	31	36	adult	adult	NOUN
ajlm-1028	31	37	bmat	bmat	NOUN
ajlm-1028	31	38	procedures	procedure	NOUN
ajlm-1028	31	39	for	for	ADP
ajlm-1028	31	40	the	the	DET
ajlm-1028	31	41	institution	institution	NOUN
ajlm-1028	31	42	.	.	PUNCT
ajlm-1028	32	1	we	we	PRON
ajlm-1028	32	2	performed	perform	VERB
ajlm-1028	32	3	a	a	DET
ajlm-1028	32	4	retrospective	retrospective	ADJ
ajlm-1028	32	5	cross	cross	ADJ
ajlm-1028	32	6	-	-	ADJ
ajlm-1028	32	7	sectional	sectional	ADJ
ajlm-1028	32	8	study	study	NOUN
ajlm-1028	32	9	on	on	ADP
ajlm-1028	32	10	results	result	NOUN
ajlm-1028	32	11	from	from	ADP
ajlm-1028	32	12	bmat	bmat	NOUN
ajlm-1028	32	13	performed	perform	VERB
ajlm-1028	32	14	at	at	ADP
ajlm-1028	32	15	grey	grey	PROPN
ajlm-1028	32	16	’s	’s	PART
ajlm-1028	32	17	hospital	hospital	NOUN
ajlm-1028	32	18	on	on	ADP
ajlm-1028	32	19	individuals	individual	NOUN
ajlm-1028	32	20	older	old	ADJ
ajlm-1028	32	21	than	than	ADP
ajlm-1028	32	22	age	age	NOUN
ajlm-1028	32	23	13	13	NUM
ajlm-1028	32	24	years	year	NOUN
ajlm-1028	32	25	from	from	ADP
ajlm-1028	32	26	01	01	NUM
ajlm-1028	32	27	january	january	PROPN
ajlm-1028	32	28	2016	2016	NUM
ajlm-1028	32	29	to	to	ADP
ajlm-1028	32	30	31	31	NUM
ajlm-1028	32	31	december	december	PROPN
ajlm-1028	32	32	2016	2016	NUM
ajlm-1028	32	33	.	.	PUNCT
ajlm-1028	33	1	data	datum	NOUN
ajlm-1028	33	2	collection	collection	NOUN
ajlm-1028	33	3	the	the	DET
ajlm-1028	33	4	following	follow	VERB
ajlm-1028	33	5	clinical	clinical	ADJ
ajlm-1028	33	6	,	,	PUNCT
ajlm-1028	33	7	demographic	demographic	ADJ
ajlm-1028	33	8	,	,	PUNCT
ajlm-1028	33	9	and	and	CCONJ
ajlm-1028	33	10	biochemical	biochemical	ADJ
ajlm-1028	33	11	parameters	parameter	NOUN
ajlm-1028	33	12	were	be	AUX
ajlm-1028	33	13	extracted	extract	VERB
ajlm-1028	33	14	from	from	ADP
ajlm-1028	33	15	the	the	DET
ajlm-1028	33	16	bmat	bmat	NOUN
ajlm-1028	33	17	records	record	NOUN
ajlm-1028	33	18	:	:	PUNCT
ajlm-1028	33	19	age	age	NOUN
ajlm-1028	33	20	;	;	PUNCT
ajlm-1028	33	21	sex	sex	NOUN
ajlm-1028	33	22	;	;	PUNCT
ajlm-1028	33	23	hiv	hiv	PROPN
ajlm-1028	33	24	status	status	NOUN
ajlm-1028	33	25	;	;	PUNCT
ajlm-1028	33	26	cluster	cluster	NOUN
ajlm-1028	33	27	of	of	ADP
ajlm-1028	33	28	differentiation	differentiation	NOUN
ajlm-1028	33	29	4	4	NUM
ajlm-1028	33	30	(	(	PUNCT
ajlm-1028	33	31	cd4	cd4	PROPN
ajlm-1028	33	32	)	)	PUNCT
ajlm-1028	33	33	lymphocyte	lymphocyte	ADJ
ajlm-1028	33	34	count	count	NOUN
ajlm-1028	33	35	cells/µl	cells/µl	NOUN
ajlm-1028	33	36	;	;	PUNCT
ajlm-1028	33	37	indication	indication	NOUN
ajlm-1028	33	38	for	for	ADP
ajlm-1028	33	39	bmat	bmat	ADJ
ajlm-1028	33	40	;	;	PUNCT
ajlm-1028	33	41	final	final	ADJ
ajlm-1028	33	42	diagnostic	diagnostic	ADJ
ajlm-1028	33	43	outcome	outcome	NOUN
ajlm-1028	33	44	of	of	ADP
ajlm-1028	33	45	bmat	bmat	NOUN
ajlm-1028	33	46	;	;	PUNCT
ajlm-1028	33	47	bmat	bmat	ADJ
ajlm-1028	33	48	quality	quality	NOUN
ajlm-1028	33	49	and	and	CCONJ
ajlm-1028	33	50	trephine	trephine	ADJ
ajlm-1028	33	51	size	size	NOUN
ajlm-1028	33	52	;	;	PUNCT
ajlm-1028	33	53	white	white	ADJ
ajlm-1028	33	54	cell	cell	NOUN
ajlm-1028	33	55	count	count	NOUN
ajlm-1028	33	56	cells	cell	NOUN
ajlm-1028	33	57	×	×	NOUN
ajlm-1028	33	58	109	109	NUM
ajlm-1028	33	59	/	/	SYM
ajlm-1028	33	60	l	l	NOUN
ajlm-1028	33	61	;	;	PUNCT
ajlm-1028	33	62	haemoglobin	haemoglobin	PROPN
ajlm-1028	33	63	grams	grams	PROPN
ajlm-1028	33	64	/	/	SYM
ajlm-1028	33	65	dl	dl	PROPN
ajlm-1028	33	66	;	;	PUNCT
ajlm-1028	33	67	platelet	platelet	NOUN
ajlm-1028	33	68	count	count	NOUN
ajlm-1028	33	69	cells	cell	NOUN
ajlm-1028	33	70	×	×	NOUN
ajlm-1028	33	71	109	109	NUM
ajlm-1028	33	72	.	.	PUNCT
ajlm-1028	33	73	bone	bone	NOUN
ajlm-1028	33	74	marrow	marrow	NOUN
ajlm-1028	33	75	and	and	CCONJ
ajlm-1028	33	76	trephine	trephine	ADJ
ajlm-1028	33	77	sampling	sampling	NOUN
ajlm-1028	33	78	and	and	CCONJ
ajlm-1028	33	79	definition	definition	NOUN
ajlm-1028	33	80	we	we	PRON
ajlm-1028	33	81	retrospectively	retrospectively	ADV
ajlm-1028	33	82	analysed	analyse	VERB
ajlm-1028	33	83	results	result	NOUN
ajlm-1028	33	84	from	from	ADP
ajlm-1028	33	85	bmat	bmat	NOUN
ajlm-1028	33	86	performed	perform	VERB
ajlm-1028	33	87	by	by	ADP
ajlm-1028	33	88	physicians	physician	NOUN
ajlm-1028	33	89	at	at	ADP
ajlm-1028	33	90	our	our	PRON
ajlm-1028	33	91	institution	institution	NOUN
ajlm-1028	33	92	’s	’s	PART
ajlm-1028	33	93	clinical	clinical	ADJ
ajlm-1028	33	94	haematology	haematology	NOUN
ajlm-1028	33	95	unit	unit	NOUN
ajlm-1028	33	96	during	during	ADP
ajlm-1028	33	97	routine	routine	ADJ
ajlm-1028	33	98	patient	patient	ADJ
ajlm-1028	33	99	care	care	NOUN
ajlm-1028	33	100	.	.	PUNCT
ajlm-1028	34	1	the	the	DET
ajlm-1028	34	2	national	national	PROPN
ajlm-1028	34	3	health	health	PROPN
ajlm-1028	34	4	laboratory	laboratory	PROPN
ajlm-1028	34	5	service	service	NOUN
ajlm-1028	34	6	processed	process	VERB
ajlm-1028	34	7	these	these	DET
ajlm-1028	34	8	biopsy	biopsy	NOUN
ajlm-1028	34	9	specimens	specimen	NOUN
ajlm-1028	34	10	in	in	ADP
ajlm-1028	34	11	accordance	accordance	NOUN
ajlm-1028	34	12	with	with	ADP
ajlm-1028	34	13	the	the	DET
ajlm-1028	34	14	recommendations	recommendation	NOUN
ajlm-1028	34	15	of	of	ADP
ajlm-1028	34	16	the	the	DET
ajlm-1028	34	17	world	world	NOUN
ajlm-1028	34	18	health	health	NOUN
ajlm-1028	34	19	organization.9	organization.9	PROPN
ajlm-1028	34	20	the	the	DET
ajlm-1028	34	21	world	world	PROPN
ajlm-1028	34	22	health	health	NOUN
ajlm-1028	34	23	organization	organization	NOUN
ajlm-1028	34	24	recommends	recommend	VERB
ajlm-1028	34	25	a	a	DET
ajlm-1028	34	26	minimum	minimum	NOUN
ajlm-1028	34	27	of	of	ADP
ajlm-1028	34	28	1.5	1.5	NUM
ajlm-1028	34	29	cm	cm	NOUN
ajlm-1028	34	30	length	length	NOUN
ajlm-1028	34	31	for	for	ADP
ajlm-1028	34	32	a	a	DET
ajlm-1028	34	33	size	size	NOUN
ajlm-1028	34	34	of	of	ADP
ajlm-1028	34	35	trephine	trephine	NOUN
ajlm-1028	34	36	core	core	NOUN
ajlm-1028	34	37	biopsy	biopsy	NOUN
ajlm-1028	34	38	as	as	ADP
ajlm-1028	34	39	adequate	adequate	ADJ
ajlm-1028	34	40	assessment.9	assessment.9	NOUN
ajlm-1028	34	41	bmat	bmat	NOUN
ajlm-1028	34	42	results	result	NOUN
ajlm-1028	34	43	were	be	AUX
ajlm-1028	34	44	included	include	VERB
ajlm-1028	34	45	if	if	SCONJ
ajlm-1028	34	46	:	:	PUNCT
ajlm-1028	34	47	(	(	PUNCT
ajlm-1028	34	48	1	1	X
ajlm-1028	34	49	)	)	PUNCT
ajlm-1028	34	50	patient	patient	NOUN
ajlm-1028	34	51	was	be	AUX
ajlm-1028	34	52	older	old	ADJ
ajlm-1028	34	53	than	than	ADP
ajlm-1028	34	54	age	age	NOUN
ajlm-1028	34	55	13	13	NUM
ajlm-1028	34	56	years	year	NOUN
ajlm-1028	34	57	at	at	ADP
ajlm-1028	34	58	the	the	DET
ajlm-1028	34	59	time	time	NOUN
ajlm-1028	34	60	of	of	ADP
ajlm-1028	34	61	the	the	DET
ajlm-1028	34	62	biopsy	biopsy	NOUN
ajlm-1028	34	63	;	;	PUNCT
ajlm-1028	34	64	and	and	CCONJ
ajlm-1028	34	65	(	(	PUNCT
ajlm-1028	34	66	2	2	X
ajlm-1028	34	67	)	)	PUNCT
ajlm-1028	34	68	bmat	bmat	NOUN
ajlm-1028	34	69	was	be	AUX
ajlm-1028	34	70	reported	report	VERB
ajlm-1028	34	71	to	to	PART
ajlm-1028	34	72	have	have	VERB
ajlm-1028	34	73	adequate	adequate	ADJ
ajlm-1028	34	74	aspirate	aspirate	NOUN
ajlm-1028	34	75	or	or	CCONJ
ajlm-1028	34	76	trephine	trephine	ADJ
ajlm-1028	34	77	quality	quality	NOUN
ajlm-1028	34	78	to	to	PART
ajlm-1028	34	79	reach	reach	VERB
ajlm-1028	34	80	final	final	ADJ
ajlm-1028	34	81	diagnoses	diagnosis	NOUN
ajlm-1028	34	82	.	.	PUNCT
ajlm-1028	35	1	statistical	statistical	ADJ
ajlm-1028	35	2	analysis	analysis	NOUN
ajlm-1028	35	3	analyses	analysis	NOUN
ajlm-1028	35	4	were	be	AUX
ajlm-1028	35	5	performed	perform	VERB
ajlm-1028	35	6	using	use	VERB
ajlm-1028	35	7	analyse	analyse	NOUN
ajlm-1028	35	8	-	-	PUNCT
ajlm-1028	35	9	it	it	PRON
ajlm-1028	35	10	ultimate	ultimate	ADJ
ajlm-1028	35	11	edition	edition	NOUN
ajlm-1028	35	12	(	(	PUNCT
ajlm-1028	35	13	analyse	analyse	NOUN
ajlm-1028	35	14	-	-	PUNCT
ajlm-1028	35	15	it	it	PRON
ajlm-1028	35	16	ltd	ltd	PROPN
ajlm-1028	35	17	,	,	PUNCT
ajlm-1028	35	18	leeds	leed	NOUN
ajlm-1028	35	19	,	,	PUNCT
ajlm-1028	35	20	united	united	ADJ
ajlm-1028	35	21	kingdom	kingdom	PROPN
ajlm-1028	35	22	)	)	PUNCT
ajlm-1028	35	23	.	.	PUNCT
ajlm-1028	36	1	distributions	distribution	NOUN
ajlm-1028	36	2	of	of	ADP
ajlm-1028	36	3	continuous	continuous	ADJ
ajlm-1028	36	4	data	datum	NOUN
ajlm-1028	36	5	were	be	AUX
ajlm-1028	36	6	determined	determine	VERB
ajlm-1028	36	7	using	use	VERB
ajlm-1028	36	8	the	the	DET
ajlm-1028	36	9	shapiro	shapiro	PROPN
ajlm-1028	36	10	wilk	wilk	PROPN
ajlm-1028	36	11	test	test	PROPN
ajlm-1028	36	12	and	and	CCONJ
ajlm-1028	36	13	odds	odd	NOUN
ajlm-1028	36	14	ratios	ratio	NOUN
ajlm-1028	36	15	with	with	ADP
ajlm-1028	36	16	95	95	NUM
ajlm-1028	36	17	%	%	NOUN
ajlm-1028	36	18	confidence	confidence	NOUN
ajlm-1028	36	19	intervals	interval	NOUN
ajlm-1028	36	20	for	for	ADP
ajlm-1028	36	21	categorical	categorical	ADJ
ajlm-1028	36	22	data	datum	NOUN
ajlm-1028	36	23	calculated	calculate	VERB
ajlm-1028	36	24	using	use	VERB
ajlm-1028	36	25	the	the	DET
ajlm-1028	36	26	fisher	fisher	PROPN
ajlm-1028	36	27	exact	exact	ADJ
ajlm-1028	36	28	test	test	NOUN
ajlm-1028	36	29	.	.	PUNCT
ajlm-1028	37	1	results	result	VERB
ajlm-1028	37	2	a	a	DET
ajlm-1028	37	3	total	total	NOUN
ajlm-1028	37	4	of	of	ADP
ajlm-1028	37	5	204	204	NUM
ajlm-1028	37	6	cases	case	NOUN
ajlm-1028	37	7	were	be	AUX
ajlm-1028	37	8	received	receive	VERB
ajlm-1028	37	9	from	from	ADP
ajlm-1028	37	10	the	the	DET
ajlm-1028	37	11	national	national	PROPN
ajlm-1028	37	12	health	health	PROPN
ajlm-1028	37	13	laboratory	laboratory	PROPN
ajlm-1028	37	14	service	service	NOUN
ajlm-1028	37	15	.	.	PUNCT
ajlm-1028	38	1	one	one	NUM
ajlm-1028	38	2	hundred	hundred	NUM
ajlm-1028	38	3	and	and	CCONJ
ajlm-1028	38	4	twenty	twenty	NUM
ajlm-1028	38	5	cases	case	NOUN
ajlm-1028	38	6	met	meet	VERB
ajlm-1028	38	7	the	the	DET
ajlm-1028	38	8	inclusion	inclusion	NOUN
ajlm-1028	38	9	criteria	criterion	NOUN
ajlm-1028	38	10	.	.	PUNCT
ajlm-1028	39	1	eighty	eighty	NUM
ajlm-1028	39	2	-	-	PUNCT
ajlm-1028	39	3	four	four	NUM
ajlm-1028	39	4	cases	case	NOUN
ajlm-1028	39	5	that	that	PRON
ajlm-1028	39	6	did	do	AUX
ajlm-1028	39	7	not	not	PART
ajlm-1028	39	8	meet	meet	VERB
ajlm-1028	39	9	the	the	DET
ajlm-1028	39	10	inclusion	inclusion	NOUN
ajlm-1028	39	11	criteria	criterion	NOUN
ajlm-1028	39	12	included	include	VERB
ajlm-1028	39	13	68	68	NUM
ajlm-1028	39	14	cases	case	NOUN
ajlm-1028	39	15	excluded	exclude	VERB
ajlm-1028	39	16	for	for	ADP
ajlm-1028	39	17	being	be	AUX
ajlm-1028	39	18	below	below	ADP
ajlm-1028	39	19	the	the	DET
ajlm-1028	39	20	cut	cut	VERB
ajlm-1028	39	21	-	-	PUNCT
ajlm-1028	39	22	off	off	ADP
ajlm-1028	39	23	age	age	NOUN
ajlm-1028	39	24	of	of	ADP
ajlm-1028	39	25	13	13	NUM
ajlm-1028	39	26	years	year	NOUN
ajlm-1028	39	27	;	;	PUNCT
ajlm-1028	39	28	15	15	NUM
ajlm-1028	39	29	cases	case	NOUN
ajlm-1028	39	30	were	be	AUX
ajlm-1028	39	31	excluded	exclude	VERB
ajlm-1028	39	32	because	because	SCONJ
ajlm-1028	39	33	they	they	PRON
ajlm-1028	39	34	were	be	AUX
ajlm-1028	39	35	out	out	ADP
ajlm-1028	39	36	of	of	ADP
ajlm-1028	39	37	the	the	DET
ajlm-1028	39	38	specified	specify	VERB
ajlm-1028	39	39	time	time	NOUN
ajlm-1028	39	40	range	range	NOUN
ajlm-1028	39	41	;	;	PUNCT
ajlm-1028	39	42	and	and	CCONJ
ajlm-1028	39	43	one	one	NUM
ajlm-1028	39	44	case	case	NOUN
ajlm-1028	39	45	that	that	PRON
ajlm-1028	39	46	had	have	VERB
ajlm-1028	39	47	a	a	DET
ajlm-1028	39	48	poor	poor	ADJ
ajlm-1028	39	49	trephine	trephine	ADJ
ajlm-1028	39	50	biopsy	biopsy	NOUN
ajlm-1028	39	51	quality	quality	NOUN
ajlm-1028	39	52	.	.	PUNCT
ajlm-1028	40	1	seven	seven	NUM
ajlm-1028	40	2	of	of	ADP
ajlm-1028	40	3	the	the	DET
ajlm-1028	40	4	120	120	NUM
ajlm-1028	40	5	bmat	bmat	ADJ
ajlm-1028	40	6	cases	case	NOUN
ajlm-1028	40	7	had	have	VERB
ajlm-1028	40	8	a	a	DET
ajlm-1028	40	9	poor	poor	ADJ
ajlm-1028	40	10	bone	bone	NOUN
ajlm-1028	40	11	marrow	marrow	NOUN
ajlm-1028	40	12	aspirate	aspirate	NOUN
ajlm-1028	40	13	but	but	CCONJ
ajlm-1028	40	14	had	have	VERB
ajlm-1028	40	15	a	a	DET
ajlm-1028	40	16	good	good	ADJ
ajlm-1028	40	17	quality	quality	NOUN
ajlm-1028	40	18	bone	bone	NOUN
ajlm-1028	40	19	marrow	marrow	NOUN
ajlm-1028	40	20	trephine	trephine	PROPN
ajlm-1028	40	21	biopsy	biopsy	PROPN
ajlm-1028	40	22	.	.	PUNCT
ajlm-1028	41	1	these	these	DET
ajlm-1028	41	2	cases	case	NOUN
ajlm-1028	41	3	were	be	AUX
ajlm-1028	41	4	treated	treat	VERB
ajlm-1028	41	5	as	as	ADP
ajlm-1028	41	6	eligible	eligible	ADJ
ajlm-1028	41	7	,	,	PUNCT
ajlm-1028	41	8	as	as	SCONJ
ajlm-1028	41	9	a	a	DET
ajlm-1028	41	10	diagnosis	diagnosis	NOUN
ajlm-1028	41	11	could	could	AUX
ajlm-1028	41	12	still	still	ADV
ajlm-1028	41	13	be	be	AUX
ajlm-1028	41	14	made	make	VERB
ajlm-1028	41	15	on	on	ADP
ajlm-1028	41	16	the	the	DET
ajlm-1028	41	17	information	information	NOUN
ajlm-1028	41	18	provided	provide	VERB
ajlm-1028	41	19	by	by	ADP
ajlm-1028	41	20	the	the	DET
ajlm-1028	41	21	trephine	trephine	ADJ
ajlm-1028	41	22	biopsy	biopsy	NOUN
ajlm-1028	41	23	.	.	PUNCT
ajlm-1028	42	1	demographics	demographic	NOUN
ajlm-1028	42	2	malignant	malignant	ADJ
ajlm-1028	42	3	diagnoses	diagnosis	NOUN
ajlm-1028	42	4	were	be	AUX
ajlm-1028	42	5	predominantly	predominantly	ADV
ajlm-1028	42	6	reported	report	VERB
ajlm-1028	42	7	in	in	ADP
ajlm-1028	42	8	all	all	DET
ajlm-1028	42	9	age	age	NOUN
ajlm-1028	42	10	groups	group	NOUN
ajlm-1028	42	11	older	old	ADJ
ajlm-1028	42	12	than	than	ADP
ajlm-1028	42	13	age	age	NOUN
ajlm-1028	42	14	30	30	NUM
ajlm-1028	42	15	years	year	NOUN
ajlm-1028	42	16	(	(	PUNCT
ajlm-1028	42	17	figure	figure	NOUN
ajlm-1028	42	18	1	1	NUM
ajlm-1028	42	19	)	)	PUNCT
ajlm-1028	42	20	.	.	PUNCT
ajlm-1028	43	1	the	the	DET
ajlm-1028	43	2	study	study	NOUN
ajlm-1028	43	3	consisted	consist	VERB
ajlm-1028	43	4	of	of	ADP
ajlm-1028	43	5	63	63	NUM
ajlm-1028	43	6	(	(	PUNCT
ajlm-1028	43	7	52.5	52.5	NUM
ajlm-1028	43	8	%	%	NOUN
ajlm-1028	43	9	)	)	PUNCT
ajlm-1028	43	10	male	male	ADJ
ajlm-1028	43	11	cases	case	NOUN
ajlm-1028	43	12	and	and	CCONJ
ajlm-1028	43	13	57	57	NUM
ajlm-1028	43	14	(	(	PUNCT
ajlm-1028	43	15	47.5	47.5	NUM
ajlm-1028	43	16	%	%	NOUN
ajlm-1028	43	17	)	)	PUNCT
ajlm-1028	43	18	female	female	ADJ
ajlm-1028	43	19	cases	case	NOUN
ajlm-1028	43	20	with	with	ADP
ajlm-1028	43	21	a	a	DET
ajlm-1028	43	22	median	median	ADJ
ajlm-1028	43	23	age	age	NOUN
ajlm-1028	43	24	of	of	ADP
ajlm-1028	43	25	40	40	NUM
ajlm-1028	43	26	years	year	NOUN
ajlm-1028	43	27	(	(	PUNCT
ajlm-1028	43	28	interquartile	interquartile	NOUN
ajlm-1028	43	29	range	range	NOUN
ajlm-1028	43	30	[	[	X
ajlm-1028	43	31	iqr	iqr	X
ajlm-1028	43	32	]	]	X
ajlm-1028	43	33	:	:	PUNCT
ajlm-1028	43	34	30–60	30–60	NUM
ajlm-1028	43	35	years	year	NOUN
ajlm-1028	43	36	)	)	PUNCT
ajlm-1028	43	37	.	.	PUNCT
ajlm-1028	44	1	age	age	NOUN
ajlm-1028	44	2	≥	≥	NOUN
ajlm-1028	44	3	50	50	NUM
ajlm-1028	44	4	years	year	NOUN
ajlm-1028	44	5	was	be	AUX
ajlm-1028	44	6	associated	associate	VERB
ajlm-1028	44	7	with	with	ADP
ajlm-1028	44	8	an	an	DET
ajlm-1028	44	9	increase	increase	NOUN
ajlm-1028	44	10	in	in	ADP
ajlm-1028	44	11	reporting	reporting	NOUN
ajlm-1028	44	12	of	of	ADP
ajlm-1028	44	13	malignancy	malignancy	NOUN
ajlm-1028	44	14	(	(	PUNCT
ajlm-1028	44	15	odds	odd	NOUN
ajlm-1028	44	16	ratio	ratio	NOUN
ajlm-1028	44	17	:	:	PUNCT
ajlm-1028	44	18	5.8	5.8	NUM
ajlm-1028	44	19	;	;	PUNCT
ajlm-1028	44	20	95	95	NUM
ajlm-1028	44	21	%	%	NOUN
ajlm-1028	44	22	confidence	confidence	NOUN
ajlm-1028	44	23	interval	interval	NOUN
ajlm-1028	44	24	:	:	PUNCT
ajlm-1028	45	1	2.2–17.1	2.2–17.1	NUM
ajlm-1028	45	2	;	;	PUNCT
ajlm-1028	45	3	p	p	X
ajlm-1028	45	4	<	<	X
ajlm-1028	45	5	0.001	0.001	NUM
ajlm-1028	45	6	)	)	PUNCT
ajlm-1028	45	7	.	.	PUNCT
ajlm-1028	46	1	figure	figure	VERB
ajlm-1028	46	2	1	1	NUM
ajlm-1028	46	3	:	:	PUNCT
ajlm-1028	46	4	distribution	distribution	NOUN
ajlm-1028	46	5	of	of	ADP
ajlm-1028	46	6	malignant	malignant	ADJ
ajlm-1028	46	7	and	and	CCONJ
ajlm-1028	46	8	non	non	ADJ
ajlm-1028	46	9	-	-	ADJ
ajlm-1028	46	10	malignant	malignant	ADJ
ajlm-1028	46	11	conditions	condition	NOUN
ajlm-1028	46	12	according	accord	VERB
ajlm-1028	46	13	to	to	ADP
ajlm-1028	46	14	age	age	NOUN
ajlm-1028	46	15	groups	group	NOUN
ajlm-1028	46	16	of	of	ADP
ajlm-1028	46	17	120	120	NUM
ajlm-1028	46	18	bone	bone	NOUN
ajlm-1028	46	19	marrow	marrow	NOUN
ajlm-1028	46	20	aspirates	aspirate	NOUN
ajlm-1028	46	21	and	and	CCONJ
ajlm-1028	46	22	trephine	trephine	NOUN
ajlm-1028	46	23	biopsies	biopsy	NOUN
ajlm-1028	46	24	performed	perform	VERB
ajlm-1028	46	25	at	at	ADP
ajlm-1028	46	26	a	a	DET
ajlm-1028	46	27	hospital	hospital	NOUN
ajlm-1028	46	28	in	in	ADP
ajlm-1028	46	29	kwazulu	kwazulu	NOUN
ajlm-1028	46	30	-	-	PUNCT
ajlm-1028	46	31	natal	natal	ADJ
ajlm-1028	46	32	,	,	PUNCT
ajlm-1028	46	33	south	south	PROPN
ajlm-1028	46	34	africa	africa	PROPN
ajlm-1028	46	35	,	,	PUNCT
ajlm-1028	46	36	january	january	PROPN
ajlm-1028	46	37	2016	2016	NUM
ajlm-1028	46	38	to	to	ADP
ajlm-1028	46	39	december	december	PROPN
ajlm-1028	46	40	2016	2016	NUM
ajlm-1028	46	41	.	.	PUNCT
ajlm-1028	47	1	indications	indication	NOUN
ajlm-1028	47	2	for	for	ADP
ajlm-1028	47	3	performing	perform	VERB
ajlm-1028	47	4	a	a	DET
ajlm-1028	47	5	bone	bone	NOUN
ajlm-1028	47	6	marrow	marrow	NOUN
ajlm-1028	47	7	aspirate	aspirate	NOUN
ajlm-1028	47	8	and	and	CCONJ
ajlm-1028	47	9	trephine	trephine	NOUN
ajlm-1028	47	10	biopsy	biopsy	VERB
ajlm-1028	47	11	the	the	DET
ajlm-1028	47	12	indications	indication	NOUN
ajlm-1028	47	13	for	for	ADP
ajlm-1028	47	14	bmat	bmat	NOUN
ajlm-1028	47	15	performed	perform	VERB
ajlm-1028	47	16	at	at	ADP
ajlm-1028	47	17	our	our	PRON
ajlm-1028	47	18	institution	institution	NOUN
ajlm-1028	47	19	included	include	VERB
ajlm-1028	47	20	38	38	NUM
ajlm-1028	47	21	cases	case	NOUN
ajlm-1028	47	22	with	with	ADP
ajlm-1028	47	23	cytopenias	cytopenia	NOUN
ajlm-1028	47	24	(	(	PUNCT
ajlm-1028	47	25	32	32	NUM
ajlm-1028	47	26	%	%	NOUN
ajlm-1028	47	27	)	)	PUNCT
ajlm-1028	47	28	,	,	PUNCT
ajlm-1028	47	29	35	35	NUM
ajlm-1028	47	30	with	with	ADP
ajlm-1028	47	31	lymphoma	lymphoma	NOUN
ajlm-1028	47	32	(	(	PUNCT
ajlm-1028	47	33	29	29	NUM
ajlm-1028	47	34	%	%	NOUN
ajlm-1028	47	35	)	)	PUNCT
ajlm-1028	47	36	,	,	PUNCT
ajlm-1028	47	37	21	21	NUM
ajlm-1028	47	38	with	with	ADP
ajlm-1028	47	39	leukaemia	leukaemia	NOUN
ajlm-1028	47	40	(	(	PUNCT
ajlm-1028	47	41	18	18	NUM
ajlm-1028	47	42	%	%	NOUN
ajlm-1028	47	43	)	)	PUNCT
ajlm-1028	47	44	,	,	PUNCT
ajlm-1028	47	45	and	and	CCONJ
ajlm-1028	47	46	17	17	NUM
ajlm-1028	47	47	with	with	ADP
ajlm-1028	47	48	multiple	multiple	ADJ
ajlm-1028	47	49	myeloma	myeloma	NOUN
ajlm-1028	47	50	(	(	PUNCT
ajlm-1028	47	51	14	14	NUM
ajlm-1028	47	52	%	%	NOUN
ajlm-1028	47	53	)	)	PUNCT
ajlm-1028	47	54	(	(	PUNCT
ajlm-1028	47	55	table	table	NOUN
ajlm-1028	47	56	1	1	NUM
ajlm-1028	47	57	)	)	PUNCT
ajlm-1028	47	58	.	.	PUNCT
ajlm-1028	48	1	table	table	NOUN
ajlm-1028	48	2	1	1	NUM
ajlm-1028	48	3	:	:	PUNCT
ajlm-1028	48	4	 	 	SPACE
ajlm-1028	48	5	indications	indication	NOUN
ajlm-1028	48	6	for	for	ADP
ajlm-1028	48	7	performing	perform	VERB
ajlm-1028	48	8	bone	bone	NOUN
ajlm-1028	48	9	marrow	marrow	NOUN
ajlm-1028	48	10	aspirate	aspirate	NOUN
ajlm-1028	48	11	and	and	CCONJ
ajlm-1028	48	12	trephine	trephine	NOUN
ajlm-1028	48	13	biopsies	biopsy	NOUN
ajlm-1028	48	14	on	on	ADP
ajlm-1028	48	15	an	an	DET
ajlm-1028	48	16	unselected	unselected	ADJ
ajlm-1028	48	17	group	group	NOUN
ajlm-1028	48	18	of	of	ADP
ajlm-1028	48	19	120	120	NUM
ajlm-1028	48	20	patients	patient	NOUN
ajlm-1028	48	21	at	at	ADP
ajlm-1028	48	22	a	a	DET
ajlm-1028	48	23	hospital	hospital	NOUN
ajlm-1028	48	24	in	in	ADP
ajlm-1028	48	25	kwazulu	kwazulu	NOUN
ajlm-1028	48	26	-	-	PUNCT
ajlm-1028	48	27	natal	natal	ADJ
ajlm-1028	48	28	,	,	PUNCT
ajlm-1028	48	29	south	south	PROPN
ajlm-1028	48	30	africa	africa	PROPN
ajlm-1028	48	31	,	,	PUNCT
ajlm-1028	48	32	january	january	PROPN
ajlm-1028	48	33	2016	2016	NUM
ajlm-1028	48	34	to	to	ADP
ajlm-1028	48	35	december	december	PROPN
ajlm-1028	48	36	2016	2016	NUM
ajlm-1028	48	37	.	.	PUNCT
ajlm-1028	49	1	indication	indication	NOUN
ajlm-1028	49	2	of	of	ADP
ajlm-1028	49	3	bone	bone	NOUN
ajlm-1028	49	4	marrow	marrow	NOUN
ajlm-1028	49	5	aspirate	aspirate	NOUN
ajlm-1028	49	6	and	and	CCONJ
ajlm-1028	49	7	trephine	trephine	NOUN
ajlm-1028	49	8	biopsy	biopsy	NOUN
ajlm-1028	49	9	among	among	ADP
ajlm-1028	49	10	hiv	hiv	PROPN
ajlm-1028	49	11	-	-	PUNCT
ajlm-1028	49	12	positive	positive	ADJ
ajlm-1028	49	13	cases	case	NOUN
ajlm-1028	49	14	hiv	hiv	NOUN
ajlm-1028	49	15	-	-	PUNCT
ajlm-1028	49	16	positive	positive	ADJ
ajlm-1028	49	17	cases	case	NOUN
ajlm-1028	49	18	accounted	account	VERB
ajlm-1028	49	19	for	for	ADP
ajlm-1028	49	20	46	46	NUM
ajlm-1028	49	21	(	(	PUNCT
ajlm-1028	49	22	38	38	NUM
ajlm-1028	49	23	%	%	NOUN
ajlm-1028	49	24	)	)	PUNCT
ajlm-1028	49	25	of	of	ADP
ajlm-1028	49	26	the	the	DET
ajlm-1028	49	27	120	120	NUM
ajlm-1028	49	28	bmats	bmat	NOUN
ajlm-1028	49	29	reported	report	VERB
ajlm-1028	49	30	with	with	ADP
ajlm-1028	49	31	a	a	DET
ajlm-1028	49	32	median	median	NOUN
ajlm-1028	49	33	cd4	cd4	PROPN
ajlm-1028	49	34	lymphocyte	lymphocyte	ADJ
ajlm-1028	49	35	count	count	NOUN
ajlm-1028	49	36	of	of	ADP
ajlm-1028	49	37	241	241	NUM
ajlm-1028	49	38	cells/µl	cells/µl	PROPN
ajlm-1028	49	39	(	(	PUNCT
ajlm-1028	49	40	iqr	iqr	NOUN
ajlm-1028	49	41	:	:	PUNCT
ajlm-1028	49	42	178.7–303.7	178.7–303.7	NUM
ajlm-1028	49	43	)	)	PUNCT
ajlm-1028	49	44	.	.	PUNCT
ajlm-1028	50	1	peripheral	peripheral	ADJ
ajlm-1028	50	2	blood	blood	NOUN
ajlm-1028	50	3	cytopenias	cytopenia	NOUN
ajlm-1028	50	4	and	and	CCONJ
ajlm-1028	50	5	lymphomas	lymphoma	NOUN
ajlm-1028	50	6	were	be	AUX
ajlm-1028	50	7	the	the	DET
ajlm-1028	50	8	common	common	ADJ
ajlm-1028	50	9	indications	indication	NOUN
ajlm-1028	50	10	for	for	ADP
ajlm-1028	50	11	bone	bone	NOUN
ajlm-1028	50	12	marrow	marrow	NOUN
ajlm-1028	50	13	examination	examination	NOUN
ajlm-1028	50	14	in	in	ADP
ajlm-1028	50	15	the	the	DET
ajlm-1028	50	16	hiv	hiv	PROPN
ajlm-1028	50	17	-	-	PUNCT
ajlm-1028	50	18	positive	positive	ADJ
ajlm-1028	50	19	cohort	cohort	NOUN
ajlm-1028	50	20	(	(	PUNCT
ajlm-1028	50	21	table	table	NOUN
ajlm-1028	50	22	2	2	NUM
ajlm-1028	50	23	)	)	PUNCT
ajlm-1028	50	24	.	.	PUNCT
ajlm-1028	51	1	a	a	DET
ajlm-1028	51	2	diagnosis	diagnosis	NOUN
ajlm-1028	51	3	of	of	ADP
ajlm-1028	51	4	diffuse	diffuse	NOUN
ajlm-1028	51	5	large	large	ADJ
ajlm-1028	51	6	b	b	NOUN
ajlm-1028	51	7	cell	cell	NOUN
ajlm-1028	51	8	lymphoma	lymphoma	NOUN
ajlm-1028	51	9	(	(	PUNCT
ajlm-1028	51	10	dlbcl	dlbcl	NOUN
ajlm-1028	51	11	)	)	PUNCT
ajlm-1028	51	12	made	make	VERB
ajlm-1028	51	13	on	on	ADP
ajlm-1028	51	14	a	a	DET
ajlm-1028	51	15	peripheral	peripheral	ADJ
ajlm-1028	51	16	lymph	lymph	NOUN
ajlm-1028	51	17	node	node	ADJ
ajlm-1028	51	18	biopsy	biopsy	NOUN
ajlm-1028	51	19	was	be	AUX
ajlm-1028	51	20	an	an	DET
ajlm-1028	51	21	indication	indication	NOUN
ajlm-1028	51	22	for	for	ADP
ajlm-1028	51	23	bmat	bmat	NOUN
ajlm-1028	51	24	in	in	ADP
ajlm-1028	51	25	22	22	NUM
ajlm-1028	51	26	(	(	PUNCT
ajlm-1028	51	27	47.8	47.8	NUM
ajlm-1028	51	28	%	%	NOUN
ajlm-1028	51	29	)	)	PUNCT
ajlm-1028	51	30	of	of	ADP
ajlm-1028	51	31	46	46	NUM
ajlm-1028	51	32	cases	case	NOUN
ajlm-1028	51	33	known	know	VERB
ajlm-1028	51	34	to	to	PART
ajlm-1028	51	35	be	be	AUX
ajlm-1028	51	36	hiv	hiv	NOUN
ajlm-1028	51	37	-	-	PUNCT
ajlm-1028	51	38	positive	positive	ADJ
ajlm-1028	51	39	.	.	PUNCT
ajlm-1028	52	1	table	table	NOUN
ajlm-1028	52	2	2	2	NUM
ajlm-1028	52	3	:	:	PUNCT
ajlm-1028	52	4	 	 	SPACE
ajlm-1028	52	5	indications	indication	NOUN
ajlm-1028	52	6	for	for	ADP
ajlm-1028	52	7	bone	bone	NOUN
ajlm-1028	52	8	marrow	marrow	NOUN
ajlm-1028	52	9	examination	examination	NOUN
ajlm-1028	52	10	of	of	ADP
ajlm-1028	52	11	46†	46†	PROPN
ajlm-1028	52	12	cases	case	NOUN
ajlm-1028	52	13	reported	report	VERB
ajlm-1028	52	14	to	to	PART
ajlm-1028	52	15	be	be	AUX
ajlm-1028	52	16	hiv	hiv	NOUN
ajlm-1028	52	17	-	-	PUNCT
ajlm-1028	52	18	positive	positive	ADJ
ajlm-1028	52	19	at	at	ADP
ajlm-1028	52	20	a	a	DET
ajlm-1028	52	21	hospital	hospital	NOUN
ajlm-1028	52	22	in	in	ADP
ajlm-1028	52	23	kwazulu	kwazulu	NOUN
ajlm-1028	52	24	-	-	PUNCT
ajlm-1028	52	25	natal	natal	ADJ
ajlm-1028	52	26	,	,	PUNCT
ajlm-1028	52	27	south	south	PROPN
ajlm-1028	52	28	africa	africa	PROPN
ajlm-1028	52	29	,	,	PUNCT
ajlm-1028	52	30	january	january	PROPN
ajlm-1028	52	31	2016	2016	NUM
ajlm-1028	52	32	to	to	ADP
ajlm-1028	52	33	december	december	PROPN
ajlm-1028	52	34	2016	2016	NUM
ajlm-1028	52	35	.	.	PUNCT
ajlm-1028	53	1	eighty	eighty	NUM
ajlm-1028	53	2	-	-	PUNCT
ajlm-1028	53	3	one	one	NUM
ajlm-1028	53	4	percent	percent	NOUN
ajlm-1028	53	5	(	(	PUNCT
ajlm-1028	53	6	22/27	22/27	NUM
ajlm-1028	53	7	)	)	PUNCT
ajlm-1028	53	8	of	of	ADP
ajlm-1028	53	9	the	the	DET
ajlm-1028	53	10	overall	overall	ADJ
ajlm-1028	53	11	dlbcl	dlbcl	NOUN
ajlm-1028	53	12	cases	case	NOUN
ajlm-1028	53	13	were	be	AUX
ajlm-1028	53	14	hiv	hiv	NOUN
ajlm-1028	53	15	-	-	PUNCT
ajlm-1028	53	16	positive	positive	ADJ
ajlm-1028	53	17	.	.	PUNCT
ajlm-1028	54	1	less	less	ADJ
ajlm-1028	54	2	than	than	ADP
ajlm-1028	54	3	1	1	NUM
ajlm-1028	54	4	%	%	NOUN
ajlm-1028	54	5	of	of	ADP
ajlm-1028	54	6	the	the	DET
ajlm-1028	54	7	cases	case	NOUN
ajlm-1028	54	8	with	with	ADP
ajlm-1028	54	9	dlbcl	dlbcl	NOUN
ajlm-1028	54	10	had	have	VERB
ajlm-1028	54	11	bone	bone	NOUN
ajlm-1028	54	12	marrow	marrow	NOUN
ajlm-1028	54	13	infiltration	infiltration	NOUN
ajlm-1028	54	14	.	.	PUNCT
ajlm-1028	55	1	sixty	sixty	NUM
ajlm-1028	55	2	percent	percent	NOUN
ajlm-1028	55	3	of	of	ADP
ajlm-1028	55	4	hiv	hiv	PROPN
ajlm-1028	55	5	-	-	PUNCT
ajlm-1028	55	6	positive	positive	ADJ
ajlm-1028	55	7	cases	case	NOUN
ajlm-1028	55	8	with	with	ADP
ajlm-1028	55	9	a	a	DET
ajlm-1028	55	10	diagnosis	diagnosis	NOUN
ajlm-1028	55	11	of	of	ADP
ajlm-1028	55	12	dlbcl	dlbcl	NOUN
ajlm-1028	55	13	had	have	VERB
ajlm-1028	55	14	a	a	DET
ajlm-1028	55	15	cd4	cd4	PROPN
ajlm-1028	55	16	count	count	NOUN
ajlm-1028	55	17	≥	≥	NUM
ajlm-1028	55	18	200	200	NUM
ajlm-1028	55	19	cells/µl	cells/µl	NOUN
ajlm-1028	55	20	.	.	PUNCT
ajlm-1028	56	1	the	the	DET
ajlm-1028	56	2	median	median	PROPN
ajlm-1028	56	3	full	full	ADJ
ajlm-1028	56	4	blood	blood	NOUN
ajlm-1028	56	5	count	count	NOUN
ajlm-1028	56	6	indices	index	NOUN
ajlm-1028	56	7	among	among	ADP
ajlm-1028	56	8	hiv	hiv	PROPN
ajlm-1028	56	9	-	-	PUNCT
ajlm-1028	56	10	positive	positive	ADJ
ajlm-1028	56	11	cases	case	NOUN
ajlm-1028	56	12	were	be	AUX
ajlm-1028	56	13	:	:	PUNCT
ajlm-1028	56	14	white	white	ADJ
ajlm-1028	56	15	blood	blood	NOUN
ajlm-1028	56	16	cell	cell	NOUN
ajlm-1028	56	17	count	count	NOUN
ajlm-1028	56	18	,	,	PUNCT
ajlm-1028	56	19	6.43	6.43	NUM
ajlm-1028	56	20	×	×	NOUN
ajlm-1028	56	21	109	109	NUM
ajlm-1028	56	22	/	/	SYM
ajlm-1028	56	23	l	l	NOUN
ajlm-1028	56	24	(	(	PUNCT
ajlm-1028	56	25	iqr	iqr	NOUN
ajlm-1028	56	26	:	:	PUNCT
ajlm-1028	56	27	5.030–8.10	5.030–8.10	NOUN
ajlm-1028	56	28	)	)	PUNCT
ajlm-1028	56	29	;	;	PUNCT
ajlm-1028	56	30	haemoglobin	haemoglobin	NOUN
ajlm-1028	56	31	,	,	PUNCT
ajlm-1028	56	32	7.9	7.9	NUM
ajlm-1028	56	33	(	(	PUNCT
ajlm-1028	56	34	iqr	iqr	NOUN
ajlm-1028	56	35	:	:	PUNCT
ajlm-1028	56	36	6.8–9.00	6.8–9.00	NUM
ajlm-1028	56	37	)	)	PUNCT
ajlm-1028	56	38	g	g	PROPN
ajlm-1028	56	39	/	/	SYM
ajlm-1028	56	40	dl	dl	PROPN
ajlm-1028	56	41	;	;	PUNCT
ajlm-1028	56	42	and	and	CCONJ
ajlm-1028	56	43	platelet	platelet	NOUN
ajlm-1028	56	44	count	count	NOUN
ajlm-1028	56	45	,	,	PUNCT
ajlm-1028	56	46	243.0	243.0	NUM
ajlm-1028	56	47	(	(	PUNCT
ajlm-1028	56	48	iqr	iqr	NOUN
ajlm-1028	56	49	:	:	PUNCT
ajlm-1028	56	50	191.0–365.0	191.0–365.0	NUM
ajlm-1028	56	51	)	)	PUNCT
ajlm-1028	56	52	×	×	NOUN
ajlm-1028	56	53	109	109	NUM
ajlm-1028	56	54	/	/	SYM
ajlm-1028	56	55	l.	l.	PROPN
ajlm-1028	56	56	diagnostic	diagnostic	ADJ
ajlm-1028	56	57	outcomes	outcome	NOUN
ajlm-1028	56	58	of	of	ADP
ajlm-1028	56	59	the	the	DET
ajlm-1028	56	60	bone	bone	NOUN
ajlm-1028	56	61	marrow	marrow	NOUN
ajlm-1028	56	62	examination	examination	NOUN
ajlm-1028	56	63	reported	report	VERB
ajlm-1028	56	64	diagnoses	diagnosis	NOUN
ajlm-1028	56	65	for	for	ADP
ajlm-1028	56	66	this	this	DET
ajlm-1028	56	67	study	study	NOUN
ajlm-1028	56	68	revealed	reveal	VERB
ajlm-1028	56	69	60	60	NUM
ajlm-1028	56	70	cases	case	NOUN
ajlm-1028	56	71	(	(	PUNCT
ajlm-1028	56	72	50	50	NUM
ajlm-1028	56	73	%	%	NOUN
ajlm-1028	56	74	)	)	PUNCT
ajlm-1028	56	75	with	with	ADP
ajlm-1028	56	76	malignancy	malignancy	NOUN
ajlm-1028	56	77	,	,	PUNCT
ajlm-1028	56	78	30	30	NUM
ajlm-1028	56	79	cases	case	NOUN
ajlm-1028	56	80	(	(	PUNCT
ajlm-1028	56	81	25	25	NUM
ajlm-1028	56	82	%	%	NOUN
ajlm-1028	56	83	)	)	PUNCT
ajlm-1028	56	84	were	be	AUX
ajlm-1028	56	85	reported	report	VERB
ajlm-1028	56	86	as	as	ADP
ajlm-1028	56	87	non	non	ADJ
ajlm-1028	56	88	-	-	ADJ
ajlm-1028	56	89	malignant	malignant	ADJ
ajlm-1028	56	90	and	and	CCONJ
ajlm-1028	56	91	a	a	DET
ajlm-1028	56	92	further	further	ADJ
ajlm-1028	56	93	30	30	NUM
ajlm-1028	56	94	cases	case	NOUN
ajlm-1028	56	95	(	(	PUNCT
ajlm-1028	56	96	25	25	NUM
ajlm-1028	56	97	%	%	NOUN
ajlm-1028	56	98	)	)	PUNCT
ajlm-1028	56	99	revealed	reveal	VERB
ajlm-1028	56	100	a	a	DET
ajlm-1028	56	101	normal	normal	ADJ
ajlm-1028	56	102	bone	bone	NOUN
ajlm-1028	56	103	marrow	marrow	NOUN
ajlm-1028	56	104	(	(	PUNCT
ajlm-1028	56	105	table	table	NOUN
ajlm-1028	56	106	3	3	NUM
ajlm-1028	56	107	)	)	PUNCT
ajlm-1028	56	108	.	.	PUNCT
ajlm-1028	57	1	the	the	DET
ajlm-1028	57	2	most	most	ADV
ajlm-1028	57	3	common	common	ADJ
ajlm-1028	57	4	diagnoses	diagnosis	NOUN
ajlm-1028	57	5	were	be	AUX
ajlm-1028	57	6	(	(	PUNCT
ajlm-1028	57	7	in	in	ADP
ajlm-1028	57	8	descending	descend	VERB
ajlm-1028	57	9	order	order	NOUN
ajlm-1028	57	10	of	of	ADP
ajlm-1028	57	11	frequency	frequency	NOUN
ajlm-1028	57	12	):	):	PUNCT
ajlm-1028	57	13	24	24	NUM
ajlm-1028	57	14	cases	case	NOUN
ajlm-1028	57	15	of	of	ADP
ajlm-1028	57	16	leukaemia	leukaemia	NOUN
ajlm-1028	57	17	(	(	PUNCT
ajlm-1028	57	18	20	20	NUM
ajlm-1028	57	19	%	%	NOUN
ajlm-1028	57	20	)	)	PUNCT
ajlm-1028	57	21	;	;	PUNCT
ajlm-1028	57	22	16	16	NUM
ajlm-1028	57	23	of	of	ADP
ajlm-1028	57	24	multiple	multiple	ADJ
ajlm-1028	57	25	myeloma	myeloma	NOUN
ajlm-1028	57	26	(	(	PUNCT
ajlm-1028	57	27	13	13	NUM
ajlm-1028	57	28	%	%	NOUN
ajlm-1028	57	29	)	)	PUNCT
ajlm-1028	57	30	and	and	CCONJ
ajlm-1028	57	31	13	13	NUM
ajlm-1028	57	32	of	of	ADP
ajlm-1028	57	33	lymphoma	lymphoma	NOUN
ajlm-1028	57	34	(	(	PUNCT
ajlm-1028	57	35	11	11	NUM
ajlm-1028	57	36	%	%	NOUN
ajlm-1028	57	37	)	)	PUNCT
ajlm-1028	57	38	.	.	PUNCT
ajlm-1028	58	1	acute	acute	PROPN
ajlm-1028	58	2	leukaemia	leukaemia	PROPN
ajlm-1028	58	3	accounted	account	VERB
ajlm-1028	58	4	for	for	ADP
ajlm-1028	58	5	46	46	NUM
ajlm-1028	58	6	%	%	NOUN
ajlm-1028	58	7	(	(	PUNCT
ajlm-1028	58	8	11/24	11/24	NUM
ajlm-1028	58	9	cases	case	NOUN
ajlm-1028	58	10	)	)	PUNCT
ajlm-1028	58	11	of	of	ADP
ajlm-1028	58	12	all	all	DET
ajlm-1028	58	13	diagnosed	diagnose	VERB
ajlm-1028	58	14	leukaemia	leukaemia	NOUN
ajlm-1028	58	15	cases	case	NOUN
ajlm-1028	58	16	when	when	SCONJ
ajlm-1028	58	17	compared	compare	VERB
ajlm-1028	58	18	to	to	ADP
ajlm-1028	58	19	chronic	chronic	ADJ
ajlm-1028	58	20	leukaemia	leukaemia	NOUN
ajlm-1028	58	21	.	.	PUNCT
ajlm-1028	59	1	the	the	DET
ajlm-1028	59	2	median	median	PROPN
ajlm-1028	59	3	full	full	ADJ
ajlm-1028	59	4	blood	blood	NOUN
ajlm-1028	59	5	count	count	NOUN
ajlm-1028	59	6	indices	index	NOUN
ajlm-1028	59	7	for	for	ADP
ajlm-1028	59	8	leukaemia	leukaemia	NOUN
ajlm-1028	59	9	cases	case	NOUN
ajlm-1028	59	10	were	be	AUX
ajlm-1028	59	11	:	:	PUNCT
ajlm-1028	59	12	white	white	ADJ
ajlm-1028	59	13	cell	cell	NOUN
ajlm-1028	59	14	count	count	VERB
ajlm-1028	59	15	93.00	93.00	NUM
ajlm-1028	59	16	×	×	NOUN
ajlm-1028	59	17	109	109	NUM
ajlm-1028	59	18	/	/	SYM
ajlm-1028	59	19	l	l	NOUN
ajlm-1028	59	20	(	(	PUNCT
ajlm-1028	59	21	iqr	iqr	NOUN
ajlm-1028	59	22	:	:	PUNCT
ajlm-1028	59	23	36.03–159.45	36.03–159.45	NUM
ajlm-1028	59	24	)	)	PUNCT
ajlm-1028	59	25	;	;	PUNCT
ajlm-1028	59	26	haemoglobin	haemoglobin	NOUN
ajlm-1028	59	27	7.3	7.3	NUM
ajlm-1028	59	28	g	g	NOUN
ajlm-1028	59	29	/	/	SYM
ajlm-1028	59	30	dl	dl	PROPN
ajlm-1028	59	31	(	(	PUNCT
ajlm-1028	59	32	iqr	iqr	NOUN
ajlm-1028	59	33	:	:	PUNCT
ajlm-1028	59	34	7.00–11.30	7.00–11.30	NOUN
ajlm-1028	59	35	)	)	PUNCT
ajlm-1028	59	36	;	;	PUNCT
ajlm-1028	59	37	and	and	CCONJ
ajlm-1028	59	38	platelet	platelet	NOUN
ajlm-1028	59	39	count	count	NOUN
ajlm-1028	59	40	130	130	NUM
ajlm-1028	59	41	×	×	NOUN
ajlm-1028	59	42	109	109	NUM
ajlm-1028	59	43	/	/	SYM
ajlm-1028	59	44	l	l	NOUN
ajlm-1028	59	45	(	(	PUNCT
ajlm-1028	59	46	iqr	iqr	NOUN
ajlm-1028	59	47	:	:	PUNCT
ajlm-1028	59	48	82.0–241.0	82.0–241.0	NUM
ajlm-1028	59	49	)	)	PUNCT
ajlm-1028	59	50	.	.	PUNCT
ajlm-1028	60	1	there	there	PRON
ajlm-1028	60	2	were	be	VERB
ajlm-1028	60	3	five	five	NUM
ajlm-1028	60	4	cases	case	NOUN
ajlm-1028	60	5	reported	report	VERB
ajlm-1028	60	6	to	to	PART
ajlm-1028	60	7	have	have	VERB
ajlm-1028	60	8	granulomas	granuloma	NOUN
ajlm-1028	60	9	,	,	PUNCT
ajlm-1028	60	10	one	one	NUM
ajlm-1028	60	11	case	case	NOUN
ajlm-1028	60	12	with	with	ADP
ajlm-1028	60	13	a	a	DET
ajlm-1028	60	14	non	non	ADJ
ajlm-1028	60	15	-	-	ADJ
ajlm-1028	60	16	specific	specific	ADJ
ajlm-1028	60	17	granuloma	granuloma	NOUN
ajlm-1028	60	18	and	and	CCONJ
ajlm-1028	60	19	a	a	DET
ajlm-1028	60	20	further	further	ADJ
ajlm-1028	60	21	four	four	NUM
ajlm-1028	60	22	cases	case	NOUN
ajlm-1028	60	23	with	with	ADP
ajlm-1028	60	24	tuberculosis	tuberculosis	NOUN
ajlm-1028	60	25	granulomas	granuloma	NOUN
ajlm-1028	60	26	.	.	PUNCT
ajlm-1028	61	1	three	three	NUM
ajlm-1028	61	2	of	of	ADP
ajlm-1028	61	3	the	the	DET
ajlm-1028	61	4	cases	case	NOUN
ajlm-1028	61	5	diagnosed	diagnose	VERB
ajlm-1028	61	6	with	with	ADP
ajlm-1028	61	7	tuberculosis	tuberculosis	NOUN
ajlm-1028	61	8	granulomas	granuloma	NOUN
ajlm-1028	61	9	were	be	AUX
ajlm-1028	61	10	hiv	hiv	NOUN
ajlm-1028	61	11	-	-	PUNCT
ajlm-1028	61	12	positive	positive	ADJ
ajlm-1028	61	13	;	;	PUNCT
ajlm-1028	61	14	all	all	PRON
ajlm-1028	61	15	had	have	VERB
ajlm-1028	61	16	cd4	cd4	PROPN
ajlm-1028	61	17	counts	count	NOUN
ajlm-1028	61	18	less	less	ADJ
ajlm-1028	61	19	than	than	ADP
ajlm-1028	61	20	200	200	NUM
ajlm-1028	61	21	cells/µl	cells/µl	NOUN
ajlm-1028	61	22	.	.	PUNCT
ajlm-1028	61	23	table	table	NOUN
ajlm-1028	61	24	3	3	NUM
ajlm-1028	61	25	:	:	PUNCT
ajlm-1028	61	26	 	 	SPACE
ajlm-1028	61	27	reported	report	VERB
ajlm-1028	61	28	final	final	ADJ
ajlm-1028	61	29	diagnoses	diagnosis	NOUN
ajlm-1028	61	30	from	from	ADP
ajlm-1028	61	31	bone	bone	NOUN
ajlm-1028	61	32	marrow	marrow	NOUN
ajlm-1028	61	33	aspirate	aspirate	NOUN
ajlm-1028	61	34	and	and	CCONJ
ajlm-1028	61	35	trephine	trephine	ADJ
ajlm-1028	61	36	results	result	NOUN
ajlm-1028	61	37	of	of	ADP
ajlm-1028	61	38	an	an	DET
ajlm-1028	61	39	unselected	unselected	ADJ
ajlm-1028	61	40	group	group	NOUN
ajlm-1028	61	41	of	of	ADP
ajlm-1028	61	42	120	120	NUM
ajlm-1028	61	43	patients	patient	NOUN
ajlm-1028	61	44	at	at	ADP
ajlm-1028	61	45	a	a	DET
ajlm-1028	61	46	hospital	hospital	NOUN
ajlm-1028	61	47	in	in	ADP
ajlm-1028	61	48	kwazulu	kwazulu	NOUN
ajlm-1028	61	49	-	-	PUNCT
ajlm-1028	61	50	natal	natal	ADJ
ajlm-1028	61	51	,	,	PUNCT
ajlm-1028	61	52	south	south	PROPN
ajlm-1028	61	53	africa	africa	PROPN
ajlm-1028	61	54	,	,	PUNCT
ajlm-1028	61	55	january	january	PROPN
ajlm-1028	61	56	2016	2016	NUM
ajlm-1028	61	57	to	to	ADP
ajlm-1028	61	58	december	december	PROPN
ajlm-1028	61	59	2016	2016	NUM
ajlm-1028	61	60	.	.	PUNCT
ajlm-1028	62	1	discussion	discussion	NOUN
ajlm-1028	62	2	bone	bone	NOUN
ajlm-1028	62	3	marrow	marrow	PROPN
ajlm-1028	62	4	aspirate	aspirate	NOUN
ajlm-1028	62	5	and	and	CCONJ
ajlm-1028	62	6	trephine	trephine	NOUN
ajlm-1028	62	7	biopsies	biopsy	NOUN
ajlm-1028	62	8	in	in	ADP
ajlm-1028	62	9	our	our	PRON
ajlm-1028	62	10	institution	institution	NOUN
ajlm-1028	62	11	were	be	AUX
ajlm-1028	62	12	performed	perform	VERB
ajlm-1028	62	13	for	for	ADP
ajlm-1028	62	14	a	a	DET
ajlm-1028	62	15	wide	wide	ADJ
ajlm-1028	62	16	array	array	NOUN
ajlm-1028	62	17	of	of	ADP
ajlm-1028	62	18	haematological	haematological	ADJ
ajlm-1028	62	19	conditions	condition	NOUN
ajlm-1028	62	20	ranging	range	VERB
ajlm-1028	62	21	from	from	ADP
ajlm-1028	62	22	highly	highly	ADV
ajlm-1028	62	23	aggressive	aggressive	ADJ
ajlm-1028	62	24	to	to	ADP
ajlm-1028	62	25	non	non	ADJ
ajlm-1028	62	26	-	-	ADJ
ajlm-1028	62	27	benign	benign	ADJ
ajlm-1028	62	28	malignancies	malignancy	NOUN
ajlm-1028	62	29	.	.	PUNCT
ajlm-1028	63	1	our	our	PRON
ajlm-1028	63	2	findings	finding	NOUN
ajlm-1028	63	3	were	be	AUX
ajlm-1028	63	4	similar	similar	ADJ
ajlm-1028	63	5	to	to	ADP
ajlm-1028	63	6	some	some	DET
ajlm-1028	63	7	international	international	ADJ
ajlm-1028	63	8	studies	study	NOUN
ajlm-1028	63	9	conducted	conduct	VERB
ajlm-1028	63	10	in	in	ADP
ajlm-1028	63	11	nigeria	nigeria	PROPN
ajlm-1028	63	12	,	,	PUNCT
ajlm-1028	63	13	nepal	nepal	PROPN
ajlm-1028	63	14	,	,	PUNCT
ajlm-1028	63	15	saudi	saudi	PROPN
ajlm-1028	63	16	arabia	arabia	PROPN
ajlm-1028	63	17	,	,	PUNCT
ajlm-1028	63	18	iran	iran	PROPN
ajlm-1028	63	19	,	,	PUNCT
ajlm-1028	63	20	india	india	PROPN
ajlm-1028	63	21	,	,	PUNCT
ajlm-1028	63	22	and	and	CCONJ
ajlm-1028	63	23	ghana	ghana	PROPN
ajlm-1028	63	24	,	,	PUNCT
ajlm-1028	63	25	all	all	PRON
ajlm-1028	63	26	of	of	ADP
ajlm-1028	63	27	which	which	PRON
ajlm-1028	63	28	had	have	AUX
ajlm-1028	63	29	reported	report	VERB
ajlm-1028	63	30	haematological	haematological	ADJ
ajlm-1028	63	31	malignant	malignant	ADJ
ajlm-1028	63	32	disease	disease	NOUN
ajlm-1028	63	33	as	as	ADP
ajlm-1028	63	34	a	a	DET
ajlm-1028	63	35	common	common	ADJ
ajlm-1028	63	36	indication	indication	NOUN
ajlm-1028	63	37	and	and	CCONJ
ajlm-1028	63	38	outcome	outcome	VERB
ajlm-1028	63	39	for	for	ADP
ajlm-1028	63	40	a	a	DET
ajlm-1028	63	41	bone	bone	NOUN
ajlm-1028	63	42	marrow	marrow	NOUN
ajlm-1028	63	43	examination.7,8,10,11,12,13	examination.7,8,10,11,12,13	PROPN
ajlm-1028	63	44	in	in	ADP
ajlm-1028	63	45	our	our	PRON
ajlm-1028	63	46	study	study	NOUN
ajlm-1028	63	47	there	there	PRON
ajlm-1028	63	48	were	be	VERB
ajlm-1028	63	49	30	30	NUM
ajlm-1028	63	50	normal	normal	ADJ
ajlm-1028	63	51	bone	bone	NOUN
ajlm-1028	63	52	marrow	marrow	NOUN
ajlm-1028	63	53	results	result	VERB
ajlm-1028	63	54	with	with	ADP
ajlm-1028	63	55	the	the	DET
ajlm-1028	63	56	majority	majority	NOUN
ajlm-1028	63	57	of	of	ADP
ajlm-1028	63	58	these	these	DET
ajlm-1028	63	59	cases	case	NOUN
ajlm-1028	63	60	being	be	AUX
ajlm-1028	63	61	bmat	bmat	NOUN
ajlm-1028	63	62	performed	perform	VERB
ajlm-1028	63	63	as	as	ADP
ajlm-1028	63	64	part	part	NOUN
ajlm-1028	63	65	of	of	ADP
ajlm-1028	63	66	the	the	DET
ajlm-1028	63	67	staging	staging	NOUN
ajlm-1028	63	68	process	process	NOUN
ajlm-1028	63	69	for	for	ADP
ajlm-1028	63	70	treatment	treatment	NOUN
ajlm-1028	63	71	of	of	ADP
ajlm-1028	63	72	malignancies	malignancy	NOUN
ajlm-1028	63	73	.	.	PUNCT
ajlm-1028	64	1	since	since	SCONJ
ajlm-1028	64	2	south	south	PROPN
ajlm-1028	64	3	africa	africa	PROPN
ajlm-1028	64	4	is	be	AUX
ajlm-1028	64	5	a	a	DET
ajlm-1028	64	6	country	country	NOUN
ajlm-1028	64	7	known	know	VERB
ajlm-1028	64	8	to	to	PART
ajlm-1028	64	9	have	have	VERB
ajlm-1028	64	10	a	a	DET
ajlm-1028	64	11	high	high	ADJ
ajlm-1028	64	12	prevalence	prevalence	NOUN
ajlm-1028	64	13	of	of	ADP
ajlm-1028	64	14	hiv	hiv	PROPN
ajlm-1028	64	15	infection	infection	NOUN
ajlm-1028	64	16	,	,	PUNCT
ajlm-1028	64	17	the	the	DET
ajlm-1028	64	18	use	use	NOUN
ajlm-1028	64	19	of	of	ADP
ajlm-1028	64	20	bmat	bmat	NOUN
ajlm-1028	64	21	in	in	ADP
ajlm-1028	64	22	the	the	DET
ajlm-1028	64	23	diagnosis	diagnosis	NOUN
ajlm-1028	64	24	of	of	ADP
ajlm-1028	64	25	tuberculosis	tuberculosis	NOUN
ajlm-1028	64	26	is	be	AUX
ajlm-1028	64	27	not	not	PART
ajlm-1028	64	28	standard	standard	ADJ
ajlm-1028	64	29	practise	practise	NOUN
ajlm-1028	64	30	at	at	ADP
ajlm-1028	64	31	our	our	PRON
ajlm-1028	64	32	institution	institution	NOUN
ajlm-1028	64	33	.	.	PUNCT
ajlm-1028	65	1	we	we	PRON
ajlm-1028	65	2	have	have	VERB
ajlm-1028	65	3	access	access	NOUN
ajlm-1028	65	4	to	to	ADP
ajlm-1028	65	5	diagnostic	diagnostic	ADJ
ajlm-1028	65	6	tools	tool	NOUN
ajlm-1028	65	7	such	such	ADJ
ajlm-1028	65	8	as	as	ADP
ajlm-1028	65	9	gene	gene	NOUN
ajlm-1028	65	10	xpert	xpert	NOUN
ajlm-1028	65	11	and	and	CCONJ
ajlm-1028	65	12	tuberculosis	tuberculosis	PRON
ajlm-1028	65	13	culture	culture	NOUN
ajlm-1028	65	14	,	,	PUNCT
ajlm-1028	65	15	which	which	PRON
ajlm-1028	65	16	can	can	AUX
ajlm-1028	65	17	be	be	AUX
ajlm-1028	65	18	used	use	VERB
ajlm-1028	65	19	in	in	ADP
ajlm-1028	65	20	testing	test	VERB
ajlm-1028	65	21	various	various	ADJ
ajlm-1028	65	22	body	body	NOUN
ajlm-1028	65	23	fluids	fluid	NOUN
ajlm-1028	65	24	of	of	ADP
ajlm-1028	65	25	individuals	individual	NOUN
ajlm-1028	65	26	with	with	ADP
ajlm-1028	65	27	suspected	suspect	VERB
ajlm-1028	65	28	tuberculosis	tuberculosis	NOUN
ajlm-1028	65	29	infection	infection	NOUN
ajlm-1028	65	30	,	,	PUNCT
ajlm-1028	65	31	as	as	ADV
ajlm-1028	65	32	well	well	ADV
ajlm-1028	65	33	as	as	ADP
ajlm-1028	65	34	urine	urine	NOUN
ajlm-1028	65	35	lipoarabinomannan	lipoarabinomannan	NOUN
ajlm-1028	65	36	,	,	PUNCT
ajlm-1028	65	37	which	which	PRON
ajlm-1028	65	38	can	can	AUX
ajlm-1028	65	39	assist	assist	VERB
ajlm-1028	65	40	with	with	ADP
ajlm-1028	65	41	early	early	ADJ
ajlm-1028	65	42	diagnosis	diagnosis	NOUN
ajlm-1028	65	43	of	of	ADP
ajlm-1028	65	44	disseminated	disseminate	VERB
ajlm-1028	65	45	tuberculosis	tuberculosis	NOUN
ajlm-1028	65	46	.	.	PUNCT
ajlm-1028	66	1	therefore	therefore	ADV
ajlm-1028	66	2	,	,	PUNCT
ajlm-1028	66	3	many	many	ADJ
ajlm-1028	66	4	patients	patient	NOUN
ajlm-1028	66	5	with	with	ADP
ajlm-1028	66	6	tuberculosis	tuberculosis	NOUN
ajlm-1028	66	7	would	would	AUX
ajlm-1028	66	8	have	have	AUX
ajlm-1028	66	9	been	be	AUX
ajlm-1028	66	10	diagnosed	diagnose	VERB
ajlm-1028	66	11	before	before	SCONJ
ajlm-1028	66	12	bmat	bmat	NOUN
ajlm-1028	66	13	was	be	AUX
ajlm-1028	66	14	considered	consider	VERB
ajlm-1028	66	15	by	by	ADP
ajlm-1028	66	16	the	the	DET
ajlm-1028	66	17	attending	attend	VERB
ajlm-1028	66	18	clinicians	clinician	NOUN
ajlm-1028	66	19	.	.	PUNCT
ajlm-1028	67	1	for	for	ADP
ajlm-1028	67	2	this	this	DET
ajlm-1028	67	3	reason	reason	NOUN
ajlm-1028	67	4	our	our	PRON
ajlm-1028	67	5	study	study	NOUN
ajlm-1028	67	6	reported	report	VERB
ajlm-1028	67	7	low	low	ADJ
ajlm-1028	67	8	rates	rate	NOUN
ajlm-1028	67	9	(	(	PUNCT
ajlm-1028	67	10	4/120	4/120	NUM
ajlm-1028	67	11	)	)	PUNCT
ajlm-1028	67	12	of	of	ADP
ajlm-1028	67	13	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	14	diagnosis	diagnosis	NOUN
ajlm-1028	67	15	on	on	ADP
ajlm-1028	67	16	bmat	bmat	NOUN
ajlm-1028	67	17	when	when	SCONJ
ajlm-1028	67	18	compared	compare	VERB
ajlm-1028	67	19	to	to	ADP
ajlm-1028	67	20	other	other	ADJ
ajlm-1028	67	21	south	south	ADJ
ajlm-1028	67	22	african	african	ADJ
ajlm-1028	67	23	studies	study	NOUN
ajlm-1028	67	24	that	that	PRON
ajlm-1028	67	25	demonstrated	demonstrate	VERB
ajlm-1028	67	26	higher	high	ADJ
ajlm-1028	67	27	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	28	diagnoses	diagnosis	NOUN
ajlm-1028	67	29	on	on	ADP
ajlm-1028	67	30	bmat	bmat	NOUN
ajlm-1028	67	31	samples.4,14	samples.4,14	ADP
ajlm-1028	67	32	these	these	DET
ajlm-1028	67	33	studies	study	NOUN
ajlm-1028	67	34	included	include	VERB
ajlm-1028	67	35	:	:	PUNCT
ajlm-1028	67	36	a	a	DET
ajlm-1028	67	37	study	study	NOUN
ajlm-1028	67	38	that	that	PRON
ajlm-1028	67	39	looked	look	VERB
ajlm-1028	67	40	at	at	ADP
ajlm-1028	67	41	410	410	NUM
ajlm-1028	67	42	case	case	NOUN
ajlm-1028	67	43	samples	sample	NOUN
ajlm-1028	67	44	of	of	ADP
ajlm-1028	67	45	adult	adult	NOUN
ajlm-1028	67	46	and	and	CCONJ
ajlm-1028	67	47	paediatric	paediatric	ADJ
ajlm-1028	67	48	bmat	bmat	NOUN
ajlm-1028	67	49	submitted	submit	VERB
ajlm-1028	67	50	for	for	ADP
ajlm-1028	67	51	excluding	exclude	VERB
ajlm-1028	67	52	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	53	,	,	PUNCT
ajlm-1028	67	54	which	which	PRON
ajlm-1028	67	55	showed	show	VERB
ajlm-1028	67	56	a	a	DET
ajlm-1028	67	57	32.5	32.5	NUM
ajlm-1028	67	58	%	%	NOUN
ajlm-1028	67	59	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	60	prevalence	prevalence	NOUN
ajlm-1028	67	61	,	,	PUNCT
ajlm-1028	67	62	and	and	CCONJ
ajlm-1028	67	63	a	a	DET
ajlm-1028	67	64	study	study	NOUN
ajlm-1028	67	65	that	that	PRON
ajlm-1028	67	66	assessed	assess	VERB
ajlm-1028	67	67	bone	bone	NOUN
ajlm-1028	67	68	marrow	marrow	NOUN
ajlm-1028	67	69	morphology	morphology	NOUN
ajlm-1028	67	70	in	in	ADP
ajlm-1028	67	71	74	74	NUM
ajlm-1028	67	72	patients	patient	NOUN
ajlm-1028	67	73	,	,	PUNCT
ajlm-1028	67	74	in	in	ADP
ajlm-1028	67	75	which	which	PRON
ajlm-1028	67	76	comparing	compare	VERB
ajlm-1028	67	77	morphology	morphology	NOUN
ajlm-1028	67	78	between	between	ADP
ajlm-1028	67	79	patients	patient	NOUN
ajlm-1028	67	80	on	on	ADP
ajlm-1028	67	81	antiretroviral	antiretroviral	ADJ
ajlm-1028	67	82	therapy	therapy	NOUN
ajlm-1028	67	83	and	and	CCONJ
ajlm-1028	67	84	patients	patient	NOUN
ajlm-1028	67	85	naïve	naïve	ADJ
ajlm-1028	67	86	to	to	ADP
ajlm-1028	67	87	antiretroviral	antiretroviral	ADJ
ajlm-1028	67	88	therapy	therapy	NOUN
ajlm-1028	67	89	showed	show	VERB
ajlm-1028	67	90	a	a	DET
ajlm-1028	67	91	31	31	NUM
ajlm-1028	67	92	%	%	NOUN
ajlm-1028	67	93	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	94	prevalance.4,14	prevalance.4,14	ADV
ajlm-1028	67	95	both	both	PRON
ajlm-1028	67	96	of	of	ADP
ajlm-1028	67	97	these	these	DET
ajlm-1028	67	98	studies	study	NOUN
ajlm-1028	67	99	had	have	VERB
ajlm-1028	67	100	higher	high	ADJ
ajlm-1028	67	101	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	102	prevalence	prevalence	NOUN
ajlm-1028	67	103	due	due	ADP
ajlm-1028	67	104	to	to	ADP
ajlm-1028	67	105	their	their	PRON
ajlm-1028	67	106	study	study	NOUN
ajlm-1028	67	107	populations	population	NOUN
ajlm-1028	67	108	being	be	AUX
ajlm-1028	67	109	cases	case	NOUN
ajlm-1028	67	110	with	with	ADP
ajlm-1028	67	111	high	high	ADJ
ajlm-1028	67	112	risk	risk	NOUN
ajlm-1028	67	113	for	for	ADP
ajlm-1028	67	114	tuberculosis	tuberculosis	NOUN
ajlm-1028	67	115	.	.	PUNCT
ajlm-1028	68	1	workup	workup	NOUN
ajlm-1028	68	2	for	for	ADP
ajlm-1028	68	3	cases	case	NOUN
ajlm-1028	68	4	presenting	present	VERB
ajlm-1028	68	5	with	with	ADP
ajlm-1028	68	6	cytopenias	cytopenia	NOUN
ajlm-1028	68	7	formed	form	VERB
ajlm-1028	68	8	a	a	DET
ajlm-1028	68	9	great	great	ADJ
ajlm-1028	68	10	majority	majority	NOUN
ajlm-1028	68	11	of	of	ADP
ajlm-1028	68	12	bmat	bmat	ADJ
ajlm-1028	68	13	cases	case	NOUN
ajlm-1028	68	14	in	in	ADP
ajlm-1028	68	15	our	our	PRON
ajlm-1028	68	16	study	study	NOUN
ajlm-1028	68	17	.	.	PUNCT
ajlm-1028	69	1	these	these	DET
ajlm-1028	69	2	results	result	NOUN
ajlm-1028	69	3	are	be	AUX
ajlm-1028	69	4	similar	similar	ADJ
ajlm-1028	69	5	to	to	ADP
ajlm-1028	69	6	studies	study	NOUN
ajlm-1028	69	7	done	do	VERB
ajlm-1028	69	8	to	to	PART
ajlm-1028	69	9	assess	assess	VERB
ajlm-1028	69	10	the	the	DET
ajlm-1028	69	11	use	use	NOUN
ajlm-1028	69	12	of	of	ADP
ajlm-1028	69	13	bmat	bmat	NOUN
ajlm-1028	69	14	in	in	ADP
ajlm-1028	69	15	hospitals	hospital	NOUN
ajlm-1028	69	16	in	in	ADP
ajlm-1028	69	17	pakistan	pakistan	PROPN
ajlm-1028	69	18	and	and	CCONJ
ajlm-1028	69	19	india.15,16	india.15,16	ADJ
ajlm-1028	69	20	cytopenias	cytopenia	NOUN
ajlm-1028	69	21	are	be	AUX
ajlm-1028	69	22	well	well	ADV
ajlm-1028	69	23	documented	document	VERB
ajlm-1028	69	24	,	,	PUNCT
ajlm-1028	69	25	multifactorial	multifactorial	ADJ
ajlm-1028	69	26	complications	complication	NOUN
ajlm-1028	69	27	of	of	ADP
ajlm-1028	69	28	hiv	hiv	PROPN
ajlm-1028	69	29	infection.4,5	infection.4,5	NOUN
ajlm-1028	69	30	our	our	PRON
ajlm-1028	69	31	study	study	NOUN
ajlm-1028	69	32	demonstrated	demonstrate	VERB
ajlm-1028	69	33	that	that	SCONJ
ajlm-1028	69	34	46	46	NUM
ajlm-1028	69	35	%	%	NOUN
ajlm-1028	69	36	of	of	ADP
ajlm-1028	69	37	hiv	hiv	PROPN
ajlm-1028	69	38	-	-	PUNCT
ajlm-1028	69	39	positive	positive	ADJ
ajlm-1028	69	40	participants	participant	NOUN
ajlm-1028	69	41	had	have	VERB
ajlm-1028	69	42	one	one	NUM
ajlm-1028	69	43	or	or	CCONJ
ajlm-1028	69	44	more	more	ADJ
ajlm-1028	69	45	forms	form	NOUN
ajlm-1028	69	46	of	of	ADP
ajlm-1028	69	47	cytopenia	cytopenia	NOUN
ajlm-1028	69	48	:	:	PUNCT
ajlm-1028	69	49	anaemia	anaemia	NOUN
ajlm-1028	69	50	,	,	PUNCT
ajlm-1028	69	51	pancytopenia	pancytopenia	NOUN
ajlm-1028	69	52	,	,	PUNCT
ajlm-1028	69	53	bicytopenia	bicytopenia	PROPN
ajlm-1028	69	54	and	and	CCONJ
ajlm-1028	69	55	thrombocytopenia	thrombocytopenia	PROPN
ajlm-1028	69	56	.	.	PUNCT
ajlm-1028	70	1	a	a	DET
ajlm-1028	70	2	study	study	NOUN
ajlm-1028	70	3	conducted	conduct	VERB
ajlm-1028	70	4	in	in	ADP
ajlm-1028	70	5	uganda	uganda	PROPN
ajlm-1028	70	6	demonstrated	demonstrate	VERB
ajlm-1028	70	7	that	that	SCONJ
ajlm-1028	70	8	65	65	NUM
ajlm-1028	70	9	%	%	NOUN
ajlm-1028	70	10	of	of	ADP
ajlm-1028	70	11	antiretroviral	antiretroviral	ADJ
ajlm-1028	70	12	-	-	PUNCT
ajlm-1028	70	13	therapy	therapy	NOUN
ajlm-1028	70	14	-	-	PUNCT
ajlm-1028	70	15	naïve	naïve	ADJ
ajlm-1028	70	16	hiv	hiv	NOUN
ajlm-1028	70	17	-	-	PUNCT
ajlm-1028	70	18	positive	positive	ADJ
ajlm-1028	70	19	participants	participant	NOUN
ajlm-1028	70	20	had	have	VERB
ajlm-1028	70	21	a	a	DET
ajlm-1028	70	22	form	form	NOUN
ajlm-1028	70	23	of	of	ADP
ajlm-1028	70	24	cytopenia.17	cytopenia.17	ADJ
ajlm-1028	70	25	we	we	PRON
ajlm-1028	70	26	could	could	AUX
ajlm-1028	70	27	not	not	PART
ajlm-1028	70	28	draw	draw	VERB
ajlm-1028	70	29	any	any	DET
ajlm-1028	70	30	conclusion	conclusion	NOUN
ajlm-1028	70	31	with	with	ADP
ajlm-1028	70	32	this	this	DET
ajlm-1028	70	33	result	result	NOUN
ajlm-1028	70	34	,	,	PUNCT
ajlm-1028	70	35	as	as	SCONJ
ajlm-1028	70	36	we	we	PRON
ajlm-1028	70	37	had	have	AUX
ajlm-1028	70	38	not	not	PART
ajlm-1028	70	39	assessed	assess	VERB
ajlm-1028	70	40	the	the	DET
ajlm-1028	70	41	status	status	NOUN
ajlm-1028	70	42	of	of	ADP
ajlm-1028	70	43	antiretroviral	antiretroviral	ADJ
ajlm-1028	70	44	therapy	therapy	NOUN
ajlm-1028	70	45	use	use	NOUN
ajlm-1028	70	46	by	by	ADP
ajlm-1028	70	47	participants	participant	NOUN
ajlm-1028	70	48	.	.	PUNCT
ajlm-1028	71	1	age	age	NOUN
ajlm-1028	71	2	is	be	AUX
ajlm-1028	71	3	known	know	VERB
ajlm-1028	71	4	to	to	PART
ajlm-1028	71	5	be	be	AUX
ajlm-1028	71	6	one	one	NUM
ajlm-1028	71	7	of	of	ADP
ajlm-1028	71	8	the	the	DET
ajlm-1028	71	9	important	important	ADJ
ajlm-1028	71	10	risk	risk	NOUN
ajlm-1028	71	11	factors	factor	NOUN
ajlm-1028	71	12	for	for	ADP
ajlm-1028	71	13	developing	develop	VERB
ajlm-1028	71	14	haematological	haematological	ADJ
ajlm-1028	71	15	malignancy	malignancy	NOUN
ajlm-1028	71	16	.	.	PUNCT
ajlm-1028	72	1	in	in	ADP
ajlm-1028	72	2	our	our	PRON
ajlm-1028	72	3	study	study	NOUN
ajlm-1028	72	4	increasing	increase	VERB
ajlm-1028	72	5	age	age	NOUN
ajlm-1028	72	6	was	be	AUX
ajlm-1028	72	7	associated	associate	VERB
ajlm-1028	72	8	with	with	ADP
ajlm-1028	72	9	an	an	DET
ajlm-1028	72	10	increased	increase	VERB
ajlm-1028	72	11	prevalence	prevalence	NOUN
ajlm-1028	72	12	of	of	ADP
ajlm-1028	72	13	malignancy	malignancy	NOUN
ajlm-1028	72	14	.	.	PUNCT
ajlm-1028	73	1	the	the	DET
ajlm-1028	73	2	age	age	NOUN
ajlm-1028	73	3	group	group	NOUN
ajlm-1028	73	4	older	old	ADJ
ajlm-1028	73	5	than	than	ADP
ajlm-1028	73	6	age	age	NOUN
ajlm-1028	73	7	70	70	NUM
ajlm-1028	73	8	years	year	NOUN
ajlm-1028	73	9	had	have	VERB
ajlm-1028	73	10	the	the	DET
ajlm-1028	73	11	highest	high	ADJ
ajlm-1028	73	12	frequency	frequency	NOUN
ajlm-1028	73	13	of	of	ADP
ajlm-1028	73	14	malignancy	malignancy	NOUN
ajlm-1028	73	15	when	when	SCONJ
ajlm-1028	73	16	compared	compare	VERB
ajlm-1028	73	17	to	to	ADP
ajlm-1028	73	18	the	the	DET
ajlm-1028	73	19	younger	young	ADJ
ajlm-1028	73	20	age	age	NOUN
ajlm-1028	73	21	study	study	NOUN
ajlm-1028	73	22	population	population	NOUN
ajlm-1028	73	23	groups	group	NOUN
ajlm-1028	73	24	for	for	ADP
ajlm-1028	73	25	this	this	DET
ajlm-1028	73	26	study	study	NOUN
ajlm-1028	73	27	.	.	PUNCT
ajlm-1028	74	1	this	this	DET
ajlm-1028	74	2	outcome	outcome	NOUN
ajlm-1028	74	3	is	be	AUX
ajlm-1028	74	4	similar	similar	ADJ
ajlm-1028	74	5	to	to	ADP
ajlm-1028	74	6	other	other	ADJ
ajlm-1028	74	7	global	global	ADJ
ajlm-1028	74	8	studies	study	NOUN
ajlm-1028	74	9	that	that	PRON
ajlm-1028	74	10	have	have	AUX
ajlm-1028	74	11	assessed	assess	VERB
ajlm-1028	74	12	increasing	increase	VERB
ajlm-1028	74	13	age	age	NOUN
ajlm-1028	74	14	as	as	ADP
ajlm-1028	74	15	a	a	DET
ajlm-1028	74	16	risk	risk	NOUN
ajlm-1028	74	17	factor	factor	NOUN
ajlm-1028	74	18	for	for	ADP
ajlm-1028	74	19	developing	develop	VERB
ajlm-1028	74	20	malignancy.18,19,20	malignancy.18,19,20	NOUN
ajlm-1028	74	21	a	a	DET
ajlm-1028	74	22	study	study	NOUN
ajlm-1028	74	23	of	of	ADP
ajlm-1028	74	24	lymphoid	lymphoid	ADJ
ajlm-1028	74	25	neoplasms	neoplasm	NOUN
ajlm-1028	74	26	in	in	ADP
ajlm-1028	74	27	the	the	DET
ajlm-1028	74	28	united	united	PROPN
ajlm-1028	74	29	states	states	PROPN
ajlm-1028	74	30	demonstrated	demonstrate	VERB
ajlm-1028	74	31	that	that	SCONJ
ajlm-1028	74	32	the	the	DET
ajlm-1028	74	33	incidence	incidence	NOUN
ajlm-1028	74	34	of	of	ADP
ajlm-1028	74	35	haematological	haematological	ADJ
ajlm-1028	74	36	malignancy	malignancy	NOUN
ajlm-1028	74	37	in	in	ADP
ajlm-1028	74	38	cases	case	NOUN
ajlm-1028	74	39	older	old	ADJ
ajlm-1028	74	40	than	than	ADP
ajlm-1028	74	41	age	age	NOUN
ajlm-1028	74	42	75	75	NUM
ajlm-1028	74	43	years	year	NOUN
ajlm-1028	74	44	increased	increase	VERB
ajlm-1028	74	45	by	by	ADP
ajlm-1028	74	46	approximately	approximately	ADV
ajlm-1028	74	47	1.4	1.4	NUM
ajlm-1028	74	48	%	%	NOUN
ajlm-1028	74	49	for	for	ADP
ajlm-1028	74	50	dlbcl	dlbcl	NOUN
ajlm-1028	74	51	and	and	CCONJ
ajlm-1028	74	52	1.8	1.8	NUM
ajlm-1028	74	53	%	%	NOUN
ajlm-1028	74	54	for	for	ADP
ajlm-1028	74	55	follicular	follicular	ADJ
ajlm-1028	74	56	lymphoma	lymphoma	NOUN
ajlm-1028	74	57	per	per	ADP
ajlm-1028	74	58	year.19	year.19	NOUN
ajlm-1028	74	59	dlbcl	dlbcl	NOUN
ajlm-1028	74	60	is	be	AUX
ajlm-1028	74	61	associated	associate	VERB
ajlm-1028	74	62	with	with	ADP
ajlm-1028	74	63	high	high	ADJ
ajlm-1028	74	64	rates	rate	NOUN
ajlm-1028	74	65	of	of	ADP
ajlm-1028	74	66	hiv	hiv	PROPN
ajlm-1028	74	67	infection	infection	NOUN
ajlm-1028	74	68	among	among	ADP
ajlm-1028	74	69	cases.21	cases.21	PROPN
ajlm-1028	74	70	our	our	PRON
ajlm-1028	74	71	hiv	hiv	PROPN
ajlm-1028	74	72	and	and	CCONJ
ajlm-1028	74	73	dlbcl	dlbcl	NOUN
ajlm-1028	74	74	burdens	burden	NOUN
ajlm-1028	74	75	are	be	AUX
ajlm-1028	74	76	in	in	ADP
ajlm-1028	74	77	keeping	keep	VERB
ajlm-1028	74	78	with	with	ADP
ajlm-1028	74	79	the	the	DET
ajlm-1028	74	80	current	current	ADJ
ajlm-1028	74	81	rates	rate	NOUN
ajlm-1028	74	82	in	in	ADP
ajlm-1028	74	83	most	most	ADJ
ajlm-1028	74	84	countries	country	NOUN
ajlm-1028	74	85	throughout	throughout	ADP
ajlm-1028	74	86	the	the	DET
ajlm-1028	74	87	world.4,21	world.4,21	PROPN
ajlm-1028	74	88	hiv	hiv	PROPN
ajlm-1028	74	89	infection	infection	NOUN
ajlm-1028	74	90	was	be	AUX
ajlm-1028	74	91	highly	highly	ADV
ajlm-1028	74	92	prevalent	prevalent	ADJ
ajlm-1028	74	93	at	at	ADP
ajlm-1028	74	94	81	81	NUM
ajlm-1028	74	95	%	%	NOUN
ajlm-1028	74	96	among	among	ADP
ajlm-1028	74	97	the	the	DET
ajlm-1028	74	98	cases	case	NOUN
ajlm-1028	74	99	that	that	PRON
ajlm-1028	74	100	had	have	AUX
ajlm-1028	74	101	undergone	undergo	VERB
ajlm-1028	74	102	bone	bone	NOUN
ajlm-1028	74	103	marrow	marrow	NOUN
ajlm-1028	74	104	examination	examination	NOUN
ajlm-1028	74	105	for	for	ADP
ajlm-1028	74	106	the	the	DET
ajlm-1028	74	107	staging	staging	NOUN
ajlm-1028	74	108	of	of	ADP
ajlm-1028	74	109	the	the	DET
ajlm-1028	74	110	dlbcl	dlbcl	NOUN
ajlm-1028	74	111	.	.	PUNCT
ajlm-1028	75	1	this	this	DET
ajlm-1028	75	2	finding	finding	NOUN
ajlm-1028	75	3	about	about	ADP
ajlm-1028	75	4	prevalence	prevalence	NOUN
ajlm-1028	75	5	of	of	ADP
ajlm-1028	75	6	hiv	hiv	PROPN
ajlm-1028	75	7	infection	infection	NOUN
ajlm-1028	75	8	in	in	ADP
ajlm-1028	75	9	cases	case	NOUN
ajlm-1028	75	10	with	with	ADP
ajlm-1028	75	11	dlbcl	dlbcl	NOUN
ajlm-1028	75	12	was	be	AUX
ajlm-1028	75	13	similar	similar	ADJ
ajlm-1028	75	14	to	to	ADP
ajlm-1028	75	15	results	result	NOUN
ajlm-1028	75	16	of	of	ADP
ajlm-1028	75	17	a	a	DET
ajlm-1028	75	18	study	study	NOUN
ajlm-1028	75	19	done	do	VERB
ajlm-1028	75	20	at	at	ADP
ajlm-1028	75	21	a	a	DET
ajlm-1028	75	22	south	south	ADJ
ajlm-1028	75	23	african	african	ADJ
ajlm-1028	75	24	hospital	hospital	NOUN
ajlm-1028	75	25	in	in	ADP
ajlm-1028	75	26	2016	2016	NUM
ajlm-1028	75	27	which	which	PRON
ajlm-1028	75	28	reported	report	VERB
ajlm-1028	75	29	the	the	DET
ajlm-1028	75	30	prevalence	prevalence	NOUN
ajlm-1028	75	31	of	of	ADP
ajlm-1028	75	32	hiv	hiv	PROPN
ajlm-1028	75	33	as	as	ADP
ajlm-1028	75	34	81	81	NUM
ajlm-1028	75	35	%	%	NOUN
ajlm-1028	75	36	in	in	ADP
ajlm-1028	75	37	139	139	NUM
ajlm-1028	75	38	patients	patient	NOUN
ajlm-1028	75	39	with	with	ADP
ajlm-1028	75	40	dlbcl.22	dlbcl.22	PROPN
ajlm-1028	75	41	sixty	sixty	NUM
ajlm-1028	75	42	percent	percent	NOUN
ajlm-1028	75	43	of	of	ADP
ajlm-1028	75	44	cases	case	NOUN
ajlm-1028	75	45	of	of	ADP
ajlm-1028	75	46	dlbcl	dlbcl	NOUN
ajlm-1028	75	47	in	in	ADP
ajlm-1028	75	48	our	our	PRON
ajlm-1028	75	49	study	study	NOUN
ajlm-1028	75	50	had	have	VERB
ajlm-1028	75	51	a	a	DET
ajlm-1028	75	52	cd4	cd4	PROPN
ajlm-1028	75	53	lymphocyte	lymphocyte	ADJ
ajlm-1028	75	54	count	count	NOUN
ajlm-1028	75	55	≥	≥	NUM
ajlm-1028	75	56	200	200	NUM
ajlm-1028	75	57	cell/µl	cell/µl	NOUN
ajlm-1028	75	58	.	.	PUNCT
ajlm-1028	76	1	the	the	DET
ajlm-1028	76	2	median	median	ADJ
ajlm-1028	76	3	cd4	cd4	PROPN
ajlm-1028	76	4	count	count	NOUN
ajlm-1028	76	5	for	for	ADP
ajlm-1028	76	6	our	our	PRON
ajlm-1028	76	7	dlbcl	dlbcl	NOUN
ajlm-1028	76	8	group	group	NOUN
ajlm-1028	76	9	was	be	AUX
ajlm-1028	76	10	259	259	NUM
ajlm-1028	76	11	(	(	PUNCT
ajlm-1028	76	12	iqr	iqr	NOUN
ajlm-1028	76	13	:	:	PUNCT
ajlm-1028	76	14	131.2–351.6	131.2–351.6	NUM
ajlm-1028	76	15	)	)	PUNCT
ajlm-1028	76	16	cells/µl	cells/µl	NOUN
ajlm-1028	76	17	.	.	PUNCT
ajlm-1028	77	1	this	this	DET
ajlm-1028	77	2	outcome	outcome	NOUN
ajlm-1028	77	3	demonstrates	demonstrate	VERB
ajlm-1028	77	4	that	that	SCONJ
ajlm-1028	77	5	hiv	hiv	PROPN
ajlm-1028	77	6	infection	infection	NOUN
ajlm-1028	77	7	placed	place	VERB
ajlm-1028	77	8	patients	patient	NOUN
ajlm-1028	77	9	at	at	ADP
ajlm-1028	77	10	a	a	DET
ajlm-1028	77	11	higher	high	ADJ
ajlm-1028	77	12	risk	risk	NOUN
ajlm-1028	77	13	for	for	ADP
ajlm-1028	77	14	developing	develop	VERB
ajlm-1028	77	15	this	this	DET
ajlm-1028	77	16	malignancy	malignancy	NOUN
ajlm-1028	77	17	and	and	CCONJ
ajlm-1028	77	18	occurrence	occurrence	NOUN
ajlm-1028	77	19	of	of	ADP
ajlm-1028	77	20	the	the	DET
ajlm-1028	77	21	malignancy	malignancy	NOUN
ajlm-1028	77	22	did	do	AUX
ajlm-1028	77	23	not	not	PART
ajlm-1028	77	24	depend	depend	VERB
ajlm-1028	77	25	on	on	ADP
ajlm-1028	77	26	low	low	ADJ
ajlm-1028	77	27	cd4	cd4	PROPN
ajlm-1028	77	28	count	count	NOUN
ajlm-1028	77	29	.	.	PUNCT
ajlm-1028	78	1	in	in	ADP
ajlm-1028	78	2	the	the	DET
ajlm-1028	78	3	united	united	PROPN
ajlm-1028	78	4	states	states	PROPN
ajlm-1028	78	5	,	,	PUNCT
ajlm-1028	78	6	a	a	DET
ajlm-1028	78	7	report	report	NOUN
ajlm-1028	78	8	on	on	ADP
ajlm-1028	78	9	41	41	NUM
ajlm-1028	78	10	patients	patient	NOUN
ajlm-1028	78	11	diagnosed	diagnose	VERB
ajlm-1028	78	12	with	with	ADP
ajlm-1028	78	13	dlbcl	dlbcl	NOUN
ajlm-1028	78	14	concluded	conclude	VERB
ajlm-1028	78	15	that	that	SCONJ
ajlm-1028	78	16	the	the	DET
ajlm-1028	78	17	blood	blood	NOUN
ajlm-1028	78	18	cd4	cd4	PROPN
ajlm-1028	78	19	level	level	NOUN
ajlm-1028	78	20	was	be	AUX
ajlm-1028	78	21	a	a	DET
ajlm-1028	78	22	lesser	less	ADJ
ajlm-1028	78	23	factor	factor	NOUN
ajlm-1028	78	24	in	in	ADP
ajlm-1028	78	25	predicting	predict	VERB
ajlm-1028	78	26	the	the	DET
ajlm-1028	78	27	occurrence	occurrence	NOUN
ajlm-1028	78	28	of	of	ADP
ajlm-1028	78	29	dlbcl.23	dlbcl.23	PROPN
ajlm-1028	78	30	the	the	DET
ajlm-1028	78	31	median	median	NOUN
ajlm-1028	78	32	cd4	cd4	PROPN
ajlm-1028	78	33	count	count	NOUN
ajlm-1028	78	34	of	of	ADP
ajlm-1028	78	35	their	their	PRON
ajlm-1028	78	36	study	study	NOUN
ajlm-1028	78	37	was	be	AUX
ajlm-1028	78	38	400	400	NUM
ajlm-1028	78	39	cells/µl	cells/µl	NOUN
ajlm-1028	78	40	.	.	PUNCT
ajlm-1028	79	1	it	it	PRON
ajlm-1028	79	2	has	have	AUX
ajlm-1028	79	3	been	be	AUX
ajlm-1028	79	4	reported	report	VERB
ajlm-1028	79	5	that	that	SCONJ
ajlm-1028	79	6	a	a	DET
ajlm-1028	79	7	haemoglobin	haemoglobin	NOUN
ajlm-1028	79	8	value	value	NOUN
ajlm-1028	79	9	of	of	ADP
ajlm-1028	79	10	less	less	ADJ
ajlm-1028	79	11	than	than	ADP
ajlm-1028	79	12	10	10	NUM
ajlm-1028	79	13	g	g	NOUN
ajlm-1028	79	14	/	/	SYM
ajlm-1028	79	15	dl	dl	PROPN
ajlm-1028	79	16	and	and	CCONJ
ajlm-1028	79	17	white	white	ADJ
ajlm-1028	79	18	cell	cell	NOUN
ajlm-1028	79	19	count	count	NOUN
ajlm-1028	79	20	less	less	ADJ
ajlm-1028	79	21	than	than	ADP
ajlm-1028	79	22	4	4	NUM
ajlm-1028	79	23	×	×	NOUN
ajlm-1028	79	24	109	109	NUM
ajlm-1028	79	25	significantly	significantly	ADV
ajlm-1028	79	26	increases	increase	VERB
ajlm-1028	79	27	the	the	DET
ajlm-1028	79	28	likelihood	likelihood	NOUN
ajlm-1028	79	29	of	of	ADP
ajlm-1028	79	30	bone	bone	NOUN
ajlm-1028	79	31	marrow	marrow	PROPN
ajlm-1028	79	32	involvement	involvement	NOUN
ajlm-1028	79	33	in	in	ADP
ajlm-1028	79	34	non	non	ADJ
ajlm-1028	79	35	-	-	ADJ
ajlm-1028	79	36	hodgkin	hodgkin	ADJ
ajlm-1028	79	37	’s	’s	PART
ajlm-1028	79	38	lymphoma.24	lymphoma.24	NOUN
ajlm-1028	79	39	about	about	ADV
ajlm-1028	79	40	99	99	NUM
ajlm-1028	79	41	%	%	NOUN
ajlm-1028	79	42	of	of	ADP
ajlm-1028	79	43	cases	case	NOUN
ajlm-1028	79	44	reported	report	VERB
ajlm-1028	79	45	for	for	ADP
ajlm-1028	79	46	dlbcl	dlbcl	NOUN
ajlm-1028	79	47	in	in	ADP
ajlm-1028	79	48	our	our	PRON
ajlm-1028	79	49	study	study	NOUN
ajlm-1028	79	50	had	have	VERB
ajlm-1028	79	51	no	no	DET
ajlm-1028	79	52	bone	bone	NOUN
ajlm-1028	79	53	marrow	marrow	NOUN
ajlm-1028	79	54	infiltration	infiltration	NOUN
ajlm-1028	79	55	.	.	PUNCT
ajlm-1028	80	1	a	a	DET
ajlm-1028	80	2	large	large	ADJ
ajlm-1028	80	3	percentage	percentage	NOUN
ajlm-1028	80	4	(	(	PUNCT
ajlm-1028	80	5	72	72	NUM
ajlm-1028	80	6	%	%	NOUN
ajlm-1028	80	7	)	)	PUNCT
ajlm-1028	80	8	of	of	ADP
ajlm-1028	80	9	our	our	PRON
ajlm-1028	80	10	cases	case	NOUN
ajlm-1028	80	11	without	without	ADP
ajlm-1028	80	12	an	an	DET
ajlm-1028	80	13	infiltration	infiltration	NOUN
ajlm-1028	80	14	had	have	VERB
ajlm-1028	80	15	anaemia	anaemia	NOUN
ajlm-1028	80	16	with	with	ADP
ajlm-1028	80	17	a	a	DET
ajlm-1028	80	18	mean	mean	ADJ
ajlm-1028	80	19	haemoglobin	haemoglobin	NOUN
ajlm-1028	80	20	of	of	ADP
ajlm-1028	80	21	9.92	9.92	NUM
ajlm-1028	80	22	g	g	PROPN
ajlm-1028	80	23	/	/	SYM
ajlm-1028	80	24	dl	dl	PROPN
ajlm-1028	80	25	,	,	PUNCT
ajlm-1028	80	26	a	a	DET
ajlm-1028	80	27	mean	mean	ADJ
ajlm-1028	80	28	normal	normal	ADJ
ajlm-1028	80	29	white	white	ADJ
ajlm-1028	80	30	cell	cell	NOUN
ajlm-1028	80	31	count	count	NOUN
ajlm-1028	80	32	9.91	9.91	NUM
ajlm-1028	80	33	×	×	NOUN
ajlm-1028	80	34	109	109	NUM
ajlm-1028	80	35	/	/	SYM
ajlm-1028	80	36	l	l	NOUN
ajlm-1028	80	37	and	and	CCONJ
ajlm-1028	80	38	mean	mean	VERB
ajlm-1028	80	39	platelet	platelet	NOUN
ajlm-1028	80	40	counts	count	NOUN
ajlm-1028	80	41	of	of	ADP
ajlm-1028	80	42	340	340	NUM
ajlm-1028	80	43	×	×	NOUN
ajlm-1028	80	44	109	109	NUM
ajlm-1028	80	45	/	/	SYM
ajlm-1028	80	46	l.	l.	PROPN
ajlm-1028	80	47	other	other	ADJ
ajlm-1028	80	48	reasons	reason	NOUN
ajlm-1028	80	49	for	for	ADP
ajlm-1028	80	50	the	the	DET
ajlm-1028	80	51	development	development	NOUN
ajlm-1028	80	52	of	of	ADP
ajlm-1028	80	53	anaemia	anaemia	NOUN
ajlm-1028	80	54	,	,	PUNCT
ajlm-1028	80	55	such	such	ADJ
ajlm-1028	80	56	as	as	ADP
ajlm-1028	80	57	:	:	PUNCT
ajlm-1028	80	58	myelosupression	myelosupression	NOUN
ajlm-1028	80	59	secondary	secondary	ADJ
ajlm-1028	80	60	to	to	ADP
ajlm-1028	80	61	chemotherapy	chemotherapy	NOUN
ajlm-1028	80	62	,	,	PUNCT
ajlm-1028	80	63	anaemia	anaemia	NOUN
ajlm-1028	80	64	associated	associate	VERB
ajlm-1028	80	65	with	with	ADP
ajlm-1028	80	66	chronic	chronic	ADJ
ajlm-1028	80	67	disease	disease	NOUN
ajlm-1028	80	68	,	,	PUNCT
ajlm-1028	80	69	autoimmune	autoimmune	ADJ
ajlm-1028	80	70	haemolytic	haemolytic	PROPN
ajlm-1028	80	71	anaemia	anaemia	NOUN
ajlm-1028	80	72	,	,	PUNCT
ajlm-1028	80	73	iron	iron	NOUN
ajlm-1028	80	74	deficiency	deficiency	NOUN
ajlm-1028	80	75	and	and	CCONJ
ajlm-1028	80	76	tumour	tumour	NOUN
ajlm-1028	80	77	infiltration	infiltration	NOUN
ajlm-1028	80	78	of	of	ADP
ajlm-1028	80	79	bone	bone	NOUN
ajlm-1028	80	80	marrow	marrow	NOUN
ajlm-1028	80	81	,	,	PUNCT
ajlm-1028	80	82	need	need	VERB
ajlm-1028	80	83	to	to	PART
ajlm-1028	80	84	be	be	AUX
ajlm-1028	80	85	explored	explore	VERB
ajlm-1028	80	86	in	in	ADP
ajlm-1028	80	87	patients	patient	NOUN
ajlm-1028	80	88	with	with	ADP
ajlm-1028	80	89	dlbcl	dlbcl	NOUN
ajlm-1028	80	90	to	to	PART
ajlm-1028	80	91	identify	identify	VERB
ajlm-1028	80	92	a	a	DET
ajlm-1028	80	93	potential	potential	ADJ
ajlm-1028	80	94	aetiology.25	aetiology.25	NOUN
ajlm-1028	80	95	the	the	DET
ajlm-1028	80	96	majority	majority	NOUN
ajlm-1028	80	97	of	of	ADP
ajlm-1028	80	98	the	the	DET
ajlm-1028	80	99	bmats	bmat	NOUN
ajlm-1028	80	100	of	of	ADP
ajlm-1028	80	101	cases	case	NOUN
ajlm-1028	80	102	with	with	ADP
ajlm-1028	80	103	dlbcl	dlbcl	NOUN
ajlm-1028	80	104	were	be	AUX
ajlm-1028	80	105	done	do	VERB
ajlm-1028	80	106	as	as	ADP
ajlm-1028	80	107	part	part	NOUN
ajlm-1028	80	108	of	of	ADP
ajlm-1028	80	109	treatment	treatment	NOUN
ajlm-1028	80	110	planning	planning	NOUN
ajlm-1028	80	111	.	.	PUNCT
ajlm-1028	81	1	our	our	PRON
ajlm-1028	81	2	hospital	hospital	NOUN
ajlm-1028	81	3	uses	use	VERB
ajlm-1028	81	4	computerized	computerized	ADJ
ajlm-1028	81	5	tomography	tomography	NOUN
ajlm-1028	81	6	(	(	PUNCT
ajlm-1028	81	7	ct	ct	NOUN
ajlm-1028	81	8	)	)	PUNCT
ajlm-1028	81	9	scanning	scanning	NOUN
ajlm-1028	81	10	and	and	CCONJ
ajlm-1028	81	11	bone	bone	NOUN
ajlm-1028	81	12	marrow	marrow	NOUN
ajlm-1028	81	13	examination	examination	NOUN
ajlm-1028	81	14	for	for	ADP
ajlm-1028	81	15	staging	stage	VERB
ajlm-1028	81	16	malignancy	malignancy	NOUN
ajlm-1028	81	17	.	.	PUNCT
ajlm-1028	82	1	our	our	PRON
ajlm-1028	82	2	access	access	NOUN
ajlm-1028	82	3	to	to	ADP
ajlm-1028	82	4	flourine-18	flourine-18	NOUN
ajlm-1028	82	5	-	-	PUNCT
ajlm-1028	82	6	flourodeoxyglucose	flourodeoxyglucose	VERB
ajlm-1028	82	7	position	position	NOUN
ajlm-1028	82	8	emission	emission	NOUN
ajlm-1028	82	9	tomography	tomography	NOUN
ajlm-1028	82	10	(	(	PUNCT
ajlm-1028	82	11	pet	pet	NOUN
ajlm-1028	82	12	)	)	PUNCT
ajlm-1028	82	13	scanning	scanning	NOUN
ajlm-1028	82	14	is	be	AUX
ajlm-1028	82	15	limited	limit	VERB
ajlm-1028	82	16	in	in	ADP
ajlm-1028	82	17	our	our	PRON
ajlm-1028	82	18	setting	setting	NOUN
ajlm-1028	82	19	.	.	PUNCT
ajlm-1028	83	1	pet	pet	ADJ
ajlm-1028	83	2	scanning	scanning	NOUN
ajlm-1028	83	3	has	have	AUX
ajlm-1028	83	4	been	be	AUX
ajlm-1028	83	5	recommended	recommend	VERB
ajlm-1028	83	6	in	in	ADP
ajlm-1028	83	7	the	the	DET
ajlm-1028	83	8	literature	literature	NOUN
ajlm-1028	83	9	as	as	ADP
ajlm-1028	83	10	a	a	DET
ajlm-1028	83	11	superior	superior	ADJ
ajlm-1028	83	12	staging	staging	NOUN
ajlm-1028	83	13	modality	modality	NOUN
ajlm-1028	83	14	for	for	ADP
ajlm-1028	83	15	bone	bone	NOUN
ajlm-1028	83	16	marrow	marrow	PROPN
ajlm-1028	83	17	involvement	involvement	NOUN
ajlm-1028	83	18	in	in	ADP
ajlm-1028	83	19	lymphoma	lymphoma	NOUN
ajlm-1028	83	20	sufferers.26	sufferers.26	ADJ
ajlm-1028	83	21	medical	medical	ADJ
ajlm-1028	83	22	literature	literature	NOUN
ajlm-1028	83	23	has	have	AUX
ajlm-1028	83	24	documented	document	VERB
ajlm-1028	83	25	the	the	DET
ajlm-1028	83	26	limitations	limitation	NOUN
ajlm-1028	83	27	of	of	ADP
ajlm-1028	83	28	bone	bone	NOUN
ajlm-1028	83	29	marrow	marrow	NOUN
ajlm-1028	83	30	examination	examination	NOUN
ajlm-1028	83	31	in	in	ADP
ajlm-1028	83	32	patients	patient	NOUN
ajlm-1028	83	33	with	with	ADP
ajlm-1028	83	34	aggressive	aggressive	ADJ
ajlm-1028	83	35	dlbcl	dlbcl	NOUN
ajlm-1028	83	36	and	and	CCONJ
ajlm-1028	83	37	early	early	ADJ
ajlm-1028	83	38	lymphoma.26	lymphoma.26	ADJ
ajlm-1028	83	39	other	other	ADJ
ajlm-1028	83	40	studies	study	NOUN
ajlm-1028	83	41	suggest	suggest	VERB
ajlm-1028	83	42	that	that	SCONJ
ajlm-1028	83	43	pet	pet	ADJ
ajlm-1028	83	44	/	/	SYM
ajlm-1028	83	45	ct	ct	NOUN
ajlm-1028	83	46	scanning	scanning	NOUN
ajlm-1028	83	47	is	be	AUX
ajlm-1028	83	48	more	more	ADV
ajlm-1028	83	49	useful	useful	ADJ
ajlm-1028	83	50	in	in	ADP
ajlm-1028	83	51	assessing	assess	VERB
ajlm-1028	83	52	the	the	DET
ajlm-1028	83	53	involvement	involvement	NOUN
ajlm-1028	83	54	of	of	ADP
ajlm-1028	83	55	the	the	DET
ajlm-1028	83	56	bone	bone	NOUN
ajlm-1028	83	57	marrow.26,27	marrow.26,27	NOUN
ajlm-1028	83	58	improved	improve	VERB
ajlm-1028	83	59	access	access	NOUN
ajlm-1028	83	60	to	to	ADP
ajlm-1028	83	61	pet	pet	NOUN
ajlm-1028	83	62	/	/	SYM
ajlm-1028	83	63	ct	ct	PROPN
ajlm-1028	83	64	scanning	scanning	NOUN
ajlm-1028	83	65	would	would	AUX
ajlm-1028	83	66	reduce	reduce	VERB
ajlm-1028	83	67	the	the	DET
ajlm-1028	83	68	frequencies	frequency	NOUN
ajlm-1028	83	69	of	of	ADP
ajlm-1028	83	70	bone	bone	NOUN
ajlm-1028	83	71	marrow	marrow	NOUN
ajlm-1028	83	72	examinations	examination	NOUN
ajlm-1028	83	73	in	in	ADP
ajlm-1028	83	74	lymphoma	lymphoma	NOUN
ajlm-1028	83	75	sufferers	sufferer	NOUN
ajlm-1028	83	76	,	,	PUNCT
ajlm-1028	83	77	as	as	SCONJ
ajlm-1028	83	78	most	most	ADJ
ajlm-1028	83	79	studies	study	NOUN
ajlm-1028	83	80	suggest	suggest	VERB
ajlm-1028	83	81	that	that	SCONJ
ajlm-1028	83	82	it	it	PRON
ajlm-1028	83	83	should	should	AUX
ajlm-1028	83	84	be	be	AUX
ajlm-1028	83	85	considered	consider	VERB
ajlm-1028	83	86	as	as	SCONJ
ajlm-1028	83	87	a	a	DET
ajlm-1028	83	88	first	first	ADJ
ajlm-1028	83	89	-	-	PUNCT
ajlm-1028	83	90	line	line	NOUN
ajlm-1028	83	91	examination	examination	NOUN
ajlm-1028	83	92	of	of	ADP
ajlm-1028	83	93	bone	bone	NOUN
ajlm-1028	83	94	marrow	marrow	NOUN
ajlm-1028	83	95	in	in	ADP
ajlm-1028	83	96	lymphoma	lymphoma	NOUN
ajlm-1028	83	97	patients.26,27	patients.26,27	ADJ
ajlm-1028	83	98	bone	bone	NOUN
ajlm-1028	83	99	marrow	marrow	PROPN
ajlm-1028	83	100	infiltration	infiltration	NOUN
ajlm-1028	83	101	in	in	ADP
ajlm-1028	83	102	dlbcl	dlbcl	NOUN
ajlm-1028	83	103	can	can	AUX
ajlm-1028	83	104	easily	easily	ADV
ajlm-1028	83	105	be	be	AUX
ajlm-1028	83	106	missed	miss	VERB
ajlm-1028	83	107	as	as	SCONJ
ajlm-1028	83	108	most	most	ADJ
ajlm-1028	83	109	dlbcl	dlbcl	NOUN
ajlm-1028	83	110	infiltration	infiltration	NOUN
ajlm-1028	83	111	are	be	AUX
ajlm-1028	83	112	focal	focal	ADJ
ajlm-1028	83	113	rather	rather	ADV
ajlm-1028	83	114	than	than	ADP
ajlm-1028	83	115	diffuse.26	diffuse.26	ADJ
ajlm-1028	83	116	pet	pet	NOUN
ajlm-1028	83	117	/	/	SYM
ajlm-1028	83	118	ct	ct	PROPN
ajlm-1028	83	119	has	have	VERB
ajlm-1028	83	120	a	a	DET
ajlm-1028	83	121	much	much	ADV
ajlm-1028	83	122	more	more	ADV
ajlm-1028	83	123	superior	superior	ADJ
ajlm-1028	83	124	sensitivity	sensitivity	NOUN
ajlm-1028	83	125	(	(	PUNCT
ajlm-1028	83	126	94	94	NUM
ajlm-1028	83	127	%	%	NOUN
ajlm-1028	83	128	vs.	vs.	ADP
ajlm-1028	83	129	24	24	NUM
ajlm-1028	83	130	%	%	NOUN
ajlm-1028	83	131	)	)	PUNCT
ajlm-1028	83	132	and	and	CCONJ
ajlm-1028	83	133	a	a	DET
ajlm-1028	83	134	higher	high	ADJ
ajlm-1028	83	135	negative	negative	ADJ
ajlm-1028	83	136	predictive	predictive	ADJ
ajlm-1028	83	137	value	value	NOUN
ajlm-1028	83	138	(	(	PUNCT
ajlm-1028	83	139	98	98	NUM
ajlm-1028	83	140	%	%	NOUN
ajlm-1028	83	141	vs.	vs.	ADP
ajlm-1028	83	142	80	80	NUM
ajlm-1028	83	143	%	%	NOUN
ajlm-1028	83	144	)	)	PUNCT
ajlm-1028	83	145	when	when	SCONJ
ajlm-1028	83	146	compared	compare	VERB
ajlm-1028	83	147	to	to	ADP
ajlm-1028	83	148	a	a	DET
ajlm-1028	83	149	bone	bone	NOUN
ajlm-1028	83	150	marrow	marrow	NOUN
ajlm-1028	83	151	examination.27	examination.27	PROPN
ajlm-1028	83	152	in	in	ADP
ajlm-1028	83	153	our	our	PRON
ajlm-1028	83	154	study	study	NOUN
ajlm-1028	83	155	there	there	PRON
ajlm-1028	83	156	was	be	VERB
ajlm-1028	83	157	only	only	ADV
ajlm-1028	83	158	one	one	NUM
ajlm-1028	83	159	case	case	NOUN
ajlm-1028	83	160	reported	report	VERB
ajlm-1028	83	161	as	as	ADP
ajlm-1028	83	162	nutritional	nutritional	ADJ
ajlm-1028	83	163	deficiency	deficiency	NOUN
ajlm-1028	83	164	and	and	CCONJ
ajlm-1028	83	165	that	that	PRON
ajlm-1028	83	166	was	be	AUX
ajlm-1028	83	167	megaloblastic	megaloblastic	ADJ
ajlm-1028	83	168	anaemia	anaemia	NOUN
ajlm-1028	83	169	due	due	ADJ
ajlm-1028	83	170	to	to	PART
ajlm-1028	83	171	folate	folate	VERB
ajlm-1028	83	172	deficiency	deficiency	NOUN
ajlm-1028	83	173	.	.	PUNCT
ajlm-1028	84	1	our	our	PRON
ajlm-1028	84	2	findings	finding	NOUN
ajlm-1028	84	3	are	be	AUX
ajlm-1028	84	4	in	in	ADP
ajlm-1028	84	5	line	line	NOUN
ajlm-1028	84	6	with	with	ADP
ajlm-1028	84	7	the	the	DET
ajlm-1028	84	8	current	current	ADJ
ajlm-1028	84	9	practice	practice	NOUN
ajlm-1028	84	10	in	in	ADP
ajlm-1028	84	11	south	south	PROPN
ajlm-1028	84	12	africa	africa	PROPN
ajlm-1028	84	13	,	,	PUNCT
ajlm-1028	84	14	which	which	PRON
ajlm-1028	84	15	states	state	VERB
ajlm-1028	84	16	that	that	SCONJ
ajlm-1028	84	17	bone	bone	NOUN
ajlm-1028	84	18	marrow	marrow	NOUN
ajlm-1028	84	19	examination	examination	NOUN
ajlm-1028	84	20	is	be	AUX
ajlm-1028	84	21	done	do	VERB
ajlm-1028	84	22	to	to	PART
ajlm-1028	84	23	prove	prove	VERB
ajlm-1028	84	24	another	another	DET
ajlm-1028	84	25	diagnosis	diagnosis	NOUN
ajlm-1028	84	26	other	other	ADJ
ajlm-1028	84	27	than	than	ADP
ajlm-1028	84	28	confirming	confirm	VERB
ajlm-1028	84	29	nutritional	nutritional	ADJ
ajlm-1028	84	30	deficiencies	deficiency	NOUN
ajlm-1028	84	31	.	.	PUNCT
ajlm-1028	85	1	in	in	ADP
ajlm-1028	85	2	our	our	PRON
ajlm-1028	85	3	current	current	ADJ
ajlm-1028	85	4	limited	limited	ADJ
ajlm-1028	85	5	resource	resource	NOUN
ajlm-1028	85	6	situation	situation	NOUN
ajlm-1028	85	7	,	,	PUNCT
ajlm-1028	85	8	the	the	DET
ajlm-1028	85	9	practice	practice	NOUN
ajlm-1028	85	10	is	be	AUX
ajlm-1028	85	11	to	to	PART
ajlm-1028	85	12	correct	correct	VERB
ajlm-1028	85	13	reversible	reversible	ADJ
ajlm-1028	85	14	factors	factor	NOUN
ajlm-1028	85	15	such	such	ADJ
ajlm-1028	85	16	as	as	ADP
ajlm-1028	85	17	nutritional	nutritional	ADJ
ajlm-1028	85	18	disorders	disorder	NOUN
ajlm-1028	85	19	having	have	VERB
ajlm-1028	85	20	a	a	DET
ajlm-1028	85	21	haematological	haematological	ADJ
ajlm-1028	85	22	impact	impact	NOUN
ajlm-1028	85	23	first	first	ADV
ajlm-1028	85	24	before	before	ADP
ajlm-1028	85	25	subjecting	subject	VERB
ajlm-1028	85	26	patients	patient	NOUN
ajlm-1028	85	27	to	to	ADP
ajlm-1028	85	28	more	more	ADV
ajlm-1028	85	29	expensive	expensive	ADJ
ajlm-1028	85	30	and	and	CCONJ
ajlm-1028	85	31	invasive	invasive	ADJ
ajlm-1028	85	32	investigations	investigation	NOUN
ajlm-1028	85	33	.	.	PUNCT
ajlm-1028	86	1	in	in	ADP
ajlm-1028	86	2	the	the	DET
ajlm-1028	86	3	south	south	ADJ
ajlm-1028	86	4	african	african	ADJ
ajlm-1028	86	5	health	health	NOUN
ajlm-1028	86	6	system	system	NOUN
ajlm-1028	86	7	,	,	PUNCT
ajlm-1028	86	8	both	both	CCONJ
ajlm-1028	86	9	in	in	ADP
ajlm-1028	86	10	the	the	DET
ajlm-1028	86	11	private	private	ADJ
ajlm-1028	86	12	and	and	CCONJ
ajlm-1028	86	13	public	public	ADJ
ajlm-1028	86	14	sector	sector	NOUN
ajlm-1028	86	15	,	,	PUNCT
ajlm-1028	86	16	there	there	PRON
ajlm-1028	86	17	is	be	VERB
ajlm-1028	86	18	easy	easy	ADJ
ajlm-1028	86	19	access	access	NOUN
ajlm-1028	86	20	to	to	ADP
ajlm-1028	86	21	testing	testing	NOUN
ajlm-1028	86	22	for	for	ADP
ajlm-1028	86	23	nutritional	nutritional	ADJ
ajlm-1028	86	24	deficiencies	deficiency	NOUN
ajlm-1028	86	25	without	without	ADP
ajlm-1028	86	26	having	have	VERB
ajlm-1028	86	27	first	first	ADV
ajlm-1028	86	28	to	to	PART
ajlm-1028	86	29	do	do	VERB
ajlm-1028	86	30	bmat	bmat	NOUN
ajlm-1028	86	31	.	.	PUNCT
ajlm-1028	87	1	this	this	PRON
ajlm-1028	87	2	is	be	AUX
ajlm-1028	87	3	possibly	possibly	ADV
ajlm-1028	87	4	the	the	DET
ajlm-1028	87	5	reason	reason	NOUN
ajlm-1028	87	6	why	why	SCONJ
ajlm-1028	87	7	there	there	PRON
ajlm-1028	87	8	was	be	VERB
ajlm-1028	87	9	a	a	DET
ajlm-1028	87	10	paucity	paucity	NOUN
ajlm-1028	87	11	of	of	ADP
ajlm-1028	87	12	bmat	bmat	NOUN
ajlm-1028	87	13	done	do	VERB
ajlm-1028	87	14	in	in	ADP
ajlm-1028	87	15	our	our	PRON
ajlm-1028	87	16	study	study	NOUN
ajlm-1028	87	17	that	that	PRON
ajlm-1028	87	18	showed	show	VERB
ajlm-1028	87	19	nutritional	nutritional	ADJ
ajlm-1028	87	20	deficiencies	deficiency	NOUN
ajlm-1028	87	21	.	.	PUNCT
ajlm-1028	88	1	we	we	PRON
ajlm-1028	88	2	expect	expect	VERB
ajlm-1028	88	3	this	this	DET
ajlm-1028	88	4	trend	trend	NOUN
ajlm-1028	88	5	to	to	PART
ajlm-1028	88	6	continue	continue	VERB
ajlm-1028	88	7	in	in	ADP
ajlm-1028	88	8	our	our	PRON
ajlm-1028	88	9	setting	setting	NOUN
ajlm-1028	88	10	because	because	SCONJ
ajlm-1028	88	11	of	of	ADP
ajlm-1028	88	12	the	the	DET
ajlm-1028	88	13	required	require	VERB
ajlm-1028	88	14	screening	screening	NOUN
ajlm-1028	88	15	of	of	ADP
ajlm-1028	88	16	nutritional	nutritional	ADJ
ajlm-1028	88	17	deficiencies	deficiency	NOUN
ajlm-1028	88	18	in	in	ADP
ajlm-1028	88	19	our	our	PRON
ajlm-1028	88	20	south	south	ADJ
ajlm-1028	88	21	african	african	ADJ
ajlm-1028	88	22	institutions	institution	NOUN
ajlm-1028	88	23	.	.	PUNCT
ajlm-1028	89	1	limitations	limitation	NOUN
ajlm-1028	89	2	as	as	SCONJ
ajlm-1028	89	3	this	this	PRON
ajlm-1028	89	4	was	be	AUX
ajlm-1028	89	5	a	a	DET
ajlm-1028	89	6	retrospective	retrospective	ADJ
ajlm-1028	89	7	study	study	NOUN
ajlm-1028	89	8	,	,	PUNCT
ajlm-1028	89	9	we	we	PRON
ajlm-1028	89	10	were	be	AUX
ajlm-1028	89	11	not	not	PART
ajlm-1028	89	12	able	able	ADJ
ajlm-1028	89	13	to	to	PART
ajlm-1028	89	14	follow	follow	VERB
ajlm-1028	89	15	up	up	ADP
ajlm-1028	89	16	on	on	ADP
ajlm-1028	89	17	the	the	DET
ajlm-1028	89	18	end	end	NOUN
ajlm-1028	89	19	-	-	PUNCT
ajlm-1028	89	20	point	point	NOUN
ajlm-1028	89	21	of	of	ADP
ajlm-1028	89	22	the	the	DET
ajlm-1028	89	23	cases	case	NOUN
ajlm-1028	89	24	that	that	PRON
ajlm-1028	89	25	had	have	VERB
ajlm-1028	89	26	dlbcl	dlbcl	NOUN
ajlm-1028	89	27	or	or	CCONJ
ajlm-1028	89	28	other	other	ADJ
ajlm-1028	89	29	malignancies	malignancy	NOUN
ajlm-1028	89	30	nor	nor	CCONJ
ajlm-1028	89	31	were	be	AUX
ajlm-1028	89	32	we	we	PRON
ajlm-1028	89	33	able	able	ADJ
ajlm-1028	89	34	to	to	PART
ajlm-1028	89	35	assess	assess	VERB
ajlm-1028	89	36	the	the	DET
ajlm-1028	89	37	number	number	NOUN
ajlm-1028	89	38	of	of	ADP
ajlm-1028	89	39	patients	patient	NOUN
ajlm-1028	89	40	that	that	PRON
ajlm-1028	89	41	were	be	AUX
ajlm-1028	89	42	on	on	ADP
ajlm-1028	89	43	antiretroviral	antiretroviral	ADJ
ajlm-1028	89	44	medications	medication	NOUN
ajlm-1028	89	45	.	.	PUNCT
ajlm-1028	90	1	since	since	SCONJ
ajlm-1028	90	2	the	the	DET
ajlm-1028	90	3	study	study	NOUN
ajlm-1028	90	4	site	site	NOUN
ajlm-1028	90	5	is	be	AUX
ajlm-1028	90	6	a	a	DET
ajlm-1028	90	7	referral	referral	ADJ
ajlm-1028	90	8	centre	centre	NOUN
ajlm-1028	90	9	,	,	PUNCT
ajlm-1028	90	10	the	the	DET
ajlm-1028	90	11	patients	patient	NOUN
ajlm-1028	90	12	that	that	PRON
ajlm-1028	90	13	are	be	AUX
ajlm-1028	90	14	referred	refer	VERB
ajlm-1028	90	15	across	across	ADP
ajlm-1028	90	16	come	come	VERB
ajlm-1028	90	17	mostly	mostly	ADV
ajlm-1028	90	18	with	with	ADP
ajlm-1028	90	19	initial	initial	ADJ
ajlm-1028	90	20	exclusion	exclusion	NOUN
ajlm-1028	90	21	of	of	ADP
ajlm-1028	90	22	a	a	DET
ajlm-1028	90	23	reversible	reversible	ADJ
ajlm-1028	90	24	cause	cause	NOUN
ajlm-1028	90	25	for	for	ADP
ajlm-1028	90	26	bone	bone	NOUN
ajlm-1028	90	27	marrow	marrow	NOUN
ajlm-1028	90	28	failure	failure	NOUN
ajlm-1028	90	29	.	.	PUNCT
ajlm-1028	91	1	our	our	PRON
ajlm-1028	91	2	results	result	NOUN
ajlm-1028	91	3	might	might	AUX
ajlm-1028	91	4	also	also	ADV
ajlm-1028	91	5	be	be	AUX
ajlm-1028	91	6	influenced	influence	VERB
ajlm-1028	91	7	by	by	ADP
ajlm-1028	91	8	the	the	DET
ajlm-1028	91	9	study	study	NOUN
ajlm-1028	91	10	population	population	NOUN
ajlm-1028	91	11	as	as	SCONJ
ajlm-1028	91	12	it	it	PRON
ajlm-1028	91	13	only	only	ADV
ajlm-1028	91	14	represents	represent	VERB
ajlm-1028	91	15	patients	patient	NOUN
ajlm-1028	91	16	who	who	PRON
ajlm-1028	91	17	were	be	AUX
ajlm-1028	91	18	treated	treat	VERB
ajlm-1028	91	19	by	by	ADP
ajlm-1028	91	20	the	the	DET
ajlm-1028	91	21	haematologists	haematologist	NOUN
ajlm-1028	91	22	with	with	ADP
ajlm-1028	91	23	experience	experience	NOUN
ajlm-1028	91	24	in	in	ADP
ajlm-1028	91	25	such	such	ADJ
ajlm-1028	91	26	cases	case	NOUN
ajlm-1028	91	27	.	.	PUNCT
ajlm-1028	92	1	recommendations	recommendation	NOUN
ajlm-1028	92	2	based	base	VERB
ajlm-1028	92	3	on	on	ADP
ajlm-1028	92	4	the	the	DET
ajlm-1028	92	5	odds	odd	NOUN
ajlm-1028	92	6	ratio	ratio	NOUN
ajlm-1028	92	7	of	of	ADP
ajlm-1028	92	8	cases	case	NOUN
ajlm-1028	92	9	older	old	ADJ
ajlm-1028	92	10	than	than	ADP
ajlm-1028	92	11	age	age	NOUN
ajlm-1028	92	12	50	50	NUM
ajlm-1028	92	13	years	year	NOUN
ajlm-1028	92	14	in	in	ADP
ajlm-1028	92	15	this	this	DET
ajlm-1028	92	16	study	study	NOUN
ajlm-1028	92	17	,	,	PUNCT
ajlm-1028	92	18	we	we	PRON
ajlm-1028	92	19	recommend	recommend	VERB
ajlm-1028	92	20	treating	treat	VERB
ajlm-1028	92	21	physicians	physician	NOUN
ajlm-1028	92	22	to	to	PART
ajlm-1028	92	23	have	have	VERB
ajlm-1028	92	24	a	a	DET
ajlm-1028	92	25	low	low	ADJ
ajlm-1028	92	26	threshold	threshold	NOUN
ajlm-1028	92	27	for	for	ADP
ajlm-1028	92	28	performing	perform	VERB
ajlm-1028	92	29	bmat	bmat	NOUN
ajlm-1028	92	30	in	in	ADP
ajlm-1028	92	31	patients	patient	NOUN
ajlm-1028	92	32	aged	age	VERB
ajlm-1028	92	33	50	50	NUM
ajlm-1028	92	34	years	year	NOUN
ajlm-1028	92	35	and	and	CCONJ
ajlm-1028	92	36	older	old	ADJ
ajlm-1028	92	37	who	who	PRON
ajlm-1028	92	38	present	present	VERB
ajlm-1028	92	39	with	with	ADP
ajlm-1028	92	40	any	any	DET
ajlm-1028	92	41	cytopenias	cytopenia	NOUN
ajlm-1028	92	42	,	,	PUNCT
ajlm-1028	92	43	as	as	SCONJ
ajlm-1028	92	44	this	this	PRON
ajlm-1028	92	45	has	have	AUX
ajlm-1028	92	46	shown	show	VERB
ajlm-1028	92	47	an	an	DET
ajlm-1028	92	48	increased	increase	VERB
ajlm-1028	92	49	likelihood	likelihood	NOUN
ajlm-1028	92	50	of	of	ADP
ajlm-1028	92	51	a	a	DET
ajlm-1028	92	52	malignant	malignant	ADJ
ajlm-1028	92	53	diagnosis	diagnosis	NOUN
ajlm-1028	92	54	.	.	PUNCT
ajlm-1028	93	1	we	we	PRON
ajlm-1028	93	2	also	also	ADV
ajlm-1028	93	3	recommend	recommend	VERB
ajlm-1028	93	4	an	an	DET
ajlm-1028	93	5	early	early	ADJ
ajlm-1028	93	6	peripheral	peripheral	ADJ
ajlm-1028	93	7	tissue	tissue	NOUN
ajlm-1028	93	8	biopsy	biopsy	NOUN
ajlm-1028	93	9	in	in	ADP
ajlm-1028	93	10	conjunction	conjunction	NOUN
ajlm-1028	93	11	with	with	ADP
ajlm-1028	93	12	bmat	bmat	NOUN
ajlm-1028	93	13	in	in	ADP
ajlm-1028	93	14	hiv	hiv	PROPN
ajlm-1028	93	15	-	-	PUNCT
ajlm-1028	93	16	positive	positive	ADJ
ajlm-1028	93	17	individuals	individual	NOUN
ajlm-1028	93	18	presenting	present	VERB
ajlm-1028	93	19	with	with	ADP
ajlm-1028	93	20	constitutional	constitutional	ADJ
ajlm-1028	93	21	symptoms	symptom	NOUN
ajlm-1028	93	22	of	of	ADP
ajlm-1028	93	23	malignancy	malignancy	NOUN
ajlm-1028	93	24	,	,	PUNCT
ajlm-1028	93	25	lymphadenopathy	lymphadenopathy	ADJ
ajlm-1028	93	26	,	,	PUNCT
ajlm-1028	93	27	or	or	CCONJ
ajlm-1028	93	28	cytopenias	cytopenia	NOUN
ajlm-1028	93	29	for	for	ADP
ajlm-1028	93	30	early	early	ADJ
ajlm-1028	93	31	identification	identification	NOUN
ajlm-1028	93	32	of	of	ADP
ajlm-1028	93	33	life	life	NOUN
ajlm-1028	93	34	-	-	PUNCT
ajlm-1028	93	35	threatening	threaten	VERB
ajlm-1028	93	36	malignancies	malignancy	NOUN
ajlm-1028	93	37	.	.	PUNCT
ajlm-1028	94	1	conclusion	conclusion	NOUN
ajlm-1028	94	2	haematological	haematological	ADJ
ajlm-1028	94	3	malignant	malignant	ADJ
ajlm-1028	94	4	disease	disease	NOUN
ajlm-1028	94	5	was	be	AUX
ajlm-1028	94	6	the	the	DET
ajlm-1028	94	7	most	most	ADV
ajlm-1028	94	8	common	common	ADJ
ajlm-1028	94	9	indication	indication	NOUN
ajlm-1028	94	10	and	and	CCONJ
ajlm-1028	94	11	outcome	outcome	NOUN
ajlm-1028	94	12	reported	report	VERB
ajlm-1028	94	13	for	for	ADP
ajlm-1028	94	14	bone	bone	NOUN
ajlm-1028	94	15	marrow	marrow	NOUN
ajlm-1028	94	16	examination	examination	NOUN
ajlm-1028	94	17	.	.	PUNCT
ajlm-1028	95	1	the	the	DET
ajlm-1028	95	2	majority	majority	NOUN
ajlm-1028	95	3	of	of	ADP
ajlm-1028	95	4	bmat	bmat	NOUN
ajlm-1028	95	5	done	do	VERB
ajlm-1028	95	6	for	for	ADP
ajlm-1028	95	7	the	the	DET
ajlm-1028	95	8	staging	staging	NOUN
ajlm-1028	95	9	of	of	ADP
ajlm-1028	95	10	dlbcl	dlbcl	NOUN
ajlm-1028	95	11	did	do	AUX
ajlm-1028	95	12	not	not	PART
ajlm-1028	95	13	reveal	reveal	VERB
ajlm-1028	95	14	evidence	evidence	NOUN
ajlm-1028	95	15	of	of	ADP
ajlm-1028	95	16	bone	bone	NOUN
ajlm-1028	95	17	marrow	marrow	NOUN
ajlm-1028	95	18	infiltration	infiltration	NOUN
ajlm-1028	95	19	.	.	PUNCT
ajlm-1028	96	1	increasing	increase	VERB
ajlm-1028	96	2	age	age	NOUN
ajlm-1028	96	3	was	be	AUX
ajlm-1028	96	4	found	find	VERB
ajlm-1028	96	5	to	to	PART
ajlm-1028	96	6	be	be	AUX
ajlm-1028	96	7	associated	associate	VERB
ajlm-1028	96	8	with	with	ADP
ajlm-1028	96	9	reporting	reporting	NOUN
ajlm-1028	96	10	of	of	ADP
ajlm-1028	96	11	haematological	haematological	ADJ
ajlm-1028	96	12	malignancies	malignancy	NOUN
ajlm-1028	96	13	.	.	PUNCT
ajlm-1028	97	1	nutritional	nutritional	ADJ
ajlm-1028	97	2	disorders	disorder	NOUN
ajlm-1028	97	3	were	be	AUX
ajlm-1028	97	4	rarely	rarely	ADV
ajlm-1028	97	5	reported	report	VERB
ajlm-1028	97	6	as	as	ADP
ajlm-1028	97	7	an	an	DET
ajlm-1028	97	8	indication	indication	NOUN
ajlm-1028	97	9	for	for	ADP
ajlm-1028	97	10	bmat	bmat	NOUN
ajlm-1028	97	11	.	.	PUNCT
ajlm-1028	98	1	acknowledgements	acknowledgement	VERB
ajlm-1028	98	2	the	the	DET
ajlm-1028	98	3	author	author	NOUN
ajlm-1028	98	4	would	would	AUX
ajlm-1028	98	5	like	like	VERB
ajlm-1028	98	6	to	to	PART
ajlm-1028	98	7	thank	thank	VERB
ajlm-1028	98	8	dr	dr	PROPN
ajlm-1028	98	9	m.k	m.k	PROPN
ajlm-1028	98	10	.	.	PUNCT
ajlm-1028	98	11	bizaare	bizaare	PROPN
ajlm-1028	98	12	for	for	ADP
ajlm-1028	98	13	initiating	initiate	VERB
ajlm-1028	98	14	the	the	DET
ajlm-1028	98	15	concept	concept	NOUN
ajlm-1028	98	16	of	of	ADP
ajlm-1028	98	17	the	the	DET
ajlm-1028	98	18	study	study	NOUN
ajlm-1028	98	19	as	as	ADV
ajlm-1028	98	20	well	well	ADV
ajlm-1028	98	21	as	as	ADP
ajlm-1028	98	22	the	the	DET
ajlm-1028	98	23	national	national	PROPN
ajlm-1028	98	24	health	health	PROPN
ajlm-1028	98	25	laboratory	laboratory	PROPN
ajlm-1028	98	26	services	service	NOUN
ajlm-1028	98	27	staff	staff	NOUN
ajlm-1028	98	28	,	,	PUNCT
ajlm-1028	98	29	tinyiko	tinyiko	NOUN
ajlm-1028	98	30	ngobeni	ngobeni	NOUN
ajlm-1028	98	31	and	and	CCONJ
ajlm-1028	98	32	dr	dr	PROPN
ajlm-1028	98	33	y.l	y.l	PROPN
ajlm-1028	98	34	.	.	PROPN
ajlm-1028	98	35	naidoo	naidoo	PROPN
ajlm-1028	98	36	for	for	ADP
ajlm-1028	98	37	assistance	assistance	NOUN
ajlm-1028	98	38	in	in	ADP
ajlm-1028	98	39	retrieving	retrieve	VERB
ajlm-1028	98	40	data	datum	NOUN
ajlm-1028	98	41	competing	compete	VERB
ajlm-1028	98	42	interests	interest	NOUN
ajlm-1028	98	43	the	the	DET
ajlm-1028	98	44	authors	author	NOUN
ajlm-1028	98	45	have	have	AUX
ajlm-1028	98	46	declared	declare	VERB
ajlm-1028	98	47	that	that	SCONJ
ajlm-1028	98	48	no	no	DET
ajlm-1028	98	49	competing	compete	VERB
ajlm-1028	98	50	interests	interest	NOUN
ajlm-1028	98	51	exist	exist	VERB
ajlm-1028	98	52	.	.	PUNCT
ajlm-1028	99	1	authors	author	NOUN
ajlm-1028	99	2	’	’	PART
ajlm-1028	99	3	contributions	contribution	NOUN
ajlm-1028	99	4	w.s.t	w.s.t	PROPN
ajlm-1028	99	5	.	.	PROPN
ajlm-1028	99	6	contributed	contribute	VERB
ajlm-1028	99	7	to	to	ADP
ajlm-1028	99	8	the	the	DET
ajlm-1028	99	9	literature	literature	PROPN
ajlm-1028	99	10	review	review	PROPN
ajlm-1028	99	11	,	,	PUNCT
ajlm-1028	99	12	study	study	NOUN
ajlm-1028	99	13	protocol	protocol	NOUN
ajlm-1028	99	14	,	,	PUNCT
ajlm-1028	99	15	ethics	ethic	NOUN
ajlm-1028	99	16	clearance	clearance	NOUN
ajlm-1028	99	17	and	and	CCONJ
ajlm-1028	99	18	writing	writing	NOUN
ajlm-1028	99	19	of	of	ADP
ajlm-1028	99	20	the	the	DET
ajlm-1028	99	21	manuscript	manuscript	NOUN
ajlm-1028	99	22	.	.	PUNCT
ajlm-1028	100	1	s.p	s.p	PROPN
ajlm-1028	100	2	.	.	PROPN
ajlm-1028	100	3	,	,	PUNCT
ajlm-1028	100	4	assisted	assist	VERB
ajlm-1028	100	5	in	in	ADP
ajlm-1028	100	6	the	the	DET
ajlm-1028	100	7	writing	writing	NOUN
ajlm-1028	100	8	and	and	CCONJ
ajlm-1028	100	9	editing	editing	NOUN
ajlm-1028	100	10	of	of	ADP
ajlm-1028	100	11	the	the	DET
ajlm-1028	100	12	manuscript	manuscript	NOUN
ajlm-1028	100	13	and	and	CCONJ
ajlm-1028	100	14	d.p.k.w	d.p.k.w	PROPN
ajlm-1028	100	15	.	.	PROPN
ajlm-1028	100	16	assisted	assist	VERB
ajlm-1028	100	17	with	with	ADP
ajlm-1028	100	18	the	the	DET
ajlm-1028	100	19	writing	writing	NOUN
ajlm-1028	100	20	of	of	ADP
ajlm-1028	100	21	the	the	DET
ajlm-1028	100	22	manuscript	manuscript	NOUN
ajlm-1028	100	23	and	and	CCONJ
ajlm-1028	100	24	statistical	statistical	ADJ
ajlm-1028	100	25	analysis	analysis	NOUN
ajlm-1028	100	26	.	.	PUNCT
ajlm-1028	101	1	sources	source	NOUN
ajlm-1028	101	2	of	of	ADP
ajlm-1028	101	3	support	support	NOUN
ajlm-1028	101	4	no	no	DET
ajlm-1028	101	5	funding	funding	NOUN
ajlm-1028	101	6	for	for	ADP
ajlm-1028	101	7	this	this	DET
ajlm-1028	101	8	research	research	NOUN
ajlm-1028	101	9	project	project	NOUN
ajlm-1028	101	10	was	be	AUX
ajlm-1028	101	11	received	receive	VERB
ajlm-1028	101	12	.	.	PUNCT
ajlm-1028	102	1	data	datum	NOUN
ajlm-1028	102	2	availability	availability	NOUN
ajlm-1028	102	3	statement	statement	NOUN
ajlm-1028	102	4	data	datum	NOUN
ajlm-1028	102	5	sharing	sharing	NOUN
ajlm-1028	102	6	is	be	AUX
ajlm-1028	102	7	not	not	PART
ajlm-1028	102	8	applicable	applicable	ADJ
ajlm-1028	102	9	to	to	ADP
ajlm-1028	102	10	this	this	DET
ajlm-1028	102	11	article	article	NOUN
ajlm-1028	102	12	as	as	SCONJ
ajlm-1028	102	13	no	no	DET
ajlm-1028	102	14	new	new	ADJ
ajlm-1028	102	15	data	datum	NOUN
ajlm-1028	102	16	were	be	AUX
ajlm-1028	102	17	created	create	VERB
ajlm-1028	102	18	or	or	CCONJ
ajlm-1028	102	19	analysed	analyse	VERB
ajlm-1028	102	20	in	in	ADP
ajlm-1028	102	21	this	this	DET
ajlm-1028	102	22	study	study	NOUN
ajlm-1028	102	23	.	.	PUNCT
ajlm-1028	103	1	disclaimer	disclaimer	ADJ
ajlm-1028	103	2	views	view	NOUN
ajlm-1028	103	3	expressed	express	VERB
ajlm-1028	103	4	in	in	ADP
ajlm-1028	103	5	the	the	DET
ajlm-1028	103	6	article	article	NOUN
ajlm-1028	103	7	are	be	AUX
ajlm-1028	103	8	by	by	ADP
ajlm-1028	103	9	w.s.t	w.s.t	PROPN
ajlm-1028	103	10	.	.	PUNCT
ajlm-1028	104	1	and	and	CCONJ
ajlm-1028	104	2	do	do	AUX
ajlm-1028	104	3	not	not	PART
ajlm-1028	104	4	necessarily	necessarily	ADV
ajlm-1028	104	5	reflect	reflect	VERB
ajlm-1028	104	6	the	the	DET
ajlm-1028	104	7	official	official	ADJ
ajlm-1028	104	8	policy	policy	NOUN
ajlm-1028	104	9	or	or	CCONJ
ajlm-1028	104	10	position	position	NOUN
ajlm-1028	104	11	of	of	ADP
ajlm-1028	104	12	any	any	DET
ajlm-1028	104	13	affiliated	affiliated	ADJ
ajlm-1028	104	14	agency	agency	NOUN
ajlm-1028	104	15	of	of	ADP
ajlm-1028	104	16	the	the	DET
ajlm-1028	104	17	authors	author	NOUN
ajlm-1028	104	18	.	.	PUNCT
ajlm-1028	105	1	references	reference	NOUN
ajlm-1028	105	2	burkhardt	burkhardt	NOUN
ajlm-1028	105	3	r	r	NOUN
ajlm-1028	105	4	,	,	PUNCT
ajlm-1028	105	5	frisch	frisch	PROPN
ajlm-1028	105	6	b	b	NUM
ajlm-1028	105	7	,	,	PUNCT
ajlm-1028	105	8	bartl	bartl	PROPN
ajlm-1028	105	9	r.	r.	PROPN
ajlm-1028	105	10	bone	bone	PROPN
ajlm-1028	105	11	marrow	marrow	PROPN
ajlm-1028	105	12	biopsy	biopsy	VERB
ajlm-1028	105	13	in	in	ADP
ajlm-1028	105	14	haematological	haematological	ADJ
ajlm-1028	105	15	disorders	disorder	NOUN
ajlm-1028	105	16	.	.	PUNCT
ajlm-1028	106	1	j	j	PROPN
ajlm-1028	106	2	clin	clin	PROPN
ajlm-1028	106	3	pathol	pathol	PROPN
ajlm-1028	106	4	.	.	PUNCT
ajlm-1028	107	1	1982;35(3):257–284	1982;35(3):257–284	X
ajlm-1028	107	2	.	.	PUNCT
ajlm-1028	107	3	thelm	thelm	PROPN
ajlm-1028	107	4	h	h	NOUN
ajlm-1028	107	5	,	,	PUNCT
ajlm-1028	107	6	diem	diem	ADJ
ajlm-1028	107	7	h	h	NOUN
ajlm-1028	107	8	,	,	PUNCT
ajlm-1028	107	9	haferlach	haferlach	NOUN
ajlm-1028	107	10	t.	t.	NOUN
ajlm-1028	107	11	colour	colour	PROPN
ajlm-1028	107	12	atlas	atlas	PROPN
ajlm-1028	107	13	of	of	ADP
ajlm-1028	107	14	hematology	hematology	NOUN
ajlm-1028	107	15	practical	practical	ADJ
ajlm-1028	107	16	microscopic	microscopic	ADJ
ajlm-1028	107	17	and	and	CCONJ
ajlm-1028	107	18	clinical	clinical	ADJ
ajlm-1028	107	19	diagnosis	diagnosis	NOUN
ajlm-1028	107	20	.	.	PUNCT
ajlm-1028	108	1	2nd	2nd	ADJ
ajlm-1028	108	2	ed	ed	NOUN
ajlm-1028	108	3	.	.	PUNCT
ajlm-1028	109	1	stuttgart	stuttgart	PROPN
ajlm-1028	109	2	:	:	PUNCT
ajlm-1028	109	3	thieme	thieme	PROPN
ajlm-1028	109	4	verlag	verlag	PROPN
ajlm-1028	109	5	,	,	PUNCT
ajlm-1028	109	6	2004	2004	NUM
ajlm-1028	109	7	;	;	PUNCT
ajlm-1028	109	8	p.	p.	NOUN
ajlm-1028	109	9	20–27	20–27	NUM
ajlm-1028	109	10	.	.	PUNCT
ajlm-1028	109	11	karstaedt	karstaedt	NOUN
ajlm-1028	109	12	as	as	ADP
ajlm-1028	109	13	,	,	PUNCT
ajlm-1028	109	14	pantanowitz	pantanowitz	NOUN
ajlm-1028	109	15	l	l	PROPN
ajlm-1028	109	16	,	,	PUNCT
ajlm-1028	109	17	omar	omar	PROPN
ajlm-1028	109	18	t	t	PROPN
ajlm-1028	109	19	,	,	PUNCT
ajlm-1028	109	20	sonnendecker	sonnendecker	VERB
ajlm-1028	109	21	he	he	PRON
ajlm-1028	109	22	,	,	PUNCT
ajlm-1028	109	23	patel	patel	PROPN
ajlm-1028	109	24	m.	m.	VERB
ajlm-1028	109	25	the	the	DET
ajlm-1028	109	26	utility	utility	NOUN
ajlm-1028	109	27	of	of	ADP
ajlm-1028	109	28	bone	bone	NOUN
ajlm-1028	109	29	-	-	PUNCT
ajlm-1028	109	30	marrow	marrow	NOUN
ajlm-1028	109	31	examination	examination	NOUN
ajlm-1028	109	32	in	in	ADP
ajlm-1028	109	33	hiv	hiv	PROPN
ajlm-1028	109	34	-	-	PUNCT
ajlm-1028	109	35	infected	infect	VERB
ajlm-1028	109	36	adults	adult	NOUN
ajlm-1028	109	37	in	in	ADP
ajlm-1028	109	38	south	south	PROPN
ajlm-1028	109	39	africa	africa	PROPN
ajlm-1028	109	40	.	.	PUNCT
ajlm-1028	110	1	qjm	qjm	INTJ
ajlm-1028	110	2	.	.	PUNCT
ajlm-1028	111	1	2001;94(2):101–105	2001;94(2):101–105	X
ajlm-1028	111	2	.	.	PUNCT
ajlm-1028	112	1	https://doi.org/10.1093/qjmed/94.2.101	https://doi.org/10.1093/qjmed/94.2.101	PROPN
ajlm-1028	112	2	naidoo	naidoo	PROPN
ajlm-1028	112	3	s	s	PROPN
ajlm-1028	112	4	,	,	PUNCT
ajlm-1028	112	5	naicker	naicker	PROPN
ajlm-1028	112	6	vl	vl	PROPN
ajlm-1028	112	7	.	.	PUNCT
ajlm-1028	113	1	retrospective	retrospective	ADJ
ajlm-1028	113	2	comparison	comparison	NOUN
ajlm-1028	113	3	of	of	ADP
ajlm-1028	113	4	cytological	cytological	ADJ
ajlm-1028	113	5	and	and	CCONJ
ajlm-1028	113	6	histological	histological	ADJ
ajlm-1028	113	7	bone	bone	NOUN
ajlm-1028	113	8	marrow	marrow	NOUN
ajlm-1028	113	9	morphology	morphology	NOUN
ajlm-1028	113	10	in	in	ADP
ajlm-1028	113	11	adult	adult	NOUN
ajlm-1028	113	12	antiretroviral	antiretroviral	ADJ
ajlm-1028	113	13	-	-	PUNCT
ajlm-1028	113	14	naïve	naïve	ADJ
ajlm-1028	113	15	and	and	CCONJ
ajlm-1028	113	16	antiretroviral	antiretroviral	ADJ
ajlm-1028	113	17	experienced	experienced	ADJ
ajlm-1028	113	18	human	human	ADJ
ajlm-1028	113	19	immunodeficiency	immunodeficiency	NOUN
ajlm-1028	113	20	virus	virus	NOUN
ajlm-1028	113	21	-	-	PUNCT
ajlm-1028	113	22	infected	infect	VERB
ajlm-1028	113	23	patients	patient	NOUN
ajlm-1028	113	24	with	with	ADP
ajlm-1028	113	25	peripheral	peripheral	ADJ
ajlm-1028	113	26	blood	blood	NOUN
ajlm-1028	113	27	cytopaenias	cytopaenia	NOUN
ajlm-1028	113	28	.	.	PUNCT
ajlm-1028	114	1	s	s	AUX
ajlm-1028	114	2	afr	afr	PROPN
ajlm-1028	114	3	j	j	PROPN
ajlm-1028	114	4	infect	infect	PROPN
ajlm-1028	114	5	dis	dis	PROPN
ajlm-1028	114	6	.	.	PUNCT
ajlm-1028	115	1	2016;31(2):50–56	2016;31(2):50–56	X
ajlm-1028	115	2	.	.	PUNCT
ajlm-1028	116	1	https://doi.org/10.1080/23120053.2016.1128147	https://doi.org/10.1080/23120053.2016.1128147	PROPN
ajlm-1028	116	2	phillips	phillips	PROPN
ajlm-1028	116	3	l	l	PROPN
ajlm-1028	116	4	,	,	PUNCT
ajlm-1028	116	5	opie	opie	PROPN
ajlm-1028	116	6	j.	j.	PROPN
ajlm-1028	116	7	the	the	DET
ajlm-1028	116	8	utility	utility	NOUN
ajlm-1028	116	9	of	of	ADP
ajlm-1028	116	10	bone	bone	NOUN
ajlm-1028	116	11	marrow	marrow	NOUN
ajlm-1028	116	12	sampling	sample	VERB
ajlm-1028	116	13	in	in	ADP
ajlm-1028	116	14	the	the	DET
ajlm-1028	116	15	diagnosis	diagnosis	NOUN
ajlm-1028	116	16	and	and	CCONJ
ajlm-1028	116	17	staging	staging	NOUN
ajlm-1028	116	18	of	of	ADP
ajlm-1028	116	19	lymphoma	lymphoma	NOUN
ajlm-1028	116	20	in	in	ADP
ajlm-1028	116	21	south	south	PROPN
ajlm-1028	116	22	africa	africa	PROPN
ajlm-1028	116	23	.	.	PUNCT
ajlm-1028	117	1	int	int	PROPN
ajlm-1028	117	2	j	j	PROPN
ajlm-1028	117	3	lab	lab	NOUN
ajlm-1028	117	4	hematol	hematol	NOUN
ajlm-1028	117	5	.	.	PUNCT
ajlm-1028	118	1	2018;40(3):276–283	2018;40(3):276–283	NUM
ajlm-1028	118	2	.	.	PUNCT
ajlm-1028	119	1	https://doi.org/10.1111/ijlh.12782	https://doi.org/10.1111/ijlh.12782	PROPN
ajlm-1028	119	2	cacoub	cacoub	VERB
ajlm-1028	119	3	p	p	X
ajlm-1028	119	4	,	,	PUNCT
ajlm-1028	119	5	gatfosse	gatfosse	NOUN
ajlm-1028	119	6	m	m	PROPN
ajlm-1028	119	7	,	,	PUNCT
ajlm-1028	119	8	derbel	derbel	VERB
ajlm-1028	119	9	a	a	PRON
ajlm-1028	119	10	,	,	PUNCT
ajlm-1028	119	11	chapelon	chapelon	PROPN
ajlm-1028	119	12	c	c	NOUN
ajlm-1028	119	13	,	,	PUNCT
ajlm-1028	119	14	verny	verny	NOUN
ajlm-1028	119	15	c	c	NOUN
ajlm-1028	119	16	,	,	PUNCT
ajlm-1028	119	17	godeau	godeau	PROPN
ajlm-1028	119	18	p.	p.	NOUN
ajlm-1028	119	19	vitamin	vitamin	NOUN
ajlm-1028	119	20	deficiency	deficiency	NOUN
ajlm-1028	119	21	-	-	PUNCT
ajlm-1028	119	22	induced	induce	VERB
ajlm-1028	119	23	pancytopenia	pancytopenia	NOUN
ajlm-1028	119	24	mimicking	mimic	VERB
ajlm-1028	119	25	leukemia	leukemia	NOUN
ajlm-1028	119	26	.	.	PUNCT
ajlm-1028	120	1	three	three	NUM
ajlm-1028	120	2	cases	case	NOUN
ajlm-1028	120	3	.	.	PUNCT
ajlm-1028	120	4	presse	presse	PROPN
ajlm-1028	120	5	med	med	PROPN
ajlm-1028	120	6	.	.	PUNCT
ajlm-1028	121	1	1991;20(33):1603–1606	1991;20(33):1603–1606	NUM
ajlm-1028	121	2	.	.	PUNCT
ajlm-1028	122	1	dapus	dapu	NOUN
ajlm-1028	122	2	do	do	VERB
ajlm-1028	122	3	,	,	PUNCT
ajlm-1028	122	4	damen	damen	PROPN
ajlm-1028	122	5	jg	jg	PROPN
ajlm-1028	122	6	.	.	PUNCT
ajlm-1028	123	1	diagnostic	diagnostic	ADJ
ajlm-1028	123	2	outcome	outcome	NOUN
ajlm-1028	123	3	of	of	ADP
ajlm-1028	123	4	bone	bone	NOUN
ajlm-1028	123	5	marrow	marrow	NOUN
ajlm-1028	123	6	aspiration	aspiration	NOUN
ajlm-1028	123	7	in	in	ADP
ajlm-1028	123	8	a	a	DET
ajlm-1028	123	9	new	new	ADJ
ajlm-1028	123	10	center	center	NOUN
ajlm-1028	123	11	in	in	ADP
ajlm-1028	123	12	nigeria	nigeria	PROPN
ajlm-1028	123	13	.	.	PUNCT
ajlm-1028	124	1	glob	glob	PROPN
ajlm-1028	124	2	adv	adv	PROPN
ajlm-1028	124	3	res	re	NOUN
ajlm-1028	124	4	j	j	PROPN
ajlm-1028	124	5	med	med	PROPN
ajlm-1028	124	6	med	med	PROPN
ajlm-1028	124	7	sci	sci	PROPN
ajlm-1028	124	8	.	.	PUNCT
ajlm-1028	125	1	2012;1(7):166–177	2012;1(7):166–177	NUM
ajlm-1028	125	2	.	.	PUNCT
ajlm-1028	125	3	jha	jha	PROPN
ajlm-1028	125	4	a	a	PROPN
ajlm-1028	125	5	,	,	PUNCT
ajlm-1028	125	6	suyami	suyami	NOUN
ajlm-1028	125	7	g	g	PROPN
ajlm-1028	125	8	,	,	PUNCT
ajlm-1028	125	9	adhikari	adhikari	PROPN
ajlm-1028	125	10	rc	rc	PROPN
ajlm-1028	125	11	,	,	PUNCT
ajlm-1028	125	12	panta	panta	PROPN
ajlm-1028	125	13	ad	ad	NOUN
ajlm-1028	125	14	,	,	PUNCT
ajlm-1028	125	15	jha	jha	PROPN
ajlm-1028	125	16	r.	r.	PROPN
ajlm-1028	125	17	bone	bone	PROPN
ajlm-1028	125	18	marrow	marrow	PROPN
ajlm-1028	125	19	examination	examination	NOUN
ajlm-1028	125	20	in	in	ADP
ajlm-1028	125	21	cases	case	NOUN
ajlm-1028	125	22	of	of	ADP
ajlm-1028	125	23	pancytopenia	pancytopenia	NOUN
ajlm-1028	125	24	.	.	PUNCT
ajlm-1028	126	1	j	j	PROPN
ajlm-1028	126	2	nepal	nepal	PROPN
ajlm-1028	126	3	med	med	PROPN
ajlm-1028	126	4	assoc	assoc	PROPN
ajlm-1028	126	5	.	.	PUNCT
ajlm-1028	127	1	2008;47(169):12–17	2008;47(169):12–17	X
ajlm-1028	127	2	.	.	PUNCT
ajlm-1028	128	1	swerdlow	swerdlow	PROPN
ajlm-1028	128	2	sh	sh	PROPN
ajlm-1028	128	3	,	,	PUNCT
ajlm-1028	128	4	campo	campo	PROPN
ajlm-1028	128	5	e	e	PROPN
ajlm-1028	128	6	,	,	PUNCT
ajlm-1028	128	7	harris	harris	PROPN
ajlm-1028	128	8	nl	nl	PROPN
ajlm-1028	128	9	,	,	PUNCT
ajlm-1028	128	10	et	et	PROPN
ajlm-1028	128	11	al	al	PROPN
ajlm-1028	128	12	.	.	PUNCT
ajlm-1028	129	1	who	who	PRON
ajlm-1028	129	2	classification	classification	NOUN
ajlm-1028	129	3	of	of	ADP
ajlm-1028	129	4	tumours	tumour	NOUN
ajlm-1028	129	5	of	of	ADP
ajlm-1028	129	6	haematopoietic	haematopoietic	ADJ
ajlm-1028	129	7	and	and	CCONJ
ajlm-1028	129	8	lymphoid	lymphoid	ADJ
ajlm-1028	129	9	tissues	tissue	NOUN
ajlm-1028	129	10	.	.	PUNCT
ajlm-1028	130	1	lyon	lyon	PROPN
ajlm-1028	130	2	:	:	PUNCT
ajlm-1028	130	3	iarc	iarc	NOUN
ajlm-1028	130	4	;	;	PUNCT
ajlm-1028	130	5	2008	2008	NUM
ajlm-1028	130	6	.	.	PUNCT
ajlm-1028	131	1	bashawri	bashawri	PROPN
ajlm-1028	131	2	la	la	PROPN
ajlm-1028	131	3	.	.	PUNCT
ajlm-1028	131	4	bone	bone	PROPN
ajlm-1028	131	5	marrow	marrow	PROPN
ajlm-1028	131	6	examination	examination	NOUN
ajlm-1028	131	7	indications	indication	NOUN
ajlm-1028	131	8	and	and	CCONJ
ajlm-1028	131	9	diagnostic	diagnostic	ADJ
ajlm-1028	131	10	values	value	NOUN
ajlm-1028	131	11	.	.	PUNCT
ajlm-1028	132	1	saudi	saudi	PROPN
ajlm-1028	132	2	med	med	PROPN
ajlm-1028	132	3	j.	j.	PROPN
ajlm-1028	132	4	2002;23(2):191–196	2002;23(2):191–196	PROPN
ajlm-1028	132	5	.	.	PROPN
ajlm-1028	132	6	mirzai	mirzai	PROPN
ajlm-1028	132	7	az	az	PROPN
ajlm-1028	132	8	,	,	PUNCT
ajlm-1028	132	9	hosseini	hosseini	PROPN
ajlm-1028	132	10	n	n	CCONJ
ajlm-1028	132	11	,	,	PUNCT
ajlm-1028	132	12	sadeghipour	sadeghipour	ADJ
ajlm-1028	132	13	a.	a.	NOUN
ajlm-1028	132	14	indications	indication	NOUN
ajlm-1028	132	15	and	and	CCONJ
ajlm-1028	132	16	diagnostic	diagnostic	ADJ
ajlm-1028	132	17	utility	utility	NOUN
ajlm-1028	132	18	of	of	ADP
ajlm-1028	132	19	bone	bone	NOUN
ajlm-1028	132	20	marrow	marrow	NOUN
ajlm-1028	132	21	examination	examination	NOUN
ajlm-1028	132	22	in	in	ADP
ajlm-1028	132	23	different	different	ADJ
ajlm-1028	132	24	bone	bone	NOUN
ajlm-1028	132	25	marrow	marrow	NOUN
ajlm-1028	132	26	disorders	disorder	NOUN
ajlm-1028	132	27	in	in	ADP
ajlm-1028	132	28	iran	iran	PROPN
ajlm-1028	132	29	.	.	PUNCT
ajlm-1028	133	1	lab	lab	NOUN
ajlm-1028	133	2	hematol	hematol	NOUN
ajlm-1028	133	3	.	.	PUNCT
ajlm-1028	134	1	2009;15(4):38–44	2009;15(4):38–44	X
ajlm-1028	134	2	.	.	PUNCT
ajlm-1028	135	1	https://doi.org/10.1532/lh96.09009	https://doi.org/10.1532/lh96.09009	AUX
ajlm-1028	135	2	shastry	shastry	PROPN
ajlm-1028	136	1	sm	sm	PROPN
ajlm-1028	136	2	,	,	PUNCT
ajlm-1028	136	3	kolte	kolte	PROPN
ajlm-1028	136	4	ss	ss	PROPN
ajlm-1028	136	5	.	.	PUNCT
ajlm-1028	137	1	spectrum	spectrum	NOUN
ajlm-1028	137	2	of	of	ADP
ajlm-1028	137	3	hematological	hematological	ADJ
ajlm-1028	137	4	disorders	disorder	NOUN
ajlm-1028	137	5	observed	observe	VERB
ajlm-1028	137	6	in	in	ADP
ajlm-1028	137	7	one	one	NUM
ajlm-1028	137	8	-	-	PUNCT
ajlm-1028	137	9	hundred	hundred	NUM
ajlm-1028	137	10	and	and	CCONJ
ajlm-1028	137	11	ten	ten	NUM
ajlm-1028	137	12	consecutive	consecutive	ADJ
ajlm-1028	137	13	bone	bone	NOUN
ajlm-1028	137	14	marrow	marrow	NOUN
ajlm-1028	137	15	aspirations	aspiration	NOUN
ajlm-1028	137	16	and	and	CCONJ
ajlm-1028	137	17	biopsies	biopsy	NOUN
ajlm-1028	137	18	.	.	PUNCT
ajlm-1028	138	1	med	med	PROPN
ajlm-1028	138	2	j	j	PROPN
ajlm-1028	138	3	dr	dr	PROPN
ajlm-1028	138	4	.	.	PROPN
ajlm-1028	139	1	d.y	d.y	PROPN
ajlm-1028	139	2	.	.	PROPN
ajlm-1028	139	3	patil	patil	PROPN
ajlm-1028	139	4	uni	uni	PROPN
ajlm-1028	139	5	.	.	PUNCT
ajlm-1028	140	1	2012;5(2):118–121	2012;5(2):118–121	NUM
ajlm-1028	140	2	.	.	PUNCT
ajlm-1028	141	1	https://doi.org/10.4103/0975-2870.103334	https://doi.org/10.4103/0975-2870.103334	PROPN
ajlm-1028	141	2	bedu	bedu	PROPN
ajlm-1028	141	3	-	-	PUNCT
ajlm-1028	141	4	addo	addo	PROPN
ajlm-1028	141	5	g	g	PROPN
ajlm-1028	141	6	,	,	PUNCT
ajlm-1028	141	7	ampem	ampem	PROPN
ajlm-1028	141	8	amoako	amoako	PROPN
ajlm-1028	141	9	y	y	PROPN
ajlm-1028	141	10	,	,	PUNCT
ajlm-1028	141	11	bates	bates	PROPN
ajlm-1028	141	12	i.	i.	PROPN
ajlm-1028	141	13	the	the	DET
ajlm-1028	141	14	role	role	NOUN
ajlm-1028	141	15	of	of	ADP
ajlm-1028	141	16	bone	bone	NOUN
ajlm-1028	141	17	marrow	marrow	NOUN
ajlm-1028	141	18	aspirate	aspirate	NOUN
ajlm-1028	141	19	and	and	CCONJ
ajlm-1028	141	20	trephine	trephine	NOUN
ajlm-1028	141	21	samples	sample	NOUN
ajlm-1028	141	22	in	in	ADP
ajlm-1028	141	23	haematological	haematological	ADJ
ajlm-1028	141	24	diagnoses	diagnosis	NOUN
ajlm-1028	141	25	in	in	ADP
ajlm-1028	141	26	patients	patient	NOUN
ajlm-1028	141	27	referred	refer	VERB
ajlm-1028	141	28	to	to	ADP
ajlm-1028	141	29	a	a	DET
ajlm-1028	141	30	teaching	teaching	NOUN
ajlm-1028	141	31	hospital	hospital	NOUN
ajlm-1028	141	32	in	in	ADP
ajlm-1028	141	33	ghana	ghana	PROPN
ajlm-1028	141	34	.	.	PUNCT
ajlm-1028	142	1	ghana	ghana	PROPN
ajlm-1028	142	2	med	med	PROPN
ajlm-1028	142	3	j.	j.	PROPN
ajlm-1028	142	4	2013;47(2):74–78	2013;47(2):74–78	PROPN
ajlm-1028	142	5	.	.	PUNCT
ajlm-1028	143	1	sedick	sedick	PROPN
ajlm-1028	143	2	q	q	PROPN
ajlm-1028	143	3	,	,	PUNCT
ajlm-1028	143	4	vaughan	vaughan	PROPN
ajlm-1028	143	5	j	j	PROPN
ajlm-1028	143	6	,	,	PUNCT
ajlm-1028	143	7	pheeha	pheeha	PROPN
ajlm-1028	143	8	t	t	PROPN
ajlm-1028	143	9	,	,	PUNCT
ajlm-1028	143	10	alli	alli	PROPN
ajlm-1028	143	11	na	na	PROPN
ajlm-1028	143	12	.	.	PUNCT
ajlm-1028	143	13	bone	bone	PROPN
ajlm-1028	143	14	marrow	marrow	PROPN
ajlm-1028	143	15	aspirates	aspirate	NOUN
ajlm-1028	143	16	microscopy	microscopy	VERB
ajlm-1028	143	17	v.	v.	ADP
ajlm-1028	143	18	bone	bone	NOUN
ajlm-1028	143	19	marrow	marrow	PROPN
ajlm-1028	143	20	trephine	trephine	PROPN
ajlm-1028	143	21	biopsy	biopsy	PROPN
ajlm-1028	143	22	microscopy	microscopy	NOUN
ajlm-1028	143	23	for	for	ADP
ajlm-1028	143	24	detection	detection	NOUN
ajlm-1028	143	25	of	of	ADP
ajlm-1028	143	26	mycobacterium	mycobacterium	NOUN
ajlm-1028	143	27	tuberculosis	tuberculosis	NOUN
ajlm-1028	143	28	infection	infection	NOUN
ajlm-1028	143	29	.	.	PUNCT
ajlm-1028	144	1	s	s	PROPN
ajlm-1028	144	2	afr	afr	PROPN
ajlm-1028	144	3	med	med	PROPN
ajlm-1028	144	4	j.	j.	PROPN
ajlm-1028	144	5	2015;105(9):773–775	2015;105(9):773–775	PROPN
ajlm-1028	144	6	.	.	PUNCT
ajlm-1028	145	1	https://doi.org/10.7196/samjnew.8171	https://doi.org/10.7196/samjnew.8171	VERB
ajlm-1028	145	2	ahmad	ahmad	PROPN
ajlm-1028	145	3	sq	sq	PROPN
ajlm-1028	145	4	,	,	PUNCT
ajlm-1028	145	5	khan	khan	PROPN
ajlm-1028	145	6	ou	ou	PROPN
ajlm-1028	145	7	,	,	PUNCT
ajlm-1028	145	8	zafar	zafar	PROPN
ajlm-1028	145	9	n.	n.	PROPN
ajlm-1028	145	10	utility	utility	NOUN
ajlm-1028	145	11	of	of	ADP
ajlm-1028	145	12	bone	bone	NOUN
ajlm-1028	145	13	marrow	marrow	NOUN
ajlm-1028	145	14	examination	examination	NOUN
ajlm-1028	145	15	in	in	ADP
ajlm-1028	145	16	a	a	DET
ajlm-1028	145	17	secondary	secondary	ADJ
ajlm-1028	145	18	care	care	NOUN
ajlm-1028	145	19	hospital	hospital	NOUN
ajlm-1028	145	20	.	.	PUNCT
ajlm-1028	146	1	jrmc	jrmc	ADJ
ajlm-1028	146	2	.	.	PUNCT
ajlm-1028	147	1	2011;15(1):40–41	2011;15(1):40–41	X
ajlm-1028	147	2	.	.	PUNCT
ajlm-1028	147	3	bashir	bashir	PROPN
ajlm-1028	147	4	n	n	CCONJ
ajlm-1028	147	5	,	,	PUNCT
ajlm-1028	147	6	musharaf	musharaf	PROPN
ajlm-1028	147	7	b	b	PROPN
ajlm-1028	147	8	,	,	PUNCT
ajlm-1028	147	9	reshi	reshi	PROPN
ajlm-1028	147	10	r	r	PROPN
ajlm-1028	147	11	,	,	PUNCT
ajlm-1028	147	12	jeelani	jeelani	PROPN
ajlm-1028	147	13	t	t	PROPN
ajlm-1028	147	14	,	,	PUNCT
ajlm-1028	147	15	rafiq	rafiq	PROPN
ajlm-1028	147	16	d	d	PROPN
ajlm-1028	147	17	,	,	PUNCT
ajlm-1028	147	18	angmo	angmo	PROPN
ajlm-1028	147	19	d.	d.	PROPN
ajlm-1028	147	20	bone	bone	PROPN
ajlm-1028	147	21	marrow	marrow	PROPN
ajlm-1028	147	22	profile	profile	NOUN
ajlm-1028	147	23	in	in	ADP
ajlm-1028	147	24	hematological	hematological	ADJ
ajlm-1028	147	25	disorders	disorder	NOUN
ajlm-1028	147	26	:	:	PUNCT
ajlm-1028	147	27	an	an	DET
ajlm-1028	147	28	experience	experience	NOUN
ajlm-1028	147	29	from	from	ADP
ajlm-1028	147	30	a	a	DET
ajlm-1028	147	31	tertiary	tertiary	ADJ
ajlm-1028	147	32	care	care	NOUN
ajlm-1028	147	33	centre	centre	NOUN
ajlm-1028	147	34	.	.	PUNCT
ajlm-1028	148	1	int	int	PROPN
ajlm-1028	148	2	j	j	PROPN
ajlm-1028	148	3	adv	adv	PROPN
ajlm-1028	148	4	med	me	VERB
ajlm-1028	148	5	.	.	PUNCT
ajlm-1028	149	1	2018;5(3):608–613	2018;5(3):608–613	NUM
ajlm-1028	149	2	.	.	PUNCT
ajlm-1028	150	1	https://doi.org/10.18203/2349-3933.ijam20182111	https://doi.org/10.18203/2349-3933.ijam20182111	PROPN
ajlm-1028	150	2	kyeyune	kyeyune	ADJ
ajlm-1028	150	3	r	r	NOUN
ajlm-1028	150	4	,	,	PUNCT
ajlm-1028	150	5	saathoff	saathoff	NOUN
ajlm-1028	150	6	e	e	NOUN
ajlm-1028	150	7	,	,	PUNCT
ajlm-1028	150	8	ezeamama	ezeamama	PROPN
ajlm-1028	150	9	a	a	X
ajlm-1028	150	10	,	,	PUNCT
ajlm-1028	150	11	löscher	löscher	NOUN
ajlm-1028	150	12	t	t	PROPN
ajlm-1028	150	13	,	,	PUNCT
ajlm-1028	150	14	fawzi	fawzi	PROPN
ajlm-1028	150	15	w	w	PROPN
ajlm-1028	150	16	,	,	PUNCT
ajlm-1028	150	17	guwatudde	guwatudde	PROPN
ajlm-1028	150	18	d.	d.	PROPN
ajlm-1028	150	19	prevalence	prevalence	NOUN
ajlm-1028	150	20	and	and	CCONJ
ajlm-1028	150	21	correlates	correlate	VERB
ajlm-1028	150	22	of	of	ADP
ajlm-1028	150	23	cytopenias	cytopenia	NOUN
ajlm-1028	150	24	in	in	ADP
ajlm-1028	150	25	hiv	hiv	PROPN
ajlm-1028	150	26	-	-	PUNCT
ajlm-1028	150	27	infected	infect	VERB
ajlm-1028	150	28	adults	adult	NOUN
ajlm-1028	150	29	initiating	initiate	VERB
ajlm-1028	150	30	highly	highly	ADV
ajlm-1028	150	31	active	active	ADJ
ajlm-1028	150	32	antiretroviral	antiretroviral	ADJ
ajlm-1028	150	33	therapy	therapy	NOUN
ajlm-1028	150	34	in	in	ADP
ajlm-1028	150	35	uganda	uganda	PROPN
ajlm-1028	150	36	.	.	PUNCT
ajlm-1028	151	1	bmc	bmc	PROPN
ajlm-1028	151	2	infect	infect	PROPN
ajlm-1028	151	3	dis	dis	PROPN
ajlm-1028	151	4	.	.	PUNCT
ajlm-1028	152	1	2014;14:496	2014;14:496	NUM
ajlm-1028	152	2	.	.	PUNCT
ajlm-1028	153	1	https://doi.org/10.1186/1471-2334-14-496	https://doi.org/10.1186/1471-2334-14-496	PROPN
ajlm-1028	153	2	hassan	hassan	PROPN
ajlm-1028	153	3	m	m	PROPN
ajlm-1028	153	4	,	,	PUNCT
ajlm-1028	153	5	abedi	abedi	ADJ
ajlm-1028	153	6	-	-	PUNCT
ajlm-1028	153	7	valugerdi	valugerdi	NOUN
ajlm-1028	153	8	m.	m.	NOUN
ajlm-1028	153	9	hematologic	hematologic	NOUN
ajlm-1028	153	10	malignancies	malignancy	NOUN
ajlm-1028	153	11	in	in	ADP
ajlm-1028	153	12	elderly	elderly	ADJ
ajlm-1028	153	13	patients	patient	NOUN
ajlm-1028	153	14	.	.	PUNCT
ajlm-1028	154	1	haematologica	haematologica	PROPN
ajlm-1028	154	2	.	.	PUNCT
ajlm-1028	155	1	2014;99(7):1124–1127	2014;99(7):1124–1127	NUM
ajlm-1028	155	2	.	.	PUNCT
ajlm-1028	156	1	https://doi.org/10.3324%2fhaematol.2014.107557	https://doi.org/10.3324%2fhaematol.2014.107557	PROPN
ajlm-1028	156	2	morton	morton	PROPN
ajlm-1028	156	3	lm	lm	PROPN
ajlm-1028	156	4	,	,	PUNCT
ajlm-1028	156	5	wang	wang	PROPN
ajlm-1028	156	6	ss	ss	PROPN
ajlm-1028	156	7	,	,	PUNCT
ajlm-1028	156	8	devesa	devesa	PROPN
ajlm-1028	156	9	ss	ss	PROPN
ajlm-1028	156	10	,	,	PUNCT
ajlm-1028	156	11	hartge	hartge	ADJ
ajlm-1028	156	12	p	p	X
ajlm-1028	156	13	,	,	PUNCT
ajlm-1028	156	14	weisenburger	weisenburger	NOUN
ajlm-1028	156	15	dd	dd	NOUN
ajlm-1028	156	16	,	,	PUNCT
ajlm-1028	156	17	linet	linet	PROPN
ajlm-1028	156	18	ms	ms	PROPN
ajlm-1028	156	19	.	.	PROPN
ajlm-1028	156	20	lymphoma	lymphoma	NOUN
ajlm-1028	156	21	incidence	incidence	NOUN
ajlm-1028	156	22	patterns	pattern	NOUN
ajlm-1028	156	23	by	by	ADP
ajlm-1028	156	24	who	who	PRON
ajlm-1028	156	25	subtype	subtype	VERB
ajlm-1028	156	26	in	in	ADP
ajlm-1028	156	27	the	the	DET
ajlm-1028	156	28	united	united	PROPN
ajlm-1028	156	29	states	states	PROPN
ajlm-1028	156	30	.	.	PUNCT
ajlm-1028	157	1	blood	blood	NOUN
ajlm-1028	157	2	.	.	PUNCT
ajlm-1028	158	1	2006;107(1):265–276	2006;107(1):265–276	X
ajlm-1028	158	2	.	.	PUNCT
ajlm-1028	158	3	https://doi.org/10.1182/blood-2005-06-2508	https://doi.org/10.1182/blood-2005-06-2508	PROPN
ajlm-1028	158	4	ohshima	ohshima	PROPN
ajlm-1028	158	5	k	k	PROPN
ajlm-1028	158	6	,	,	PUNCT
ajlm-1028	158	7	suzumiya	suzumiya	PROPN
ajlm-1028	158	8	j	j	PROPN
ajlm-1028	158	9	,	,	PUNCT
ajlm-1028	158	10	kikuchi	kikuchi	PROPN
ajlm-1028	158	11	m.	m.	PROPN
ajlm-1028	158	12	the	the	DET
ajlm-1028	158	13	world	world	PROPN
ajlm-1028	158	14	health	health	NOUN
ajlm-1028	158	15	organization	organization	NOUN
ajlm-1028	158	16	classification	classification	NOUN
ajlm-1028	158	17	of	of	ADP
ajlm-1028	158	18	malignant	malignant	ADJ
ajlm-1028	158	19	lymphoma	lymphoma	NOUN
ajlm-1028	158	20	:	:	PUNCT
ajlm-1028	158	21	incidence	incidence	NOUN
ajlm-1028	158	22	and	and	CCONJ
ajlm-1028	158	23	clinical	clinical	ADJ
ajlm-1028	158	24	prognosis	prognosis	NOUN
ajlm-1028	158	25	in	in	ADP
ajlm-1028	158	26	htlv-1	htlv-1	ADJ
ajlm-1028	158	27	-	-	ADJ
ajlm-1028	158	28	endemic	endemic	ADJ
ajlm-1028	158	29	area	area	NOUN
ajlm-1028	158	30	of	of	ADP
ajlm-1028	158	31	fukuoka	fukuoka	NOUN
ajlm-1028	158	32	.	.	PUNCT
ajlm-1028	159	1	pathol	pathol	NOUN
ajlm-1028	159	2	int	int	NOUN
ajlm-1028	159	3	.	.	PUNCT
ajlm-1028	160	1	2002;52(1):1–12	2002;52(1):1–12	X
ajlm-1028	160	2	.	.	PUNCT
ajlm-1028	161	1	https://doi.org/10.1046/j.1440-1827.2002.01308.x	https://doi.org/10.1046/j.1440-1827.2002.01308.x	NOUN
ajlm-1028	161	2	hicks	hicks	PROPN
ajlm-1028	161	3	l	l	PROPN
ajlm-1028	161	4	,	,	PUNCT
ajlm-1028	161	5	cheung	cheung	PROPN
ajlm-1028	161	6	m	m	PROPN
ajlm-1028	161	7	,	,	PUNCT
ajlm-1028	161	8	boro	boro	PROPN
ajlm-1028	161	9	j	j	PROPN
ajlm-1028	161	10	,	,	PUNCT
ajlm-1028	161	11	ezzat	ezzat	ADJ
ajlm-1028	161	12	h	h	NOUN
ajlm-1028	161	13	,	,	PUNCT
ajlm-1028	161	14	leitch	leitch	PROPN
ajlm-1028	161	15	h.	h.	PROPN
ajlm-1028	161	16	hiv	hiv	PROPN
ajlm-1028	161	17	-	-	PUNCT
ajlm-1028	161	18	associated	associate	VERB
ajlm-1028	161	19	diffuse	diffuse	PROPN
ajlm-1028	161	20	large	large	ADJ
ajlm-1028	161	21	b	b	NOUN
ajlm-1028	161	22	cell	cell	NOUN
ajlm-1028	161	23	lymphoma	lymphoma	NOUN
ajlm-1028	161	24	:	:	PUNCT
ajlm-1028	161	25	determinants	determinant	NOUN
ajlm-1028	161	26	of	of	ADP
ajlm-1028	161	27	survival	survival	NOUN
ajlm-1028	161	28	in	in	ADP
ajlm-1028	161	29	the	the	DET
ajlm-1028	161	30	era	era	NOUN
ajlm-1028	161	31	of	of	ADP
ajlm-1028	161	32	rituximab	rituximab	NOUN
ajlm-1028	161	33	and	and	CCONJ
ajlm-1028	161	34	haart	haart	PROPN
ajlm-1028	161	35	.	.	PUNCT
ajlm-1028	162	1	blood	blood	NOUN
ajlm-1028	162	2	.	.	PUNCT
ajlm-1028	163	1	2010;116(21):2835	2010;116(21):2835	NOUN
ajlm-1028	163	2	.	.	PUNCT
ajlm-1028	164	1	https://doi.org/10.1182/blood.v116.21.2835.2835	https://doi.org/10.1182/blood.v116.21.2835.2835	PROPN
ajlm-1028	164	2	machialo	machialo	PROPN
ajlm-1028	164	3	jt	jt	PROPN
ajlm-1028	164	4	.	.	PUNCT
ajlm-1028	165	1	diffuse	diffuse	VERB
ajlm-1028	165	2	large	large	ADJ
ajlm-1028	165	3	b	b	PROPN
ajlm-1028	165	4	cell	cell	NOUN
ajlm-1028	165	5	lymphoma	lymphoma	NOUN
ajlm-1028	165	6	in	in	ADP
ajlm-1028	165	7	adults	adult	NOUN
ajlm-1028	165	8	at	at	ADP
ajlm-1028	165	9	chris	chris	PROPN
ajlm-1028	165	10	baragwanath	baragwanath	PROPN
ajlm-1028	165	11	hospital	hospital	PROPN
ajlm-1028	166	1	[	[	X
ajlm-1028	166	2	homepage	homepage	NOUN
ajlm-1028	166	3	on	on	ADP
ajlm-1028	166	4	the	the	DET
ajlm-1028	166	5	internet	internet	NOUN
ajlm-1028	166	6	]	]	PUNCT
ajlm-1028	166	7	.	.	PUNCT
ajlm-1028	167	1	johannesburg	johannesburg	PROPN
ajlm-1028	167	2	:	:	PUNCT
ajlm-1028	167	3	witwatersrand	witwatersrand	PROPN
ajlm-1028	167	4	university	university	PROPN
ajlm-1028	167	5	;	;	PUNCT
ajlm-1028	167	6	2016	2016	NUM
ajlm-1028	168	1	[	[	PUNCT
ajlm-1028	168	2	cited	cite	VERB
ajlm-1028	168	3	2018	2018	NUM
ajlm-1028	168	4	aug	aug	NOUN
ajlm-1028	168	5	3	3	NUM
ajlm-1028	168	6	]	]	PUNCT
ajlm-1028	168	7	.	.	PUNCT
ajlm-1028	169	1	available	available	ADJ
ajlm-1028	169	2	from	from	ADP
ajlm-1028	169	3	:	:	PUNCT
ajlm-1028	169	4	http://hdl.handle.net/10539/23175	http://hdl.handle.net/10539/23175	PROPN
ajlm-1028	169	5	al	al	PROPN
ajlm-1028	169	6	-	-	PUNCT
ajlm-1028	169	7	saleem	saleem	PROPN
ajlm-1028	169	8	ti	ti	NOUN
ajlm-1028	169	9	,	,	PUNCT
ajlm-1028	169	10	dulaimi	dulaimi	ADJ
ajlm-1028	169	11	e	e	NOUN
ajlm-1028	169	12	,	,	PUNCT
ajlm-1028	169	13	millenson	millenson	PROPN
ajlm-1028	169	14	mm	mm	PROPN
ajlm-1028	169	15	,	,	PUNCT
ajlm-1028	169	16	smith	smith	PROPN
ajlm-1028	169	17	mr	mr	PROPN
ajlm-1028	169	18	,	,	PUNCT
ajlm-1028	169	19	judd	judd	PROPN
ajlm-1028	169	20	j	j	PROPN
ajlm-1028	169	21	,	,	PUNCT
ajlm-1028	169	22	li	li	PROPN
ajlm-1028	169	23	t	t	PROPN
ajlm-1028	169	24	,	,	PUNCT
ajlm-1028	169	25	borghaei	borghaei	PROPN
ajlm-1028	169	26	h.	h.	PROPN
ajlm-1028	169	27	low	low	PROPN
ajlm-1028	169	28	blood	blood	PROPN
ajlm-1028	169	29	absolute	absolute	PROPN
ajlm-1028	169	30	cd4	cd4	PROPN
ajlm-1028	169	31	counts	count	NOUN
ajlm-1028	169	32	is	be	AUX
ajlm-1028	169	33	associated	associate	VERB
ajlm-1028	169	34	with	with	ADP
ajlm-1028	169	35	inferior	inferior	ADJ
ajlm-1028	169	36	progression	progression	NOUN
ajlm-1028	169	37	free	free	ADJ
ajlm-1028	169	38	survival	survival	NOUN
ajlm-1028	169	39	in	in	ADP
ajlm-1028	169	40	diffuse	diffuse	PROPN
ajlm-1028	169	41	large	large	ADJ
ajlm-1028	169	42	b	b	NOUN
ajlm-1028	169	43	-	-	PUNCT
ajlm-1028	169	44	cell	cell	NOUN
ajlm-1028	169	45	lymphoma	lymphoma	NOUN
ajlm-1028	169	46	independent	independent	ADJ
ajlm-1028	169	47	of	of	ADP
ajlm-1028	169	48	age	age	NOUN
ajlm-1028	169	49	and	and	CCONJ
ajlm-1028	169	50	ipi	ipi	PROPN
ajlm-1028	169	51	.	.	PUNCT
ajlm-1028	169	52	blood	blood	NOUN
ajlm-1028	169	53	.	.	PUNCT
ajlm-1028	170	1	2014;124(21):5420	2014;124(21):5420	NUM
ajlm-1028	170	2	.	.	PUNCT
ajlm-1028	171	1	https://doi.org/10.1182/blood.v124.21.5420.5420	https://doi.org/10.1182/blood.v124.21.5420.5420	PROPN
ajlm-1028	171	2	lim	lim	PROPN
ajlm-1028	171	3	st	st	PROPN
ajlm-1028	171	4	,	,	PUNCT
ajlm-1028	171	5	tao	tao	PROPN
ajlm-1028	171	6	m	m	PROPN
ajlm-1028	171	7	,	,	PUNCT
ajlm-1028	171	8	cheung	cheung	PROPN
ajlm-1028	171	9	yb	yb	PROPN
ajlm-1028	171	10	,	,	PUNCT
ajlm-1028	171	11	rajan	rajan	PROPN
ajlm-1028	171	12	s	s	PROPN
ajlm-1028	171	13	,	,	PUNCT
ajlm-1028	171	14	mann	mann	PROPN
ajlm-1028	171	15	b.	b.	PROPN
ajlm-1028	172	1	can	can	AUX
ajlm-1028	172	2	patients	patient	NOUN
ajlm-1028	172	3	with	with	ADP
ajlm-1028	172	4	early	early	ADJ
ajlm-1028	172	5	-	-	PUNCT
ajlm-1028	172	6	stage	stage	NOUN
ajlm-1028	172	7	diffuse	diffuse	VERB
ajlm-1028	172	8	large	large	ADJ
ajlm-1028	172	9	b	b	NOUN
ajlm-1028	172	10	-	-	PUNCT
ajlm-1028	172	11	cell	cell	NOUN
ajlm-1028	172	12	lymphoma	lymphoma	NOUN
ajlm-1028	172	13	be	be	AUX
ajlm-1028	172	14	treated	treat	VERB
ajlm-1028	172	15	without	without	ADP
ajlm-1028	172	16	bone	bone	NOUN
ajlm-1028	172	17	marrow	marrow	NOUN
ajlm-1028	172	18	biopsy	biopsy	NOUN
ajlm-1028	172	19	?	?	PUNCT
ajlm-1028	173	1	ann	ann	PROPN
ajlm-1028	173	2	oncol	oncol	PROPN
ajlm-1028	173	3	.	.	PUNCT
ajlm-1028	174	1	2005;16(2):215–218	2005;16(2):215–218	NUM
ajlm-1028	174	2	.	.	PUNCT
ajlm-1028	174	3	https://doi.org/10.1093/annonc/mdi050	https://doi.org/10.1093/annonc/mdi050	PROPN
ajlm-1028	174	4	sung	sung	PROPN
ajlm-1028	174	5	hj	hj	PROPN
ajlm-1028	174	6	,	,	PUNCT
ajlm-1028	174	7	kim	kim	PROPN
ajlm-1028	174	8	sj	sj	PROPN
ajlm-1028	174	9	,	,	PUNCT
ajlm-1028	174	10	lee	lee	PROPN
ajlm-1028	174	11	jh	jh	PROPN
ajlm-1028	174	12	,	,	PUNCT
ajlm-1028	174	13	et	et	PROPN
ajlm-1028	174	14	al	al	PROPN
ajlm-1028	174	15	.	.	PUNCT
ajlm-1028	175	1	persistent	persistent	ADJ
ajlm-1028	175	2	anemia	anemia	NOUN
ajlm-1028	175	3	in	in	ADP
ajlm-1028	175	4	a	a	DET
ajlm-1028	175	5	patient	patient	NOUN
ajlm-1028	175	6	with	with	ADP
ajlm-1028	175	7	diffuse	diffuse	PROPN
ajlm-1028	175	8	large	large	ADJ
ajlm-1028	175	9	b	b	NOUN
ajlm-1028	175	10	cell	cell	NOUN
ajlm-1028	175	11	lymphoma	lymphoma	NOUN
ajlm-1028	175	12	:	:	PUNCT
ajlm-1028	175	13	pure	pure	ADJ
ajlm-1028	175	14	red	red	ADJ
ajlm-1028	175	15	cell	cell	NOUN
ajlm-1028	175	16	aplasia	aplasia	NOUN
ajlm-1028	175	17	associated	associate	VERB
ajlm-1028	175	18	with	with	ADP
ajlm-1028	175	19	latent	latent	PROPN
ajlm-1028	175	20	epstein	epstein	PROPN
ajlm-1028	175	21	-	-	PUNCT
ajlm-1028	175	22	barr	barr	PROPN
ajlm-1028	175	23	virus	virus	PROPN
ajlm-1028	175	24	infection	infection	NOUN
ajlm-1028	175	25	in	in	ADP
ajlm-1028	175	26	bone	bone	NOUN
ajlm-1028	175	27	marrow	marrow	NOUN
ajlm-1028	175	28	.	.	PUNCT
ajlm-1028	176	1	j	j	PROPN
ajlm-1028	176	2	korean	korean	PROPN
ajlm-1028	176	3	med	med	PROPN
ajlm-1028	176	4	sci	sci	PROPN
ajlm-1028	176	5	.	.	PUNCT
ajlm-1028	176	6	2007;22:167–170	2007;22:167–170	X
ajlm-1028	176	7	.	.	PUNCT
ajlm-1028	177	1	https://doi.org/10.3346/jkms.2007.22.s.s167	https://doi.org/10.3346/jkms.2007.22.s.s167	PROPN
ajlm-1028	177	2	khan	khan	PROPN
ajlm-1028	177	3	ab	ab	PROPN
ajlm-1028	177	4	,	,	PUNCT
ajlm-1028	177	5	barrington	barrington	PROPN
ajlm-1028	177	6	sf	sf	PROPN
ajlm-1028	177	7	,	,	PUNCT
ajlm-1028	177	8	mikhaeel	mikhaeel	PROPN
ajlm-1028	177	9	ng	ng	PROPN
ajlm-1028	177	10	,	,	PUNCT
ajlm-1028	177	11	et	et	PROPN
ajlm-1028	177	12	al	al	PROPN
ajlm-1028	177	13	.	.	PROPN
ajlm-1028	177	14	pet	pet	PROPN
ajlm-1028	177	15	-	-	PUNCT
ajlm-1028	177	16	ct	ct	PROPN
ajlm-1028	177	17	staging	staging	NOUN
ajlm-1028	177	18	of	of	ADP
ajlm-1028	177	19	dlbcl	dlbcl	NOUN
ajlm-1028	177	20	accurately	accurately	ADV
ajlm-1028	177	21	identifies	identify	VERB
ajlm-1028	177	22	and	and	CCONJ
ajlm-1028	177	23	provides	provide	VERB
ajlm-1028	177	24	new	new	ADJ
ajlm-1028	177	25	insight	insight	NOUN
ajlm-1028	177	26	into	into	ADP
ajlm-1028	177	27	the	the	DET
ajlm-1028	177	28	clinical	clinical	ADJ
ajlm-1028	177	29	significance	significance	NOUN
ajlm-1028	177	30	of	of	ADP
ajlm-1028	177	31	bone	bone	NOUN
ajlm-1028	177	32	marrow	marrow	NOUN
ajlm-1028	177	33	involvement	involvement	NOUN
ajlm-1028	177	34	.	.	PUNCT
ajlm-1028	178	1	blood	blood	NOUN
ajlm-1028	178	2	.	.	PUNCT
ajlm-1028	179	1	2013;122(1):61–67	2013;122(1):61–67	X
ajlm-1028	179	2	.	.	PUNCT
ajlm-1028	179	3	https://doi.org/10.1182/blood-2012-12-473389	https://doi.org/10.1182/blood-2012-12-473389	PROPN
ajlm-1028	179	4	berthet	berthet	PROPN
ajlm-1028	179	5	l	l	PROPN
ajlm-1028	179	6	,	,	PUNCT
ajlm-1028	179	7	cochet	cochet	PROPN
ajlm-1028	179	8	a	a	NOUN
ajlm-1028	179	9	,	,	PUNCT
ajlm-1028	179	10	kanoun	kanoun	PROPN
ajlm-1028	179	11	s	s	PROPN
ajlm-1028	179	12	,	,	PUNCT
ajlm-1028	179	13	et	et	PROPN
ajlm-1028	179	14	al	al	PROPN
ajlm-1028	179	15	.	.	PUNCT
ajlm-1028	180	1	in	in	ADP
ajlm-1028	180	2	newly	newly	ADV
ajlm-1028	180	3	diagnosed	diagnose	VERB
ajlm-1028	180	4	diffuse	diffuse	NOUN
ajlm-1028	180	5	large	large	ADJ
ajlm-1028	180	6	b	b	NOUN
ajlm-1028	180	7	-	-	PUNCT
ajlm-1028	180	8	cell	cell	NOUN
ajlm-1028	180	9	lymphoma	lymphoma	NOUN
ajlm-1028	180	10	,	,	PUNCT
ajlm-1028	180	11	determination	determination	NOUN
ajlm-1028	180	12	of	of	ADP
ajlm-1028	180	13	bone	bone	NOUN
ajlm-1028	180	14	marrow	marrow	PROPN
ajlm-1028	180	15	involvement	involvement	NOUN
ajlm-1028	180	16	with	with	ADP
ajlm-1028	180	17	18f	18f	PROPN
ajlm-1028	180	18	-	-	PUNCT
ajlm-1028	180	19	fdg	fdg	PROPN
ajlm-1028	180	20	pet	pet	PROPN
ajlm-1028	180	21	/	/	SYM
ajlm-1028	180	22	ct	ct	PROPN
ajlm-1028	180	23	provides	provide	VERB
ajlm-1028	180	24	better	well	ADJ
ajlm-1028	180	25	diagnostic	diagnostic	ADJ
ajlm-1028	180	26	performance	performance	NOUN
ajlm-1028	180	27	and	and	CCONJ
ajlm-1028	180	28	prognostic	prognostic	ADJ
ajlm-1028	180	29	stratification	stratification	NOUN
ajlm-1028	180	30	than	than	SCONJ
ajlm-1028	180	31	does	do	AUX
ajlm-1028	180	32	biopsy	biopsy	VERB
ajlm-1028	180	33	.	.	PUNCT
ajlm-1028	181	1	j	j	PROPN
ajlm-1028	181	2	nucl	nucl	PROPN
ajlm-1028	181	3	med	me	VERB
ajlm-1028	181	4	.	.	PUNCT
ajlm-1028	182	1	2013;122(1):61–67	2013;122(1):61–67	X
ajlm-1028	182	2	.	.	PUNCT
ajlm-1028	183	1	https://doi.org/10.2967/jnumed.112.114710	https://doi.org/10.2967/jnumed.112.114710	ADJ